© 2000-2019 QIAGEN. All rights reserved.

Analysis Details for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Workspace	My Projects
Project	AIH_WGCNA
Analysis	Observation 1
Date	Tue Jun 04 22:50:34 PDT 2019
Analysis ID	17897615

Analysis Settings
Cutoff before duplicate resolution	true
Resolve duplicate on	Expression logfoldchange
Color using	Expression logfoldchange
Cutoff for Expression logfoldchange	--
Cutoff for Expression pvalue	--
Reference set	Ingenuity Knowledge Base (Genes Only)
Relationship to include	Direct and Indirect
Includes Endogenous Chemicals	No
Optional Analyses	My Pathways My List
Filter Summary	
Consider only relationships where
confidence = Experimentally Observed

Canonical Pathways for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Ingenuity Canonical Pathways	 -log(p-value)	zScore	Ratio	Molecules
Cardiac Hypertrophy Signaling (Enhanced)	-0E00	NaN	2.01E-03	MAP2K3,	
Xenobiotic Metabolism Signaling	2.07E-01	NaN	3.30E-03	MAP2K3,	
G-Protein Coupled Receptor Signaling	2.23E-01	NaN	3.50E-03	CREB5,	
Colorectal Cancer Metastasis Signaling	2.41E-01	NaN	3.75E-03	BCL2L1,	
Phospholipase C Signaling	2.52E-01	NaN	3.89E-03	CREB5,	
Cardiac Hypertrophy Signaling	2.55E-01	NaN	3.94E-03	MAP2K3,	
EIF2 Signaling	2.82E-01	NaN	4.31E-03	UBA52,	
Role of NFAT in Cardiac Hypertrophy	2.85E-01	NaN	4.37E-03	MAP2K3,	
cAMP-mediated signaling	2.88E-01	NaN	4.41E-03	CREB5,	
Sperm Motility	2.91E-01	NaN	4.44E-03	MAP2K3,	
CREB Signaling in Neurons	2.95E-01	NaN	4.50E-03	CREB5,	
IL-8 Signaling	3.04E-01	NaN	4.65E-03	BCL2L1,	
Adrenomedullin signaling pathway	3.12E-01	NaN	4.76E-03	MAP2K3,	
ERK/MAPK Signaling	3.14E-01	NaN	4.81E-03	CREB5,	
ILK Signaling	3.19E-01	NaN	4.88E-03	CREB5,	
Axonal Guidance Signaling	3.25E-01	NaN	3.99E-03	MME,NTNG2	
Regulation of the Epithelial-Mesenchymal Transition Pathway	3.25E-01	NaN	4.98E-03	MAP2K3,	
Dendritic Cell Maturation	3.33E-01	NaN	5.10E-03	CREB5,	
T Cell Exhaustion Signaling Pathway	3.43E-01	NaN	5.26E-03	BCL6,	
Germ Cell-Sertoli Cell Junction Signaling	3.46E-01	NaN	5.32E-03	MAP2K3,	
HMGB1 Signaling	3.58E-01	NaN	5.52E-03	MAP2K3,	
Acute Phase Response Signaling	3.62E-01	NaN	5.59E-03	MAP2K3,	
eNOS Signaling	3.71E-01	NaN	5.75E-03	AQP9,	
Mitochondrial Dysfunction	3.77E-01	NaN	5.85E-03	SNCA,	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	3.81E-01	NaN	5.92E-03	OAS2,	
Insulin Receptor Signaling	4.21E-01	NaN	6.67E-03	FOXO4,	
Phagosome Maturation	4.25E-01	NaN	6.76E-03	CTSB,	
Aryl Hydrocarbon Receptor Signaling	4.37E-01	NaN	6.99E-03	NFIX,	
Corticotropin Releasing Hormone Signaling	4.37E-01	NaN	6.99E-03	CREB5,	
P2Y Purigenic Receptor Signaling Pathway	4.37E-01	NaN	6.99E-03	CREB5,	
Molecular Mechanisms of Cancer	4.38E-01	NaN	4.98E-03	MAP2K3,BCL2L1	
14-3-3-mediated Signaling	4.39E-01	NaN	7.04E-03	SNCA,	
Protein Kinase A Signaling	4.41E-01	NaN	5.00E-03	CREB5,PYGL	
IL-6 Signaling	4.47E-01	NaN	7.19E-03	MAP2K3,	
Iron homeostasis signaling pathway	4.52E-01	NaN	7.30E-03	SLC25A37,	
Role of Tissue Factor in Cancer	4.57E-01	NaN	7.41E-03	BCL2L1,	
PI3K/AKT Signaling	4.65E-01	NaN	7.58E-03	BCL2L1,	
Fc Epsilon RI Signaling	4.7E-01	NaN	7.69E-03	MAP2K3,	
HIF1α Signaling	4.73E-01	NaN	7.75E-03	SLC2A1,	
Endocannabinoid Neuronal Synapse Pathway	4.76E-01	NaN	7.81E-03	GRINA,	
NGF Signaling	4.76E-01	NaN	7.81E-03	CREB5,	
Rac Signaling	4.78E-01	NaN	7.87E-03	ANK1,	
Pancreatic Adenocarcinoma Signaling	4.87E-01	NaN	8.06E-03	BCL2L1,	
IL-15 Production	4.95E-01	NaN	8.26E-03	MAP2K3,	
LXR/RXR Activation	4.95E-01	NaN	8.26E-03	ABCA1,	
Virus Entry via Endocytic Pathways	4.95E-01	NaN	8.26E-03	AP2A1,	
Neuroprotective Role of THOP1 in Alzheimer's Disease	4.98E-01	NaN	8.33E-03	MME,	
Cholecystokinin/Gastrin-mediated Signaling	5.01E-01	NaN	8.40E-03	MAP2K3,	
Neuropathic Pain Signaling In Dorsal Horn Neurons	5.08E-01	NaN	8.55E-03	GRINA,	
Chronic Myeloid Leukemia Signaling	5.11E-01	NaN	8.62E-03	BCL2L1,	
Glucocorticoid Receptor Signaling	5.16E-01	NaN	5.71E-03	BAG1,BCL2L1	
VEGF Signaling	5.17E-01	NaN	8.77E-03	BCL2L1,	
p53 Signaling	5.2E-01	NaN	8.85E-03	BCL2L1,	
Antioxidant Action of Vitamin C	5.27E-01	NaN	9.01E-03	SLC2A1,	
Type I Diabetes Mellitus Signaling	5.27E-01	NaN	9.01E-03	MAP2K3,	
ErbB Signaling	5.33E-01	NaN	9.17E-03	MAP2K3,	
Melanocyte Development and Pigmentation Signaling	5.37E-01	NaN	9.26E-03	CREB5,	
Gαs Signaling	5.4E-01	NaN	9.35E-03	CREB5,	
Prostate Cancer Signaling	5.43E-01	NaN	9.43E-03	CREB5,	
Acute Myeloid Leukemia Signaling	5.54E-01	NaN	9.71E-03	MAP2K3,	
Sumoylation Pathway	5.54E-01	NaN	9.71E-03	SNCA,	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	5.57E-01	NaN	6.12E-03	CREB5,MAP2K3	
CTLA4 Signaling in Cytotoxic T Lymphocytes	5.61E-01	NaN	9.90E-03	AP2A1,	
TR/RXR Activation	5.65E-01	NaN	1.00E-02	SLC2A1,	
Apoptosis Signaling	5.69E-01	NaN	1.01E-02	BCL2L1,	
LPS-stimulated MAPK Signaling	5.72E-01	NaN	1.02E-02	MAP2K3,	
PEDF Signaling	5.72E-01	NaN	1.02E-02	BCL2L1,	
ATM Signaling	5.76E-01	NaN	1.03E-02	CREB5,	
IL-17 Signaling	5.8E-01	NaN	1.04E-02	MAP2K3,	
TGF-β Signaling	5.8E-01	NaN	1.04E-02	MAP2K3,	
FLT3 Signaling in Hematopoietic Progenitor Cells	5.84E-01	NaN	1.05E-02	CREB5,	
α-Adrenergic Signaling	5.84E-01	NaN	1.05E-02	PYGL,	
JAK/Stat Signaling	5.88E-01	NaN	1.06E-02	BCL2L1,	
Death Receptor Signaling	6E-01	NaN	1.10E-02	PARP9,	
IL-1 Signaling	6E-01	NaN	1.10E-02	MAP2K3,	
Estrogen-Dependent Breast Cancer Signaling	6.04E-01	NaN	1.11E-02	CREB5,	
OX40 Signaling Pathway	6.04E-01	NaN	1.11E-02	BCL2L1,	
IL-15 Signaling	6.17E-01	NaN	1.15E-02	BCL2L1,	
Small Cell Lung Cancer Signaling	6.17E-01	NaN	1.15E-02	BCL2L1,	
GM-CSF Signaling	6.3E-01	NaN	1.19E-02	BCL2L1,	
Role of MAPK Signaling in the Pathogenesis of Influenza	6.39E-01	NaN	1.22E-02	MAP2K3,	
CD40 Signaling	6.44E-01	NaN	1.23E-02	MAP2K3,	
T Helper Cell Differentiation	6.84E-01	NaN	1.37E-02	BCL6,	
ERK5 Signaling	6.89E-01	NaN	1.39E-02	CREB5,	
Melatonin Signaling	6.89E-01	NaN	1.39E-02	MAP2K3,	
Role of IL-17A in Arthritis	7E-01	NaN	1.43E-02	MAP2K3,	
Lymphotoxin β Receptor Signaling	7.06E-01	NaN	1.45E-02	BCL2L1,	
Pyridoxal 5'-phosphate Salvage Pathway	7.29E-01	NaN	1.54E-02	MAP2K3,	
Wnt/Ca+ pathway	7.48E-01	NaN	1.61E-02	CREB5,	
Superpathway of Inositol Phosphate Compounds	7.54E-01	NaN	8.33E-03	ALPL,PHOSPHO1	
Autophagy	7.54E-01	NaN	1.64E-02	CTSB,	
Induction of Apoptosis by HIV1	7.54E-01	NaN	1.64E-02	BCL2L1,	
Retinoic acid Mediated Apoptosis Signaling	7.61E-01	NaN	1.67E-02	PARP9,	
SPINK1 Pancreatic Cancer Pathway	7.61E-01	NaN	1.67E-02	CTSB,	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	7.65E-01	NaN	8.47E-03	ALPL,MAP2K3	
LPS/IL-1 Mediated Inhibition of RXR Function	8E-01	NaN	8.93E-03	ACSL1,ABCA1	
Docosahexaenoic Acid (DHA) Signaling	8.02E-01	NaN	1.85E-02	BCL2L1,	
Osteoarthritis Pathway	8.38E-01	NaN	9.43E-03	ALPL,CREB5	
Calcium Signaling	8.58E-01	NaN	9.71E-03	CREB5,GRINA	
NRF2-mediated Oxidative Stress Response	8.58E-01	NaN	9.71E-03	UBB,MAP2K3	
nNOS Signaling in Neurons	8.58E-01	NaN	2.13E-02	GRINA,	
3-phosphoinositide Biosynthesis	8.61E-01	NaN	9.76E-03	ALPL,PHOSPHO1	
Role of IL-17F in Allergic Inflammatory Airway Diseases	8.76E-01	NaN	2.22E-02	CREB5,	
Stearate Biosynthesis I (Animals)	8.85E-01	NaN	2.27E-02	ACSL1,	
BAG2 Signaling Pathway	8.94E-01	NaN	2.33E-02	CTSB,	
Role of PKR in Interferon Induction and Antiviral Response	9.13E-01	NaN	2.44E-02	MAP2K3,	
Sertoli Cell-Sertoli Cell Junction Signaling	9.3E-01	NaN	1.08E-02	MAP2K3,SPTB	
Ephrin Receptor Signaling	9.53E-01	NaN	1.11E-02	CREB5,GRINA	
GNRH Signaling	9.82E-01	NaN	1.16E-02	CREB5,MAP2K3	
Wnt/β-catenin Signaling	9.82E-01	NaN	1.16E-02	UBA52,UBB	
Ethanol Degradation II	9.9E-01	NaN	2.94E-02	ACSL1,	
Fatty Acid β-oxidation I	1.01E00	NaN	3.12E-02	ACSL1,	
D-myo-inositol-5-phosphate Metabolism	1.03E00	NaN	1.23E-02	ALPL,PHOSPHO1	
Endocannabinoid Cancer Inhibition Pathway	1.04E00	NaN	1.26E-02	CREB5,MAP2K3	
3-phosphoinositide Degradation	1.05E00	NaN	1.27E-02	ALPL,PHOSPHO1	
Hereditary Breast Cancer Signaling	1.06E00	NaN	1.29E-02	UBA52,UBB	
Type II Diabetes Mellitus Signaling	1.06E00	NaN	1.29E-02	ACSL1,ADIPOR1	
Lipid Antigen Presentation by CD1	1.1E00	NaN	3.85E-02	AP2A1,	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	1.12E00	NaN	1.39E-02	ALPL,PHOSPHO1	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	1.12E00	NaN	1.39E-02	ALPL,PHOSPHO1	
Ethanol Degradation IV	1.12E00	NaN	4.00E-02	ACSL1,	
Sirtuin Signaling Pathway	1.18E00	NaN	1.03E-02	ABCA1,FOXO4,SLC2A1	
Endocannabinoid Developing Neuron Pathway	1.19E00	NaN	1.53E-02	CREB5,MAP2K3	
Oxidative Ethanol Degradation III	1.19E00	NaN	4.76E-02	ACSL1,	
Synaptic Long Term Potentiation	1.2E00	NaN	1.55E-02	CREB5,GRINA	
Inflammasome pathway	1.21E00	NaN	5.00E-02	CTSB,	
PTEN Signaling	1.22E00	NaN	1.59E-02	FOXO4,BCL2L1	
p38 MAPK Signaling	1.27E00	NaN	1.69E-02	CREB5,MAP2K3	
Mitochondrial L-carnitine Shuttle Pathway	1.28E00	NaN	5.88E-02	ACSL1,	
γ-linolenate Biosynthesis II (Animals)	1.28E00	NaN	5.88E-02	ACSL1,	
UVA-Induced MAPK Signaling	1.29E00	NaN	1.75E-02	PARP9,BCL2L1	
Parkinson's Signaling	1.31E00	NaN	6.25E-02	SNCA,	
Vitamin-C Transport	1.31E00	NaN	6.25E-02	SLC2A1,	
Fatty Acid Activation	1.39E00	NaN	7.69E-02	ACSL1,	
Glycogen Degradation II	1.39E00	NaN	7.69E-02	PYGL,	
Salvage Pathways of Pyrimidine Ribonucleotides	1.42E00	NaN	2.06E-02	APOBEC3A,MAP2K3	
FGF Signaling	1.46E00	NaN	2.17E-02	CREB5,MAP2K3	
Dolichyl-diphosphooligosaccharide Biosynthesis	1.46E00	NaN	9.09E-02	DPM2,	
Neurotrophin/TRK Signaling	1.5E00	NaN	2.27E-02	CREB5,MAP2K3	
Clathrin-mediated Endocytosis Signaling	1.55E00	NaN	1.44E-02	UBA52,UBB,AP2A1	
Salvage Pathways of Pyrimidine Deoxyribonucleotides	1.6E00	NaN	1.25E-01	APOBEC3A,	
Hypoxia Signaling in the Cardiovascular System	1.64E00	NaN	2.70E-02	UBE2H,CREB5	
PPARα/RXRα Activation	1.65E00	NaN	1.59E-02	ADIPOR1,ABCA1,MAP2K3	
IL-10 Signaling	1.69E00	NaN	2.90E-02	BLVRB,MAP2K3	
Synaptogenesis Signaling Pathway	1.7E00	2.0	1.22E-02	SNCA,CREB5,GRINA,AP2A1	
Neuroinflammation Signaling Pathway	1.76E00	NaN	1.28E-02	SNCA,GLUL,CREB5,GRINA	
Dopamine-DARPP32 Feedback in cAMP Signaling	1.82E00	NaN	1.84E-02	CREB5,GRINA,KCNJ15	
Cancer Drug Resistance By Drug Efflux	1.84E00	NaN	3.45E-02	FOXO4,YBX1	
Glutamate Receptor Signaling	1.85E00	NaN	3.51E-02	GLUL,GRINA	
Acetate Conversion to Acetyl-CoA	1.9E00	NaN	2.50E-01	ACSL1,	
Heme Degradation	1.9E00	NaN	2.50E-01	BLVRB,	
CD27 Signaling in Lymphocytes	1.91E00	NaN	3.77E-02	MAP2K3,BCL2L1	
Protein Ubiquitination Pathway	1.97E00	NaN	1.48E-02	UBA52,UBE2H,UBB,BAG1	
PFKFB4 Signaling Pathway	2.03E00	NaN	4.35E-02	CREB5,MAP2K3	
Opioid Signaling Pathway	2.09E00	2.0	1.60E-02	CREB5,GRINA,MAP2K3,AP2A1	
AMPK Signaling	2.24E00	NaN	1.77E-02	CREB5,FOXO4,MAP2K3,SLC2A1	
Amyotrophic Lateral Sclerosis Signaling	2.26E00	NaN	2.65E-02	GLUL,GRINA,BCL2L1	
Circadian Rhythm Signaling	2.31E00	NaN	6.06E-02	CREB5,GRINA	
B Cell Receptor Signaling	2.45E00	2.0	2.03E-02	BCL6,CREB5,MAP2K3,BCL2L1	
GABA Receptor Signaling	2.47E00	NaN	3.16E-02	UBA52,UBB,AP2A1	
IL-7 Signaling Pathway	2.49E00	NaN	3.23E-02	BCL6,FOXO4,SLC2A1	
Renal Cell Carcinoma Signaling	2.49E00	NaN	3.23E-02	UBA52,UBB,SLC2A1	
Glutamine Biosynthesis I	2.5E00	NaN	1.00E00	GLUL,	
Toll-like Receptor Signaling	2.74E00	NaN	3.95E-02	UBA52,UBB,MAP2K3	
Huntington's Disease Signaling	2.91E00	NaN	1.98E-02	SNCA,UBA52,CREB5,UBB,BCL2L1	
Glycogen Degradation III	3E00	NaN	1.33E-01	MGAM,PYGL	

Upstream Regulators for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Analysis	ID	Upstream Regulator	Expr Log Ratio	Molecule Type	Predicted Activation State	Activation z-score	Notes	Bias Term	Bias-corrected z-score	p-value of overlap	Target molecules in dataset	Mechanistic Network	
Observation 1	 	PRL	 	cytokine	 	1.416	bias	0.672	 	3.04E-07	BAG1,BCL2L1,BCL6,CTSB,DDX60L,GMPR,MME,OAS2,SAMD9L	ESR1,ESR2,FOXO3,PRL,STAT1,STAT3,STAT6	
Observation 1	 	EPO	 	cytokine	 	0.495	bias	0.521	 	3.74E-07	ANK1,BCL2L1,BCL6,BLVRB,BNIP3L,GLUL,SLC4A1,STRADB,YBX1	EPO,FOXO3,GATA1	
Observation 1	 	LGR5	 	transmembrane receptor	 	 	 	 	 	5.64E-07	AQP9,BCL2L1,BLVRB,GLUL	 	
Observation 1	 	HIPK2	 	kinase	 	1.486	bias	0.323	0.766	2.46E-06	ANK1,BCL2L1,SLC25A37,SLC4A1,SPTB	 	
Observation 1	 	dexamethasone	 	chemical drug	 	0.657	 	0.100	0.253	4.69E-06	ACSL1,ADGRG3,ALPL,BAG1,BCL2L1,BCL6,BLVRB,BSG,CRISPLD2,CTSB,GBP5,GLUL,GRINA,IGF2BP2,KCNJ15,MGAM,MME,SLC25A37,SLC2A1,SLC4A1	 	
Observation 1	 	Immunoglobulin	 	complex	Inhibited	-2.789	 	0.028	-2.877	4.80E-06	ACSL1,ADIPOR1,AQP9,BCL2L1,BCL6,BLVRB,CRISPLD2,GMPR,SLC25A37,SLC2A1	BCR (complex),ESR1,FOXO4,Immunoglobulin,PPARG,STAT3,STAT6,TNF	
Observation 1	 	TGM2	 	enzyme	Activated	2.621	bias	0.430	1.494	8.17E-06	ALPL,AQP9,BCL6,DDX60L,OAS2,PARP9,SAMD9L	 	
Observation 1	 	tretinoin	 	chemical - endogenous mammalian	Activated	2.126	bias	0.336	0.857	9.37E-06	ABCA1,ACSL1,ALPL,AQP9,BCL2L1,BCL6,BNIP3L,CTSB,DDX60L,HDGF,MAP2K3,OAS2,OPTN,PARP9,RNF10,SAMD9L,YBX1	ESR1,FOXO3,FOXO4,IFNG,MAX,MYC,PPARG,STAT1,STAT3,STAT6,TGFB1,TNF,tretinoin	
Observation 1	 	FOXO3	 	transcription regulator	 	 	 	 	 	9.80E-06	BCL6,BNIP3L,CTSB,FOXO4,GLUL,MXI1,OPTN,YBX1	 	
Observation 1	 	filgrastim	 	biologic drug	 	0.670	 	-0.240	1.383	1.18E-05	ACSL1,ADGRG3,ALPL,BCL2L1,GBP5,GRINA,IGF2BP2,MGAM,MME	 	
Observation 1	 	KLF1	 	transcription regulator	 	 	 	 	 	1.45E-05	BSG,MPP1,SLC2A1,SPTB	 	
Observation 1	 	GATA1	 	transcription regulator	 	1.649	 	0.168	1.217	4.43E-05	ANK1,BCL2L1,BLVRB,LYL1,SLC4A1,SNCA,SPTB	 	
Observation 1	 	RXRB	 	ligand-dependent nuclear receptor	 	 	 	 	 	8.56E-05	ABCA1,ACSL1,CTSB,SLC6A8	 	
Observation 1	 	temsirolimus	 	chemical drug	 	 	 	 	 	1.01E-04	BCL2L1,SLC2A1	 	
Observation 1	 	bortezomib	 	chemical drug	 	-1.666	 	0.090	-1.885	1.10E-04	ALPL,BCL2L1,BNIP3L,DCAF12,SLC25A37,SNCA	 	
Observation 1	 	CA4	 	enzyme	 	 	 	 	 	1.10E-04	ANK1,SLC4A1,SPTB	 	
Observation 1	 	beta-estradiol	 	chemical - endogenous mammalian	Activated	2.527	bias	0.330	1.324	1.12E-04	ABCA1,ACSL1,ANK1,BAG1,BCL2L1,BCL6,BNIP3L,BSG,CTSB,DPM2,HDGF,LYL1,MME,PYGL,SIAH2,SLC2A1,ST6GALNAC4	ESR1,ESR2,FOXO3,FOXO4,MAX,MYC,NR3C1,PGR,PPARG,STAT3,TGFB1,beta-estradiol,progesterone	
Observation 1	 	anakinra	 	biologic drug	 	 	 	 	 	1.22E-04	GRINA,MAP2K3,SLC25A37	 	
Observation 1	 	enterotoxin B	 	biologic drug	Activated	2.000	bias	1.000	 	1.23E-04	BNIP3L,DCAF12,SLC25A37,SNCA	 	
Observation 1	 	INS	 	other	 	0.000	 	0.147	-0.287	1.43E-04	ADIPOR1,AQP9,BCL2L1,SLC2A1,SNCA	D-glucose,INS,Insulin,MYC,PPARG	
Observation 1	 	everolimus	 	chemical drug	 	 	 	 	 	1.48E-04	ABCA1,BCL2L1,SLC2A1	 	
Observation 1	 	valproic acid	 	chemical drug	 	0.135	 	0.049	0.016	1.51E-04	BAG1,BCL2L1,CTSB,DPM2,GLUL,MME,SIAH2,UBE2H	ESR1,ESR2,NR3C1,beta-estradiol,valproic acid	
Observation 1	 	progesterone	 	chemical - endogenous mammalian	 	0.758	 	0.242	0.086	1.55E-04	ACSL1,ALPL,BCL2L1,BCL6,BSG,GRINA,MAP2K3,MME,SLC2A1	PGR,PPARG,progesterone	
Observation 1	 	IRF4	 	transcription regulator	 	-1.342	bias	-0.398	-0.451	1.57E-04	ALPL,BCL6,SLC2A1,UBE2H,YBX1	 	
Observation 1	 	STAT1	 	transcription regulator	Activated	2.213	bias	0.690	 	1.59E-04	ABCA1,BCL2L1,BCL6,GBP5,OAS2,PARP9,SAMD9L	FOXO3,IFNG,STAT1,STAT3,STAT6	
Observation 1	 	trichostatin A	 	chemical drug	 	-0.073	bias	0.531	 	1.75E-04	ABCA1,ALPL,BAG1,BCL2L1,DPM2,MME,SIAH2,SLC2A1,UBE2H	ESR1,ESR2,PPARG,trichostatin A	
Observation 1	 	NPC1	 	transporter	 	 	 	 	 	1.79E-04	ABCA1,ALPL,CTSB,SNCA	 	
Observation 1	 	IL21	 	cytokine	 	1.000	bias	0.671	 	2.66E-04	BCL2L1,BCL6,BSG,GBP5,OAS2	FOXO3,IL21,STAT1,STAT3,STAT6	
Observation 1	 	INSR	 	kinase	 	 	 	 	 	2.93E-04	ACSL1,BAG1,CTSB,KCNJ15,MXI1,SLC2A1,YBX1	 	
Observation 1	 	LGR4	 	transmembrane receptor	 	 	 	 	 	3.11E-04	AQP9,BLVRB,GLUL	 	
Observation 1	 	NR3C1	 	ligand-dependent nuclear receptor	 	 	 	 	 	3.16E-04	ABCA1,BAG1,BCL2L1,BCL6,BNIP3L,GLUL,RNF10,SIAH2,SNCA	ESR1,ESR2,NR3C1,beta-estradiol	
Observation 1	 	4-hydroxynonenal	 	chemical toxicant	 	 	 	 	 	3.59E-04	BCL2L1,CTSB,MME	 	
Observation 1	 	IFNG	 	cytokine	 	0.976	bias	0.442	-0.492	3.75E-04	ABCA1,ALPL,AQP9,BCL2L1,CTSB,DDX60L,GBP5,GLUL,GMPR,OAS2,OPTN,PARP9,SLC2A1	D-glucose,ESR1,FOXO3,FOXO4,IFNG,MYC,PPARG,SOCS1,STAT1,STAT3,STAT6,TNF	
Observation 1	 	VLDLR	 	transporter	 	 	 	 	 	4.51E-04	ABCA1,SLC2A1	 	
Observation 1	 	PI3K (family)	 	group	 	1.195	bias	0.482	0.255	4.69E-04	ABCA1,FOXO4,SIAH2,SLC2A1	 	
Observation 1	 	pirinixic acid	 	chemical toxicant	 	1.651	bias	0.620	 	5.41E-04	ABCA1,ACSL1,ADIPOR1,AQP9,BSG,CTSB,GLUL	N-cor,pirinixic acid	
Observation 1	 	NCKAP1L	 	other	 	 	 	 	 	5.51E-04	MPP1,SLC4A1	 	
Observation 1	 	STAT3	 	transcription regulator	 	1.135	bias	0.475	-0.097	5.67E-04	BCL2L1,BCL6,BNIP3L,CTSB,GBP5,MXI1,OAS2,SLC2A1	ESR1,FOXO3,FOXO4,IFNG,MYC,PPARG,SRC,STAT1,STAT3,STAT6,TNF	
Observation 1	 	Interferon alpha	 	group	 	1.220	bias	0.642	 	5.79E-04	APOBEC3A,ASCC2,BCL2L1,BCL6,OAS2,PARP9,SAMD9L	IRF7,Interferon alpha,STAT1,STAT3,STAT6	
Observation 1	 	butyric acid	 	chemical - endogenous mammalian	Inhibited	-2.401	 	0.093	-2.623	5.86E-04	BAG1,BCL2L1,HDGF,NUCB1,OAS2,PYGL,SLC2A1	HNF4A,MAX,MYC,butyric acid	
Observation 1	 	Ifn	 	group	 	1.091	bias	0.686	 	6.28E-04	APOBEC3A,BAG1,BCL6,OAS2	 	
Observation 1	 	lipopolysaccharide	 	chemical drug	Activated	2.444	bias	0.499	0.640	6.34E-04	ABCA1,ACSL1,APOBEC3A,BCL2L1,BCL6,CTSB,GBP5,HDGF,KCNJ15,MME,NFIX,OAS2,PARP9,SLC2A1,YBX1	FOXO3,IL13,PGR,PPARG,STAT1,STAT3,STAT6,lipopolysaccharide	
Observation 1	 	NKX2-3	 	transcription regulator	Inhibited	-2.236	 	0.018	-2.277	6.87E-04	ALPL,DDX60L,GMPR,PARP9,SAMD9L	 	
Observation 1	 	LIPE	 	enzyme	 	 	 	 	 	6.89E-04	ABCA1,ACSL1,BCL6,LYL1	 	
Observation 1	 	cholesterol	 	chemical - endogenous mammalian	 	1.385	bias	0.317	0.681	7.61E-04	ABCA1,ACSL1,AQP9,BSG,MME	 	
Observation 1	 	RBBP7	 	transcription regulator	 	 	 	 	 	7.78E-04	LYL1,SLC4A1	 	
Observation 1	 	RV 538	 	chemical reagent	 	 	 	 	 	7.78E-04	ABCA1,BCL2L1	 	
Observation 1	 	rotenone	 	chemical toxicant	 	 	 	 	 	8.66E-04	ADIPOR1,BSG,SNCA	 	
Observation 1	 	NFkB (family)	 	group	 	 	 	 	 	9.05E-04	BCL2L1,BSG	 	
Observation 1	 	ESR1	 	ligand-dependent nuclear receptor	 	0.000	 	0.143	-0.367	1.01E-03	ACSL1,AQP9,BAG1,BCL2L1,BCL6,CTSB,FOXO4,MME,NUCB1,PYGL,SIAH2,SLC6A8	ESR1,ESR2,NR3C1,PPARG,PRL,STAT1,STAT3,beta-estradiol	
Observation 1	 	PNN	 	other	 	 	 	 	 	1.04E-03	BCL2L1,BSG	 	
Observation 1	 	tetrandrine	 	chemical drug	 	 	 	 	 	1.19E-03	BCL2L1,YBX1	 	
Observation 1	 	TCR	 	complex	Activated	2.177	bias	0.633	 	1.29E-03	BCL2L1,BSG,CTSB,SIAH2,SLC2A1,UBA52	MYC,SRC,STAT3,TCR	
Observation 1	 	PPP1R1B	 	phosphatase	 	 	 	 	 	1.34E-03	BCL2L1,SNCA	 	
Observation 1	 	troglitazone	 	chemical drug	 	-0.391	 	0.092	-0.595	1.36E-03	ABCA1,ACSL1,ADIPOR1,BCL2L1,MME,SLC2A1	D-glucose,HNF4A,Insulin,MAX,MYC,PGR,PPARG,troglitazone	
Observation 1	 	cigarette smoke	 	chemical toxicant	 	0.958	bias	0.581	 	1.38E-03	ABCA1,BCL2L1,MAP2K3,OAS2,SLC2A1	ESR1,FOXO3,FOXO4,MAX,MYC,PGR,PPARG,STAT1,STAT3,STAT6,TGFB1,TNF,cigarette smoke	
Observation 1	 	ATG7	 	enzyme	 	 	 	 	 	1.43E-03	ACSL1,CTSB,SLC2A1	ATG7,ESR1,FOXO4,PPARG,STAT3,STAT6,TNF	
Observation 1	 	tyrphostin AG 1478	 	chemical - kinase inhibitor	 	 	 	 	 	1.56E-03	BCL2L1,MME,SLC2A1	EGFR,MYC,PPARG,SRC,STAT3,tyrphostin AG 1478	
Observation 1	 	TGFB1	 	growth factor	 	1.189	bias	0.324	0.104	1.62E-03	ABCA1,AQP9,BCL2L1,BCL6,BNIP3L,BSG,CTSB,GMPR,HDGF,MAP2K3,MXI1,SLC2A1,SLC4A1,YBX1	EGFR,ESR1,ESR2,FOXO3,FOXO4,HNF4A,MAX,MYC,NR3C1,PPARG,STAT1,STAT3,STAT6,TGFB1,TNF,beta-estradiol	
Observation 1	 	KLF13	 	transcription regulator	 	 	 	 	 	1.68E-03	BCL2L1,GYPC	 	
Observation 1	 	PARP9	0.549	enzyme	 	 	 	 	 	1.68E-03	BCL6,OAS2	 	
Observation 1	 	trastuzumab	 	biologic drug	 	 	 	 	 	1.68E-03	BCL2L1,BNIP3L	 	
Observation 1	 	IL13	 	cytokine	 	0.264	bias	0.415	-0.723	1.74E-03	ABCA1,ACSL1,BCL2L1,CTSB,KCNJ15,SNCA	IL13,PGR,PPARG,STAT1,STAT3,STAT6	
Observation 1	 	ammonium chloride	 	chemical drug	 	 	 	 	 	1.87E-03	CTSB,SNCA	 	
Observation 1	 	HTT	 	transcription regulator	 	 	 	 	 	1.96E-03	ABCA1,BCL6,DPM2,GLUL,SLC2A1,SNCA,UBE2H,YBX1	 	
Observation 1	 	ascorbic acid	 	chemical - endogenous mammalian	 	 	 	 	 	2.04E-03	ALPL,BCL2L1,SLC2A1	 	
Observation 1	 	PGR	 	ligand-dependent nuclear receptor	 	1.964	bias	0.632	 	2.05E-03	ACSL1,BCL2L1,BCL6,GLUL,MAP2K3	PGR,PPARG,progesterone	
Observation 1	 	TNFRSF11A	 	transmembrane receptor	 	 	 	 	 	2.06E-03	BCL2L1,MME	 	
Observation 1	 	dihydrotestosterone	 	chemical - endogenous mammalian	 	0.343	bias	0.487	-0.492	2.13E-03	ABCA1,BCL2L1,GLUL,MME,NUCB1,SLC25A37,SLC2A1	EGFR,HNF4A,MAX,MYC,PPARG,STAT3,dihydrotestosterone	
Observation 1	 	MYCN	 	transcription regulator	 	0.447	 	0.213	-0.028	2.18E-03	ABCA1,BCL2L1,MXI1,NUCB1,SLC2A1	 	
Observation 1	 	IRF7	 	transcription regulator	 	1.969	bias	1.000	 	2.21E-03	BCL2L1,GBP5,OAS2,SAMD9L	IRF7,Interferon alpha,STAT1	
Observation 1	 	PD98059	 	chemical - kinase inhibitor	 	-1.021	bias	-0.630	 	2.21E-03	ABCA1,ADIPOR1,BCL2L1,BCL6,CTSB,IGF2BP2,SLC2A1	EGFR,ESR1,FOXO3,FOXO4,HNF4A,MAX,MYC,PD98059,PGR,PPARG,STAT1,STAT3,STAT6,TNF	
Observation 1	 	BTRC	 	enzyme	 	 	 	 	 	2.26E-03	BCL2L1,GLUL	 	
Observation 1	 	PD184352	 	chemical drug	 	 	 	 	 	2.26E-03	BCL2L1,OPTN	 	
Observation 1	 	SP1	 	transcription regulator	 	 	 	 	 	2.30E-03	ABCA1,ACSL1,ALPL,ANK1,BNIP3L,SLC2A1,SPTB	 	
Observation 1	 	Insulin	 	group	 	0.903	bias	0.293	0.203	2.31E-03	ACSL1,ADIPOR1,AQP9,BCL2L1,FKBP8,SLC2A1	D-glucose,Insulin,MYC,PGR,PPARG	
Observation 1	 	SGPL1	 	enzyme	 	 	 	 	 	2.47E-03	ABCA1,BCL2L1	 	
Observation 1	 	6-hydroxydopamine	 	chemical toxicant	 	 	 	 	 	2.52E-03	BCL2L1,BNIP3L,SNCA	6-hydroxydopamine,SNCA,STAT3	
Observation 1	 	FGF19	 	growth factor	 	 	 	 	 	2.61E-03	ACSL1,BCL2L1,MME	 	
Observation 1	 	ESR2	 	ligand-dependent nuclear receptor	 	 	 	 	 	2.63E-03	ABCA1,ANK1,BAG1,BCL2L1,MME,PYGL	ESR1,ESR2,NR3C1,PGR,PPARG,beta-estradiol	
Observation 1	 	TRPS1	 	transcription regulator	 	 	 	 	 	2.69E-03	ALPL,PHOSPHO1	 	
Observation 1	 	thapsigargin	 	chemical toxicant	 	0.577	bias	0.585	 	2.77E-03	ADIPOR1,BCL2L1,BCL6,SLC38A5	 	
Observation 1	 	ERBB4	 	kinase	 	 	 	 	 	2.78E-03	MAP2K3,MXI1,SLC2A1	 	
Observation 1	 	UCN-01	 	chemical drug	 	 	 	 	 	2.92E-03	BAG1,BCL2L1	KRAS,MYC,UCN-01	
Observation 1	 	MAX	 	transcription regulator	 	 	 	 	 	2.97E-03	BCL6,SLC2A1,YBX1	 	
Observation 1	 	MTA2	 	transcription regulator	 	 	 	 	 	3.15E-03	LYL1,SLC4A1	MTA2,RBBP7	
Observation 1	 	Pka catalytic subunit	 	group	 	 	 	 	 	3.15E-03	ABCA1,BCL2L1	PGR,PPARG,Pka catalytic subunit	
Observation 1	 	linolenic acid	 	chemical - endogenous mammalian	 	 	 	 	 	3.15E-03	ACSL1,SNCA	 	
Observation 1	 	HNF4A	 	transcription regulator	Activated	2.000	bias	0.324	1.351	3.18E-03	ACSL1,ADIPOR1,AP2A1,AQP9,BCL2L1,BCL6,BLVRB,CTSB,DPM2,MPP1,NUCB1,PARP9,PYGL,SNX3,YBX1	 	
Observation 1	 	(+)-terpinen-4-ol	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	(-)-gossypol-enriched cottonseed oil	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	1-benzyl-2-phenylbenzimidazole	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	2,2-dichloroacetophenone	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	4-(3',5'-dimethoxybenzyloxy)-6-methoxyquinolin-2(1H)-one	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	4-methoxyhonokiol	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	6-azidomethyl-1-hydroxy-3,8-dimethoxy-9,10-anthraquinone	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	7,8-dihydroxy-4-methylcoumarin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	8-hydrocalamenene	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	AB1	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	ACAT2	 	enzyme	 	 	 	 	 	3.22E-03	ABCA1	 	
Observation 1	 	ACSL1	0.399	enzyme	 	 	 	 	 	3.22E-03	ABCA1	 	
Observation 1	 	AUH-6-96	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	BCYRN1	 	other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	CDC42BPB	 	kinase	 	 	 	 	 	3.22E-03	CTSB	 	
Observation 1	 	CLPTM1L	 	other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	CPEB4	 	other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	CPS49	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	EAPB0203	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	FBXO11	 	enzyme	 	 	 	 	 	3.22E-03	BCL6	 	
Observation 1	 	H9 extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	HO-3867	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	Il2 beta gamma receptor	 	complex	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	JOT01006	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	MAPK substrate-4	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	MCM8	 	enzyme	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	MI-319	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	MPT0B169	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	MPT0G009	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	N-[3-(trifluoromethyl)phenyl]retinamide	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	NBR2	 	other	 	 	 	 	 	3.22E-03	SLC2A1	 	
Observation 1	 	NEK2	 	kinase	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	PTPN13	 	phosphatase	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	RBM25	 	other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	REG1A	 	growth factor	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	REG4	 	other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	RNPS1	 	other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	RRAS	 	enzyme	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	SAIT301	 	biologic drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	SNTB1	 	other	 	 	 	 	 	3.22E-03	ABCA1	 	
Observation 1	 	SPI-112Me	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	STARD3	 	transporter	 	 	 	 	 	3.22E-03	ABCA1	 	
Observation 1	 	STX12	 	other	 	 	 	 	 	3.22E-03	ABCA1	 	
Observation 1	 	TCEAL7	 	transcription regulator	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	TL-77	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	TMEM139	 	other	 	 	 	 	 	3.22E-03	SLC4A1	 	
Observation 1	 	TRAPPC9	 	other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	Timp	 	group	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	WJ9708012	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	ZSCAN21	 	transcription regulator	 	 	 	 	 	3.22E-03	SNCA	 	
Observation 1	 	acetylapoaranotin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	acetylaranotin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	aloin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	alpinetin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	atractylenolide I	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	azide	 	chemical reagent	 	 	 	 	 	3.22E-03	SLC2A1	 	
Observation 1	 	barasertib	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	bisindole-linked pyrrolo[2,1-c][1,4]benzodiazepine 5b	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	bornyl caffeate	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	cardiotoxin III	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	colestimide	 	chemical drug	 	 	 	 	 	3.22E-03	ABCA1	 	
Observation 1	 	deoxyapoaranotin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	depsipeptide	 	chemical - other	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	dianthus chinensis l. ethanol extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	farnesiferol C	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	flacourtia indica methanol extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	fungal taxol	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	galiximab	 	biologic drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	gelam honey	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	gypenoside	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	hederagenin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	heteronemin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	hydroxyaminoindan	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	icariin	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	iodine-131	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	korean red ginseng extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	let-7c mimic	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	liriope platyphylla root part extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	luffa echinata roxb fruit extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	mansonone E	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	melamine	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	miR-135a mimic	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	miR-33-5p (and other miRNAs w/seed UGCAUUG)	 	mature microrna	 	 	 	 	 	3.22E-03	ABCA1	 	
Observation 1	 	miR-4651 (and other miRNAs w/seed GGGGUGG)	 	mature microrna	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	mir-216	 	microrna	 	 	 	 	 	3.22E-03	YBX1	 	
Observation 1	 	mir-491	 	microrna	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	morusin	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	nitidine	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	norcantharidin	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	p-cuminaldehyde	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	pepleomycin	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	persea declinata (bl.) kosterm bark methanolic crude extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	picolog	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	pien tze huang methanol extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	procyanidin B2-3'-O-gallate	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	procyanidin B2-3,3'-di-O-gallate	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	pseudolaric acid B	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	raddeanin A	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	rifamycin SV	 	chemical drug	 	 	 	 	 	3.22E-03	BCL6	 	
Observation 1	 	rocaglaol	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	sargramostim	 	biologic drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	silmitasertib	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	solamargine	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	subditine	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	sun ginseng extract	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	tetraacetyl-phytosphingosine	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	tetracaine	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	tinostamustine	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	uncarinic acid E	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	zinc-citrate	 	chemical reagent	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	ziram	 	chemical toxicant	 	 	 	 	 	3.22E-03	SNCA	 	
Observation 1	 	zuo-jin-wan	 	chemical drug	 	 	 	 	 	3.22E-03	BCL2L1	 	
Observation 1	 	eicosapentenoic acid	 	chemical drug	 	 	 	 	 	3.26E-03	BCL2L1,SLC2A1,SNCA	 	
Observation 1	 	PRKCD	 	kinase	 	1.000	bias	0.475	0.049	3.29E-03	ABCA1,APOBEC3A,BCL2L1,CTSB	MYC,PRKCA,PRKCD,SRC,STAT3	
Observation 1	 	MYC	 	transcription regulator	 	-0.274	bias	0.350	-1.233	3.31E-03	ABCA1,ADIPOR1,BAG1,BCL2L1,BCL6,CTSB,GLUL,NUCB1,SLC2A1,YBX1	HNF4A,MAX,MYC	
Observation 1	 	MYOD1	 	transcription regulator	 	 	 	 	 	3.36E-03	BCL2L1,BCL6,RBM38,SLC2A1	 	
Observation 1	 	CTSB	0.282	peptidase	 	 	 	 	 	3.40E-03	BCL2L1,CTSB	CTSB,SNCA,STAT3	
Observation 1	 	hydroxypropyl-beta-cyclodextrin	 	chemical drug	 	 	 	 	 	3.40E-03	ABCA1,CTSB	 	
Observation 1	 	FOXO4	0.595	transcription regulator	 	 	 	 	 	3.47E-03	BCL2L1,BCL6,SLC2A1	 	
Observation 1	 	choline fenofibrate	 	chemical drug	 	 	 	 	 	3.65E-03	ACSL1,ADIPOR1	 	
Observation 1	 	APOE	 	transporter	 	 	 	 	 	3.90E-03	ABCA1,ACSL1,CTSB,GLUL,MAP2K3	APOE,ESR1,FOXO4,PPARG,STAT3,STAT6,TNF	
Observation 1	 	NPC2	 	transporter	 	 	 	 	 	3.91E-03	CREB5,CTSB	 	
Observation 1	 	SIAH2	0.536	transcription regulator	 	 	 	 	 	4.19E-03	MME,SIAH2	 	
Observation 1	 	betulinic acid	 	chemical drug	 	 	 	 	 	4.19E-03	ABCA1,BCL2L1	 	
Observation 1	 	N-cor	 	group	 	 	 	 	 	4.24E-03	ABCA1,ACSL1,CTSB	ESR1,FOXO4,N-cor,PPARG,STAT3,STAT6,TNF	
Observation 1	 	PPARG	 	ligand-dependent nuclear receptor	 	1.686	bias	0.307	1.169	4.49E-03	ABCA1,ACSL1,BCL2L1,BCL6,PYGL,SLC2A1	ESR1,FOXO4,IL13,MYC,PGR,PPARG,STAT3,STAT6,TNF,progesterone,troglitazone	
Observation 1	 	caffeic acid phenethyl ester	 	chemical drug	 	 	 	 	 	4.60E-03	BAG1,BCL2L1,CTSB	 	
Observation 1	 	NOX4	 	enzyme	 	 	 	 	 	4.75E-03	BCL2L1,SLC2A1	MYC,NOX4,SRC,STAT3	
Observation 1	 	D-glucose	 	chemical - endogenous mammalian	 	-0.522	bias	0.290	-1.260	4.83E-03	ABCA1,ACSL1,ADIPOR1,BCL2L1,CTSB,GLUL,SLC2A1	D-glucose,ESR1,FOXO4,HNF4A,Insulin,MAX,MYC,PGR,PPARG,STAT3,STAT6,TNF	
Observation 1	 	IL3	 	cytokine	 	 	 	 	 	4.89E-03	BCL2L1,BNIP3L,HDGF,SLC2A1,YBX1	 	
Observation 1	 	TNF	 	cytokine	Activated	2.658	bias	0.370	1.400	4.90E-03	ABCA1,ACSL1,AQP9,BCL2L1,BCL6,CRISPLD2,CTSB,FOXO4,MAP2K3,OAS2,OPTN,SLC2A1,UBE2H	D-glucose,FOXO3,FOXO4,IFNG,MAX,MYC,PGR,PPARG,STAT1,STAT3,STAT6,TGFB1,TNF	
Observation 1	 	simvastatin	 	chemical drug	 	 	 	 	 	5.02E-03	ABCA1,BCL2L1,NFIX,ST6GALNAC4	 	
Observation 1	 	TIMP1	 	cytokine	 	 	 	 	 	5.05E-03	BCL2L1,MME	 	
Observation 1	 	alvocidib	 	chemical drug	 	 	 	 	 	5.05E-03	BAG1,BCL2L1	 	
Observation 1	 	Secretase gamma	 	complex	 	 	 	 	 	5.35E-03	MME,SLC2A1	 	
Observation 1	 	bardoxolone	 	chemical drug	 	 	 	 	 	5.35E-03	BCL2L1,UBE2H	 	
Observation 1	 	miR-30c-5p (and other miRNAs w/seed GUAAACA)	 	mature microrna	 	 	 	 	 	5.52E-03	AP2A1,BCL6,NUCB1	 	
Observation 1	 	GAPDH	 	enzyme	 	 	 	 	 	5.67E-03	BCL2L1,OAS2	 	
Observation 1	 	mir-19	 	microrna	 	 	 	 	 	5.67E-03	ABCA1,MAP2K3	 	
Observation 1	 	L-dopa	 	chemical - endogenous mammalian	 	1.134	 	0.111	0.839	5.92E-03	ALPL,BCL2L1,CTSB,FAM210B,SIAH2,SLC2A1,UBXN6	 	
Observation 1	 	SRC	 	kinase	 	 	 	 	 	5.94E-03	BCL2L1,CTSB,SLC2A1	ESR1,FOXO3,FOXO4,HNF4A,MAX,MYC,PPARG,SNCA,SRC,STAT1,STAT3,STAT6,TNF	
Observation 1	 	CRNDE	 	other	 	 	 	 	 	5.99E-03	BCL2L1,FOXO4	 	
Observation 1	 	N-acetyl-L-cysteine	 	chemical drug	 	0.152	bias	-0.578	 	5.99E-03	ADIPOR1,BCL2L1,BSG,SNCA	 	
Observation 1	 	streptozocin	 	chemical drug	 	 	 	 	 	6.08E-03	ADIPOR1,ALPL,AQP9,BCL2L1	Insulin,PPARG,streptozocin	
Observation 1	 	BTK	 	kinase	 	 	 	 	 	6.23E-03	BAG1,BCL2L1,OAS2	 	
Observation 1	 	CD4	 	transmembrane receptor	 	 	 	 	 	6.32E-03	BCL2L1,MME	 	
Observation 1	 	XDH	 	enzyme	 	 	 	 	 	6.32E-03	ABCA1,SLC2A1	 	
Observation 1	 	SNCA	0.461	enzyme	 	-0.152	 	0.151	-0.451	6.37E-03	BCL2L1,CTSB,GBP5,SNCA	FOXO3,SNCA,STAT1,STAT3	
Observation 1	 	oleic acid	 	chemical - endogenous mammalian	 	 	 	 	 	6.38E-03	ABCA1,ACSL1,AQP9	ESR1,FOXO4,PPARG,STAT3,STAT6,TNF,oleic acid	
Observation 1	 	3-hydroxyflavone	 	chemical - endogenous non-mammalian	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	3830403N18Rik/Xlr	 	other	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	4-nitrophenol	 	chemical - endogenous mammalian	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	8-aminoadenosine	 	chemical reagent	 	 	 	 	 	6.42E-03	SLC2A1	 	
Observation 1	 	ALKBH3	 	enzyme	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	Alpha 1 antitrypsin	 	group	 	 	 	 	 	6.42E-03	CTSB	 	
Observation 1	 	Camkk	 	group	 	 	 	 	 	6.42E-03	ABCA1	 	
Observation 1	 	E. coli 011:B4 lipopolysaccharide	 	chemical - endogenous non-mammalian	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	EIF4A3	 	enzyme	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	GSTA1	 	enzyme	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	Gm4836 (includes others)	 	other	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	IBTK	 	other	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	IDE	 	peptidase	 	 	 	 	 	6.42E-03	SNCA	 	
Observation 1	 	IGK	 	other	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	LRP1B	 	transmembrane receptor	 	 	 	 	 	6.42E-03	ABCA1	 	
Observation 1	 	MLIP	 	other	 	 	 	 	 	6.42E-03	SLC2A1	 	
Observation 1	 	NEU2	 	enzyme	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	PREB	 	transcription regulator	 	 	 	 	 	6.42E-03	ABCA1	 	
Observation 1	 	PTPRT	 	phosphatase	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	PTPase	 	group	 	 	 	 	 	6.42E-03	ABCA1	 	
Observation 1	 	Prl3d1 (includes others)	 	other	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	RNF43	 	enzyme	 	 	 	 	 	6.42E-03	GLUL	 	
Observation 1	 	SAP18	 	transcription regulator	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	SD-1008	 	chemical - kinase inhibitor	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	SYCP3	 	other	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	Setd1b	 	other	 	 	 	 	 	6.42E-03	ADIPOR1	 	
Observation 1	 	TJP2	 	kinase	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	TTC39B	 	other	 	 	 	 	 	6.42E-03	ABCA1	 	
Observation 1	 	TXNDC5	 	enzyme	 	 	 	 	 	6.42E-03	CTSB	 	
Observation 1	 	Zingiber officiale ginger extract	 	chemical drug	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	caseamembrin C	 	chemical reagent	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	dacetuzumab	 	biologic drug	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	dibucaine	 	chemical drug	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	dimethyl succinate	 	chemical - endogenous mammalian	 	 	 	 	 	6.42E-03	BSG	 	
Observation 1	 	fedratinib	 	chemical drug	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	ginkgetin	 	chemical - endogenous non-mammalian	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	gliclazide	 	chemical drug	 	 	 	 	 	6.42E-03	SLC2A1	 	
Observation 1	 	glucose oxidase	 	group	 	 	 	 	 	6.42E-03	SLC2A1	 	
Observation 1	 	lynestrenol	 	chemical drug	 	 	 	 	 	6.42E-03	ABCA1	 	
Observation 1	 	malonic acid	 	chemical - endogenous mammalian	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	mefenamic acid	 	chemical drug	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	metacept-1	 	chemical reagent	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	phytic acid	 	chemical - endogenous non-mammalian	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	pinitol	 	chemical drug	 	 	 	 	 	6.42E-03	BCL2L1	 	
Observation 1	 	rutaecarpine	 	chemical - endogenous non-mammalian	 	 	 	 	 	6.42E-03	ABCA1	 	
Observation 1	 	prednisolone	 	chemical drug	Inhibited	-2.000	bias	-0.518	 	6.56E-03	BAG1,BCL2L1,CTSB,SNCA	NR3C1,prednisolone	
Observation 1	 	LY294002	 	chemical - kinase inhibitor	 	-1.812	bias	-0.771	 	6.70E-03	ABCA1,ADIPOR1,BCL2L1,BCL6,BSG,SLC2A1	EGFR,FOXO4,KRAS,LY294002,MYC,NFkB (family),PPARG,STAT3	
Observation 1	 	KITLG	 	growth factor	 	 	 	 	 	6.76E-03	BCL2L1,BLVRB,MME,SLC4A1	 	
Observation 1	 	PRDM1	 	transcription regulator	 	-0.293	 	-0.234	0.159	6.76E-03	ALPL,BCL6,CRISPLD2,SLC25A37	 	
Observation 1	 	TNFSF13	 	cytokine	 	 	 	 	 	7.00E-03	BCL2L1,BCL6	 	
Observation 1	 	PRKCA	 	kinase	 	 	 	 	 	7.00E-03	BCL2L1,BNIP3L,CTSB	FOXO3,MYC,PRKCA,SRC,STAT1,STAT3	
Observation 1	 	TO-901317	 	chemical reagent	 	1.895	bias	0.306	1.315	7.07E-03	ABCA1,ACSL1,ADIPOR1,BCL2L1	D-glucose,Insulin,MYC,N-cor,PGR,PPARG,TO-901317	
Observation 1	 	WT1	 	transcription regulator	 	 	 	 	 	7.07E-03	BCL2L1,MPP1,NUCB1,YBX1	 	
Observation 1	 	AMPK	 	complex	 	 	 	 	 	7.16E-03	SLC2A1,SLC6A8,YBX1	 	
Observation 1	 	FLT3	 	kinase	 	 	 	 	 	7.35E-03	BCL2L1,SLC2A1	 	
Observation 1	 	LG100268	 	chemical reagent	 	 	 	 	 	7.35E-03	ABCA1,BCL2L1	LG100268,PGR,PPARG	
Observation 1	 	PLAUR	 	transmembrane receptor	 	 	 	 	 	7.35E-03	BCL2L1,CTSB	MYC,PLAUR,SRC,STAT3	
Observation 1	 	SET	 	phosphatase	 	 	 	 	 	7.35E-03	BCL2L1,YBX1	 	
Observation 1	 	L-triiodothyronine	 	chemical - endogenous mammalian	 	-0.739	bias	0.300	-1.404	7.82E-03	ABCA1,ACSL1,BNIP3L,PHOSPHO1,PYGL	L-triiodothyronine,PGR,PPARG	
Observation 1	 	STAT6	 	transcription regulator	Activated	2.183	 	0.134	1.891	7.90E-03	ACSL1,BCL2L1,BCL6,CTSB,GBP5	D-glucose,ESR1,FOXO3,FOXO4,IL13,MYC,PPARG,STAT1,STAT3,STAT6,TNF	
Observation 1	 	forskolin	 	chemical toxicant	 	 	 	 	 	7.90E-03	ABCA1,ALPL,BAG1,BNIP3L,CRISPLD2,MAP2K3,SLC2A1	SP1,forskolin	
Observation 1	 	PKM	 	kinase	 	 	 	 	 	8.08E-03	BCL2L1,SLC2A1	EGFR,PKM,PPARG,STAT3	
Observation 1	 	APP	 	other	 	0.446	bias	0.317	-0.240	8.13E-03	ABCA1,BCL2L1,BSG,CTSB,IGF2BP2,MME,MXI1,SNCA	APP,SNCA,STAT3	
Observation 1	 	ABCB6	 	transporter	 	 	 	 	 	8.46E-03	GLRX5,SLC25A37	 	
Observation 1	 	ACVR1	 	kinase	 	 	 	 	 	8.46E-03	ALPL,SAMD9L	 	
Observation 1	 	Lh	 	complex	 	 	 	 	 	8.74E-03	ALPL,BAG1,BNIP3L,MAP2K3	 	
Observation 1	 	KRAS	 	enzyme	 	0.492	 	0.004	0.484	8.78E-03	ABCA1,BAG1,BCL2L1,BSG,GLUL,IGF2BP2	HNF4A,KRAS,MAX,MYC	
Observation 1	 	EGR3	 	transcription regulator	 	 	 	 	 	8.84E-03	BCL2L1,BCL6	 	
Observation 1	 	SMAD1	 	transcription regulator	 	 	 	 	 	8.84E-03	ALPL,BCL2L1	 	
Observation 1	 	advanced glycation end-products	 	chemical - endogenous mammalian	 	 	 	 	 	8.84E-03	ABCA1,BSG	 	
Observation 1	 	EGFR	 	kinase	 	1.199	bias	0.497	0.230	9.23E-03	BCL2L1,BCL6,MME,MXI1,SLC2A1	EGFR,FOXO3,FOXO4,MAX,MYC,PGR,PPARG,STAT1,STAT3,TGFB1	
Observation 1	 	BCR (complex)	 	complex	 	 	 	 	 	9.25E-03	BCL2L1,BCL6,SLC2A1	BCR (complex),ESR1,FOXO3,FOXO4,PGR,PPARG,STAT1,STAT3,STAT6,TNF	
Observation 1	 	VHL	 	transcription regulator	 	 	 	 	 	9.25E-03	BCL2L1,MXI1,SLC2A1	 	
Observation 1	 	3,4-methylenedioxyamphetamine	 	chemical drug	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	ACAT1	 	enzyme	 	 	 	 	 	9.62E-03	ABCA1	 	
Observation 1	 	AGPS	 	enzyme	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	ANKRD1	 	transcription regulator	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	ARHGEF11	 	other	 	 	 	 	 	9.62E-03	ABCA1	 	
Observation 1	 	ARID1B	 	transcription regulator	 	 	 	 	 	9.62E-03	ALPL	 	
Observation 1	 	AZ-960	 	chemical reagent	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	BTG1	 	transcription regulator	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	Beta Secretase	 	group	 	 	 	 	 	9.62E-03	MME	 	
Observation 1	 	CIAPIN1	 	other	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	DUB	 	group	 	 	 	 	 	9.62E-03	ABCA1	 	
Observation 1	 	GLUD1	 	enzyme	 	 	 	 	 	9.62E-03	SLC2A1	 	
Observation 1	 	HSPH1	 	other	 	 	 	 	 	9.62E-03	BCL6	 	
Observation 1	 	Integrin alpha 4 beta 1	 	complex	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	LSS	 	enzyme	 	 	 	 	 	9.62E-03	ABCA1	 	
Observation 1	 	MAP1S	 	enzyme	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	PPP1R3C	 	phosphatase	 	 	 	 	 	9.62E-03	SLC2A1	 	
Observation 1	 	PRMT7	 	enzyme	 	 	 	 	 	9.62E-03	BCL6	 	
Observation 1	 	RBM8A	 	other	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	RPS7	 	other	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	SIVA1	 	other	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	SLC48A1	 	transporter	 	 	 	 	 	9.62E-03	SLC2A1	 	
Observation 1	 	SPTBN1	 	other	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	benzo(a)pyrene 7,8-dihydrodiol	 	chemical toxicant	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	danusertib	 	chemical drug	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	ethyl-3-trifluoromethylbenzyl-alpha-ketoglutarate	 	chemical reagent	 	 	 	 	 	9.62E-03	SLC2A1	 	
Observation 1	 	hyodeoxycholic acid	 	chemical - endogenous mammalian	 	 	 	 	 	9.62E-03	ABCA1	 	
Observation 1	 	interferon beta-1b	 	biologic drug	 	 	 	 	 	9.62E-03	BSG	 	
Observation 1	 	mir-191	 	microrna	 	 	 	 	 	9.62E-03	MXI1	 	
Observation 1	 	navitoclax	 	chemical drug	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	pentosan polysulfate	 	chemical drug	 	 	 	 	 	9.62E-03	ABCA1	 	
Observation 1	 	quisinostat	 	chemical drug	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	stigmasterol	 	chemical - endogenous mammalian	 	 	 	 	 	9.62E-03	ABCA1	 	
Observation 1	 	thiotepa	 	chemical drug	 	 	 	 	 	9.62E-03	BCL2L1	 	
Observation 1	 	SOCS1	 	other	 	 	 	 	 	9.63E-03	BCL2L1,GBP5,OAS2	FOXO3,IFNG,SOCS1,STAT1,STAT3,STAT6	
Observation 1	 	ABCA1	0.467	transporter	 	 	 	 	 	9.64E-03	ABCA1,SLC2A1	 	
Observation 1	 	SPHK1	 	kinase	 	 	 	 	 	9.64E-03	BCL2L1,SLC2A1	 	
Observation 1	 	FSH	 	complex	 	 	 	 	 	9.71E-03	ALPL,BAG1,BNIP3L,MAP2K3,SLC2A1	 	
Observation 1	 	TNFSF11	 	cytokine	 	1.966	bias	0.786	 	1.04E-02	AQP9,BCL2L1,BSG,SLC2A1	 	
Observation 1	 	Hsp70	 	group	 	 	 	 	 	1.05E-02	BCL2L1,SNCA	 	
Observation 1	 	IKZF1	 	transcription regulator	 	 	 	 	 	1.08E-02	BCL2L1,BCL6,NFIX	 	
Observation 1	 	BSG	0.575	transporter	 	 	 	 	 	1.09E-02	BCL2L1,BSG	 	
Observation 1	 	IFN type 1	 	group	 	 	 	 	 	1.09E-02	BCL2L1,BCL6	 	
Observation 1	 	IL24	 	cytokine	 	 	 	 	 	1.09E-02	BCL2L1,BCL6	 	
Observation 1	 	SCARB1	 	transporter	 	 	 	 	 	1.13E-02	ABCA1,SIAH2	 	
Observation 1	 	HIF1A	 	transcription regulator	 	1.953	bias	0.704	 	1.15E-02	AQP9,BCL2L1,BNIP3L,SLC25A37,SLC2A1	 	
Observation 1	 	OSM	 	cytokine	 	0.816	bias	0.396	-0.153	1.15E-02	ABCA1,AQP9,BSG,GLUL,GMPR,PYGL	 	
Observation 1	 	APOA1	 	transporter	 	 	 	 	 	1.17E-02	ABCA1,SLC2A1	 	
Observation 1	 	NCOA1	 	transcription regulator	 	 	 	 	 	1.19E-02	ABCA1,NFIX,SLC2A1	 	
Observation 1	 	FSHR	 	g-protein coupled receptor	 	 	 	 	 	1.22E-02	ADIPOR1,SLC38A5	 	
Observation 1	 	rosiglitazone	 	chemical drug	Activated	2.233	bias	0.361	1.426	1.25E-02	ABCA1,ACSL1,ADIPOR1,OAS2,SLC2A1	 	
Observation 1	 	RELA	 	transcription regulator	 	 	 	 	 	1.26E-02	BCL2L1,BNIP3L,CTSB,OAS2,UBE2H	 	
Observation 1	 	cisplatin	 	chemical drug	 	0.421	bias	0.374	-0.410	1.26E-02	ANK1,BCL2L1,BNIP3L,CTSB,FAM210B,SLC2A1,YBX1	 	
Observation 1	 	IL4	 	cytokine	 	1.968	bias	0.532	 	1.28E-02	ABCA1,ACSL1,BCL2L1,BCL6,BNIP3L,GBP5,LYL1,SLC2A1	 	
Observation 1	 	1-[2,3-bis(furan-2-yl)quinoxalin-6-yl]-3-(4-bromophenyl)urea	 	chemical reagent	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	1-butanol	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.28E-02	ABCA1	 	
Observation 1	 	2-[[4-[(e)-styryl]phenoxy]methyl]oxirane	 	chemical reagent	 	 	 	 	 	1.28E-02	ABCA1	 	
Observation 1	 	6-dimethylaminopurine	 	chemical - endogenous mammalian	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	ABCC9	 	ion channel	 	 	 	 	 	1.28E-02	SLC2A1	 	
Observation 1	 	AKR1C3	 	enzyme	 	 	 	 	 	1.28E-02	SIAH2	 	
Observation 1	 	ARID2	 	transcription regulator	 	 	 	 	 	1.28E-02	ALPL	 	
Observation 1	 	BAG2	 	other	 	 	 	 	 	1.28E-02	CTSB	 	
Observation 1	 	BRD3	 	kinase	 	 	 	 	 	1.28E-02	SLC4A1	 	
Observation 1	 	CANX	 	other	 	 	 	 	 	1.28E-02	ABCA1	 	
Observation 1	 	CTSD	 	peptidase	 	 	 	 	 	1.28E-02	ABCA1	 	
Observation 1	 	CYP8B1	 	enzyme	 	 	 	 	 	1.28E-02	ABCA1	 	
Observation 1	 	EEF2K	 	kinase	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	ENPP1	 	enzyme	 	 	 	 	 	1.28E-02	ALPL	 	
Observation 1	 	HCAR1	 	g-protein coupled receptor	 	 	 	 	 	1.28E-02	BSG	 	
Observation 1	 	IGL	 	other	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	LY5	 	chemical reagent	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	MAD1L1	 	other	 	 	 	 	 	1.28E-02	MXI1	 	
Observation 1	 	MS4A2	 	transmembrane receptor	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	OSGIN1	 	growth factor	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	PAK4	 	kinase	 	 	 	 	 	1.28E-02	CTSB	 	
Observation 1	 	PD 180970	 	chemical - kinase inhibitor	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	PLK3	 	kinase	 	 	 	 	 	1.28E-02	SIAH2	 	
Observation 1	 	RPRD1A	 	other	 	 	 	 	 	1.28E-02	CTSB	 	
Observation 1	 	S3I-1757	 	chemical reagent	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	Stat dimer	 	complex	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	TNK2	 	kinase	 	 	 	 	 	1.28E-02	SIAH2	 	
Observation 1	 	TSN	 	other	 	 	 	 	 	1.28E-02	BCL6	 	
Observation 1	 	durapatite	 	chemical - endogenous mammalian	 	 	 	 	 	1.28E-02	ALPL	 	
Observation 1	 	firtecan pegol	 	chemical drug	 	 	 	 	 	1.28E-02	SLC2A1	 	
Observation 1	 	flavokawain A	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	flavone	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	goserelin	 	biologic drug	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	isoflavone	 	chemical drug	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	methylamine	 	chemical - endogenous mammalian	 	 	 	 	 	1.28E-02	SLC2A1	 	
Observation 1	 	miR-127-3p (miRNAs w/seed CGGAUCC)	 	mature microrna	 	 	 	 	 	1.28E-02	BCL6	 	
Observation 1	 	miR-330-5p (and other miRNAs w/seed CUCUGGG)	 	mature microrna	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	miR-339-5p (and other miRNAs w/seed CCCUGUC)	 	mature microrna	 	 	 	 	 	1.28E-02	BCL6	 	
Observation 1	 	mir-574	 	microrna	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	neopterin	 	chemical - endogenous mammalian	 	 	 	 	 	1.28E-02	ABCA1	 	
Observation 1	 	parbendazole	 	chemical reagent	 	 	 	 	 	1.28E-02	ALPL	 	
Observation 1	 	phenformin	 	chemical drug	 	 	 	 	 	1.28E-02	SLC2A1	 	
Observation 1	 	sepantronium	 	chemical drug	 	 	 	 	 	1.28E-02	BCL2L1	 	
Observation 1	 	SHC1	 	other	 	 	 	 	 	1.31E-02	BCL2L1,MAP2K3	 	
Observation 1	 	BNIP3L	0.376	other	 	 	 	 	 	1.36E-02	ANK1,BCL2L1	 	
Observation 1	 	chloroquine	 	chemical drug	 	 	 	 	 	1.36E-02	BCL2L1,SNCA	 	
Observation 1	 	oblimersen	 	biologic drug	 	 	 	 	 	1.36E-02	BCL2L1,OAS2	 	
Observation 1	 	let-7a-5p (and other miRNAs w/seed GAGGUAG)	 	mature microrna	 	 	 	 	 	1.37E-02	BCL2L1,BSG,IGF2BP2	 	
Observation 1	 	IL5	 	cytokine	 	1.000	bias	0.951	 	1.39E-02	BCL2L1,BCL6,BNIP3L,SLC2A1	 	
Observation 1	 	ELK1	 	transcription regulator	 	 	 	 	 	1.40E-02	BCL2L1,SLC2A1	 	
Observation 1	 	H2AFY	 	other	 	 	 	 	 	1.40E-02	ABCA1,SLC2A1	 	
Observation 1	 	glucagon	 	biologic drug	 	 	 	 	 	1.40E-02	MME,SNX3	 	
Observation 1	 	STAT5A	 	transcription regulator	 	 	 	 	 	1.44E-02	BCL2L1,BCL6,SLC2A1,YBX1	 	
Observation 1	 	mifepristone	 	chemical drug	 	0.000	 	-0.200	0.400	1.44E-02	ALPL,BCL2L1,MME,SLC2A1	 	
Observation 1	 	EGR2	 	transcription regulator	 	 	 	 	 	1.47E-02	BCL6,BNIP3L,MME	 	
Observation 1	 	IFNB1	 	cytokine	 	 	 	 	 	1.47E-02	BCL2L1,GBP5,NFIX,OAS2	 	
Observation 1	 	resveratrol	 	chemical drug	 	-0.371	 	-0.124	-0.128	1.49E-02	BCL2L1,BSG,FOXO4,HDGF	 	
Observation 1	 	SCD	 	enzyme	 	 	 	 	 	1.50E-02	ABCA1,SLC2A1	 	
Observation 1	 	CD38	 	enzyme	 	 	 	 	 	1.52E-02	BCL6,BNIP3L,SLC2A1	 	
Observation 1	 	PTH	 	other	 	 	 	 	 	1.54E-02	ALPL,MME,SNX3	 	
Observation 1	 	ST1926	 	chemical drug	 	 	 	 	 	1.54E-02	SLC25A37,UBA52,YBX1	 	
Observation 1	 	RXRA	 	ligand-dependent nuclear receptor	 	 	 	 	 	1.54E-02	ABCA1,ACSL1,CTSB,SLC6A8	 	
Observation 1	 	CSHL1	 	growth factor	 	 	 	 	 	1.55E-02	BCL6,SLC2A1	 	
Observation 1	 	PPARA	 	ligand-dependent nuclear receptor	 	1.974	bias	0.263	1.454	1.56E-02	ABCA1,ACSL1,AQP9,BCL2L1,GLUL	 	
Observation 1	 	paclitaxel	 	chemical drug	 	 	 	 	 	1.59E-02	APOBEC3A,BCL2L1,GRINA,YBX1	 	
Observation 1	 	BP-1-102	 	chemical reagent	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	CDR2	 	other	 	 	 	 	 	1.60E-02	SLC2A1	 	
Observation 1	 	CREB3L4	 	transcription regulator	 	 	 	 	 	1.60E-02	AQP9	 	
Observation 1	 	DAB1	 	other	 	 	 	 	 	1.60E-02	ABCA1	 	
Observation 1	 	FOXI1	 	transcription regulator	 	 	 	 	 	1.60E-02	SLC4A1	 	
Observation 1	 	HK2	 	kinase	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	HLA-B	 	transmembrane receptor	 	 	 	 	 	1.60E-02	OAS2	 	
Observation 1	 	LRP8	 	transmembrane receptor	 	 	 	 	 	1.60E-02	ABCA1	 	
Observation 1	 	MAP4K1	 	kinase	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	Nrg1	 	other	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	PAPPA	 	peptidase	 	 	 	 	 	1.60E-02	ABCA1	 	
Observation 1	 	PINK1	 	kinase	 	 	 	 	 	1.60E-02	SLC2A1	 	
Observation 1	 	RNF34	 	enzyme	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	RSF1	 	transcription regulator	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	SOAT2	 	enzyme	 	 	 	 	 	1.60E-02	ABCA1	 	
Observation 1	 	STK17B	 	kinase	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	TIMP4	 	other	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	TWSG1	 	other	 	 	 	 	 	1.60E-02	BCL6	 	
Observation 1	 	Vla-4	 	complex	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	Z-VRPR-FMK	 	chemical - protease inhibitor	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	aclarubicin	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	allosamidin	 	chemical reagent	 	 	 	 	 	1.60E-02	ABCA1	 	
Observation 1	 	anthralin	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	atrasentan	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	beta-elemene	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	betulin	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	emetine	 	chemical toxicant	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	hesperidin	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	luminespib	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	lupeol	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	omacetaxine mepesuccinate	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	paxilline	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.60E-02	ABCA1	 	
Observation 1	 	rigosertib	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	tazarotene	 	chemical drug	 	 	 	 	 	1.60E-02	BCL2L1	 	
Observation 1	 	metformin	 	chemical drug	 	 	 	 	 	1.62E-02	ABCA1,ADIPOR1,SLC2A1	 	
Observation 1	 	MAPK8	 	kinase	 	 	 	 	 	1.70E-02	ABCA1,BCL2L1,FOXO4	 	
Observation 1	 	Hif1	 	complex	 	 	 	 	 	1.70E-02	BNIP3L,SLC2A1	 	
Observation 1	 	SIN3A	 	transcription regulator	 	 	 	 	 	1.70E-02	BCL6,MXI1	 	
Observation 1	 	erlotinib	 	chemical drug	 	 	 	 	 	1.70E-02	BCL2L1,MME	 	
Observation 1	 	25-hydroxycholesterol	 	chemical reagent	 	 	 	 	 	1.81E-02	ABCA1,ACSL1	 	
Observation 1	 	Go 6976	 	chemical - kinase inhibitor	 	 	 	 	 	1.81E-02	ABCA1,BCL2L1	 	
Observation 1	 	TNFSF13B	 	cytokine	 	 	 	 	 	1.81E-02	BCL2L1,BCL6	 	
Observation 1	 	IL10RA	 	transmembrane receptor	Inhibited	-2.000	 	0.033	-2.065	1.81E-02	ACSL1,GBP5,PYGL,SLC2A1	 	
Observation 1	 	fluticasone propionate	 	chemical drug	 	 	 	 	 	1.83E-02	AQP9,GBP5,OAS2	 	
Observation 1	 	BSCL2	 	other	 	 	 	 	 	1.86E-02	ACSL1,PYGL	 	
Observation 1	 	IGF1	 	growth factor	 	0.277	bias	0.486	-0.667	1.89E-02	ABCA1,BCL2L1,BSG,MXI1,SLC2A1	 	
Observation 1	 	APBA3	 	transporter	 	 	 	 	 	1.91E-02	SLC2A1	 	
Observation 1	 	BAD	 	other	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	BCL2A1	 	other	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	CD27	 	transmembrane receptor	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	CIMO	 	chemical reagent	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	EFNB1	 	kinase	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	EN2	 	transcription regulator	 	 	 	 	 	1.91E-02	SNCA	 	
Observation 1	 	GPR119	 	g-protein coupled receptor	 	 	 	 	 	1.91E-02	ABCA1	 	
Observation 1	 	GRM5	 	g-protein coupled receptor	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	GSI34	 	chemical reagent	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	IL12RB1	 	transmembrane receptor	 	 	 	 	 	1.91E-02	OAS2	 	
Observation 1	 	Muc4	 	other	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	PADI4	 	enzyme	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	PEBP4	 	other	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	Plin2	 	other	 	 	 	 	 	1.91E-02	SLC2A1	 	
Observation 1	 	RNF17	 	other	 	 	 	 	 	1.91E-02	MXI1	 	
Observation 1	 	RTKN	 	other	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	SLC16A1	 	transporter	 	 	 	 	 	1.91E-02	BSG	 	
Observation 1	 	SLIT2	 	other	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	SRPK1	 	kinase	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	SSPN	 	other	 	 	 	 	 	1.91E-02	CTSB	 	
Observation 1	 	WAC	 	other	 	 	 	 	 	1.91E-02	ALPL	 	
Observation 1	 	WDFY2	 	other	 	 	 	 	 	1.91E-02	SLC2A1	 	
Observation 1	 	ZNRF3	 	enzyme	 	 	 	 	 	1.91E-02	GLUL	 	
Observation 1	 	belinostat	 	chemical drug	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	dieldrin	 	chemical toxicant	 	 	 	 	 	1.91E-02	SNCA	 	
Observation 1	 	equol	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	erismodegib	 	chemical drug	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	ferric nitrilotriacetate	 	chemical toxicant	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	ingenol mebutate	 	chemical drug	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	lestaurtinib	 	chemical drug	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	vinorelbine	 	chemical drug	 	 	 	 	 	1.91E-02	BCL2L1	 	
Observation 1	 	CSF2	 	cytokine	 	1.461	bias	0.784	 	1.99E-02	ABCA1,BCL2L1,BSG,MME,SLC2A1	 	
Observation 1	 	3,3'-diindolylmethane	 	chemical drug	 	 	 	 	 	2.03E-02	BCL2L1,OAS2	 	
Observation 1	 	ITGB3	 	transmembrane receptor	 	 	 	 	 	2.03E-02	BCL2L1,UBA52	 	
Observation 1	 	PLAU	 	peptidase	 	 	 	 	 	2.03E-02	BCL2L1,SLC2A1	 	
Observation 1	 	4-hydroxytamoxifen	 	chemical drug	 	 	 	 	 	2.06E-02	BCL2L1,HDGF,SLC2A1	 	
Observation 1	 	IL18	 	cytokine	 	 	 	 	 	2.06E-02	BCL2L1,BCL6,BSG	 	
Observation 1	 	MAVS	 	other	 	 	 	 	 	2.08E-02	ALPL,OAS2	 	
Observation 1	 	RIPK2	 	kinase	 	 	 	 	 	2.14E-02	ABCA1,ACSL1	 	
Observation 1	 	calphostin C	 	chemical - kinase inhibitor	 	 	 	 	 	2.14E-02	BCL2L1,SLC2A1	 	
Observation 1	 	KLF6	 	transcription regulator	 	 	 	 	 	2.20E-02	BCL2L1,BCL6	 	
Observation 1	 	TCOF1	 	transporter	 	 	 	 	 	2.20E-02	BNIP3L,SLC2A1	 	
Observation 1	 	E. coli serotype 0127B8 lipopolysaccharide	 	chemical - endogenous non-mammalian	 	 	 	 	 	2.21E-02	AQP9,GLUL,GMPR	 	
Observation 1	 	TCF7L2	 	transcription regulator	Activated	2.000	bias	0.881	 	2.22E-02	ACSL1,AQP9,CREB5,GLUL	 	
Observation 1	 	2-mercaptoethanol	 	chemical - endogenous mammalian	 	 	 	 	 	2.23E-02	SLC2A1	 	
Observation 1	 	20alpha-hydroxycholesterol	 	chemical - endogenous mammalian	 	 	 	 	 	2.23E-02	ABCA1	 	
Observation 1	 	24(S),25-epoxycholesterol	 	chemical - endogenous mammalian	 	 	 	 	 	2.23E-02	ABCA1	 	
Observation 1	 	ABL2	 	kinase	 	 	 	 	 	2.23E-02	CTSB	 	
Observation 1	 	ACIN1	 	enzyme	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	AR-A014418	 	chemical reagent	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	CLEC2A	 	other	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	CTSE	 	peptidase	 	 	 	 	 	2.23E-02	CTSB	 	
Observation 1	 	ENO1	 	enzyme	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	GABBR2	 	g-protein coupled receptor	 	 	 	 	 	2.23E-02	GLUL	 	
Observation 1	 	GLP1R	 	g-protein coupled receptor	 	 	 	 	 	2.23E-02	ABCA1	 	
Observation 1	 	GNMT	 	enzyme	 	 	 	 	 	2.23E-02	ABCA1	 	
Observation 1	 	IER3	 	other	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	KD025	 	chemical drug	 	 	 	 	 	2.23E-02	BCL6	 	
Observation 1	 	KHDRBS1	 	transcription regulator	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	LPCAT3	 	enzyme	 	 	 	 	 	2.23E-02	ABCA1	 	
Observation 1	 	LRP2	 	transporter	 	 	 	 	 	2.23E-02	CTSB	 	
Observation 1	 	Muscarinic cholinergic receptor	 	group	 	 	 	 	 	2.23E-02	ALPL	 	
Observation 1	 	NACC1	 	transcription regulator	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	PTGDS	 	enzyme	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	QRFP	 	other	 	 	 	 	 	2.23E-02	ACSL1	 	
Observation 1	 	RHOC	 	enzyme	 	 	 	 	 	2.23E-02	GLUL	 	
Observation 1	 	SDHA	 	enzyme	 	 	 	 	 	2.23E-02	SLC2A1	 	
Observation 1	 	SNED1	 	other	 	 	 	 	 	2.23E-02	SLC2A1	 	
Observation 1	 	TRPV2	 	ion channel	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	WISP1	 	other	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	casticin	 	chemical - endogenous non-mammalian	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	diacerein	 	chemical drug	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	gliotoxin	 	chemical toxicant	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	miR-491-5p (and other miRNAs w/seed GUGGGGA)	 	mature microrna	 	 	 	 	 	2.23E-02	BCL2L1	 	
Observation 1	 	pictilisib	 	chemical drug	 	 	 	 	 	2.23E-02	SLC2A1	 	
Observation 1	 	triacetyl-3-hydroxyphenyladenosine	 	chemical reagent	 	 	 	 	 	2.23E-02	ABCA1	 	
Observation 1	 	PPARGC1B	 	transcription regulator	 	 	 	 	 	2.26E-02	ABCA1,PHOSPHO1	 	
Observation 1	 	minocycline	 	chemical drug	 	 	 	 	 	2.26E-02	BCL2L1,BSG	 	
Observation 1	 	PAX7	 	transcription regulator	 	 	 	 	 	2.31E-02	ABCA1,NFIX	 	
Observation 1	 	GCG	 	other	 	 	 	 	 	2.43E-02	BCL2L1,SLC2A1	 	
Observation 1	 	PTPN11	 	phosphatase	 	 	 	 	 	2.43E-02	BCL2L1,BSG	 	
Observation 1	 	isotretinoin	 	biologic drug	 	 	 	 	 	2.43E-02	ABCA1,BCL2L1	 	
Observation 1	 	NRAS	 	enzyme	 	 	 	 	 	2.44E-02	BCL2L1,RBM38,SLC2A1	 	
Observation 1	 	cocaine	 	chemical drug	 	 	 	 	 	2.44E-02	PITHD1,SIAH2,SNCA	 	
Observation 1	 	Il3	 	cytokine	 	 	 	 	 	2.49E-02	BAG1,BCL2L1	 	
Observation 1	 	3-deazaadenosine	 	chemical reagent	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	AQP4	 	transporter	 	 	 	 	 	2.54E-02	SLC2A1	 	
Observation 1	 	CD8A	 	other	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	COL4A1	 	other	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	CXCR1	 	g-protein coupled receptor	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	FYB1	 	other	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	GCS-100	 	chemical drug	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	GW 5074	 	chemical - kinase inhibitor	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	MED12	 	transcription regulator	 	 	 	 	 	2.54E-02	CREB5	 	
Observation 1	 	N-methyl-3,4-methylenedioxyamphetamine	 	chemical drug	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	NELFCD	 	other	 	 	 	 	 	2.54E-02	BSG	 	
Observation 1	 	PIWIL2	 	enzyme	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	PSIP1	 	transcription regulator	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	RNF40	 	enzyme	 	 	 	 	 	2.54E-02	ALPL	 	
Observation 1	 	SLC25A4	 	transporter	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	TFR2	 	transporter	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	acetone	 	chemical - endogenous mammalian	 	 	 	 	 	2.54E-02	ABCA1	 	
Observation 1	 	ciclopirox olamine	 	chemical drug	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	collagen	 	group	 	 	 	 	 	2.54E-02	BSG	 	
Observation 1	 	glimepiride	 	chemical drug	 	 	 	 	 	2.54E-02	SLC2A1	 	
Observation 1	 	methadone	 	chemical drug	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	oleoylethanolamide	 	chemical - endogenous mammalian	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	pyrophosphate	 	chemical - endogenous mammalian	 	 	 	 	 	2.54E-02	ALPL	 	
Observation 1	 	sobetirome	 	chemical drug	 	 	 	 	 	2.54E-02	SLC4A1	 	
Observation 1	 	tectorigenin	 	chemical - endogenous non-mammalian	 	 	 	 	 	2.54E-02	BCL2L1	 	
Observation 1	 	IL1B	 	cytokine	 	1.965	bias	0.449	1.083	2.56E-02	ALPL,BCL2L1,BCL6,CTSB,OAS2,SLC2A1,SNCA	 	
Observation 1	 	FLT1	 	kinase	 	 	 	 	 	2.62E-02	BNIP3L,UBE2H	 	
Observation 1	 	MAP3K7	 	kinase	 	 	 	 	 	2.62E-02	MAP2K3,OAS2	 	
Observation 1	 	MMP9	 	peptidase	 	 	 	 	 	2.62E-02	BCL2L1,CTSB	 	
Observation 1	 	mir-17	 	microrna	 	 	 	 	 	2.62E-02	ABCA1,MAP2K3	 	
Observation 1	 	rottlerin	 	chemical toxicant	 	 	 	 	 	2.62E-02	ABCA1,APOBEC3A	 	
Observation 1	 	IRF3	 	transcription regulator	 	 	 	 	 	2.67E-02	GBP5,OAS2,SAMD9L	 	
Observation 1	 	PIK3R1	 	kinase	 	 	 	 	 	2.68E-02	BCL2L1,SLC2A1	 	
Observation 1	 	SREBF2	 	transcription regulator	 	 	 	 	 	2.68E-02	ABCA1,ACSL1	 	
Observation 1	 	let-7	 	microrna	 	 	 	 	 	2.70E-02	BCL2L1,IGF2BP2,RBM38	 	
Observation 1	 	etoposide	 	chemical drug	 	 	 	 	 	2.74E-02	BCL2L1,MME,SLC2A1	 	
Observation 1	 	N-Ac-Leu-Leu-norleucinal	 	chemical - protease inhibitor	 	 	 	 	 	2.74E-02	ABCA1,BCL2L1	 	
Observation 1	 	R5020	 	chemical reagent	 	 	 	 	 	2.74E-02	BCL2L1,BCL6	 	
Observation 1	 	ciglitazone	 	chemical drug	 	 	 	 	 	2.74E-02	ABCA1,BCL2L1	 	
Observation 1	 	curcumin	 	chemical drug	 	-1.130	bias	-0.366	-0.434	2.80E-02	ABCA1,BCL2L1,FKBP8,GLUL	 	
Observation 1	 	AICAR	 	chemical - endogenous mammalian	 	 	 	 	 	2.81E-02	ABCA1,FOXO4	 	
Observation 1	 	BMP2	 	growth factor	 	 	 	 	 	2.84E-02	ALPL,BCL2L1,BSG	 	
Observation 1	 	CD 437	 	chemical drug	 	 	 	 	 	2.84E-02	SLC25A37,UBA52,YBX1	 	
Observation 1	 	22(S)-hydroxycholesterol	 	chemical - endogenous mammalian	 	 	 	 	 	2.86E-02	ABCA1	 	
Observation 1	 	CD160	 	transmembrane receptor	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	CD53	 	other	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	Ck2	 	complex	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	EPB41	 	other	 	 	 	 	 	2.86E-02	GYPC	 	
Observation 1	 	GPR183	 	g-protein coupled receptor	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	HBP1	 	transcription regulator	 	 	 	 	 	2.86E-02	CTSB	 	
Observation 1	 	LRRK2	 	kinase	 	 	 	 	 	2.86E-02	SNCA	 	
Observation 1	 	MPL	 	transmembrane receptor	 	 	 	 	 	2.86E-02	SLC2A1	 	
Observation 1	 	NELFA	 	other	 	 	 	 	 	2.86E-02	BSG	 	
Observation 1	 	NELFE	 	other	 	 	 	 	 	2.86E-02	BSG	 	
Observation 1	 	NPC1L1	 	transporter	 	 	 	 	 	2.86E-02	ABCA1	 	
Observation 1	 	Presenilin	 	group	 	 	 	 	 	2.86E-02	FKBP8	 	
Observation 1	 	RPS6KB2	 	kinase	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	SLC18A2	 	transporter	 	 	 	 	 	2.86E-02	SNCA	 	
Observation 1	 	ST6GAL1	 	enzyme	 	 	 	 	 	2.86E-02	SLC2A1	 	
Observation 1	 	TET3	 	enzyme	 	 	 	 	 	2.86E-02	PHOSPHO1	 	
Observation 1	 	TNFRSF17	 	transmembrane receptor	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	TRAF1	 	other	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	TWIST	 	group	 	 	 	 	 	2.86E-02	YBX1	 	
Observation 1	 	UTS2R	 	g-protein coupled receptor	 	 	 	 	 	2.86E-02	ABCA1	 	
Observation 1	 	ammonium trichloro(dioxoethylene-O,O'-)tellurate	 	chemical drug	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	arachidic acid	 	chemical - endogenous mammalian	 	 	 	 	 	2.86E-02	SNCA	 	
Observation 1	 	cholesterol sulfate	 	chemical - endogenous mammalian	 	 	 	 	 	2.86E-02	ABCA1	 	
Observation 1	 	cysteamine	 	chemical drug	 	 	 	 	 	2.86E-02	CTSB	 	
Observation 1	 	cytidylyl-3'-5'-guanosine	 	chemical reagent	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	miR-142-3p (and other miRNAs w/seed GUAGUGU)	 	mature microrna	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	nilotinib	 	chemical drug	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	phosphatidylcholine	 	chemical - endogenous mammalian	 	 	 	 	 	2.86E-02	ABCA1	 	
Observation 1	 	tangeretin	 	chemical - endogenous non-mammalian	 	 	 	 	 	2.86E-02	BCL2L1	 	
Observation 1	 	TCF4	 	transcription regulator	 	 	 	 	 	2.88E-02	BCL6,OPTN,SAMD9L	 	
Observation 1	 	ARNT2	 	transcription regulator	 	 	 	 	 	2.91E-02	GLUL,KCNJ15,SLC2A1	 	
Observation 1	 	FN1	 	enzyme	 	 	 	 	 	2.91E-02	BNIP3L,SLC2A1,UBE2H	 	
Observation 1	 	SCAP	 	other	 	 	 	 	 	2.94E-02	ABCA1,ACSL1	 	
Observation 1	 	TFRC	 	transporter	 	 	 	 	 	2.94E-02	SLC2A1,SNCA	 	
Observation 1	 	PAX6	 	transcription regulator	 	 	 	 	 	3.06E-02	CRISPLD2,DPM2,SNCA	 	
Observation 1	 	5-O-mycolyl-beta-araf-(1->2)-5-O-mycolyl-alpha-araf-(1->1')-glycerol	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.07E-02	ACSL1,AQP9	 	
Observation 1	 	Hsp90	 	group	 	 	 	 	 	3.07E-02	BCL2L1,BCL6	 	
Observation 1	 	IFNL1	 	cytokine	 	 	 	 	 	3.07E-02	DDX60L,OAS2	 	
Observation 1	 	lithium	 	chemical drug	 	 	 	 	 	3.07E-02	BAG1,YBX1	 	
Observation 1	 	mycophenolic acid	 	chemical drug	 	 	 	 	 	3.07E-02	MGAM,MME	 	
Observation 1	 	amphetamine	 	chemical drug	 	 	 	 	 	3.13E-02	BCL2L1,SNCA	 	
Observation 1	 	AEBP1	 	peptidase	 	 	 	 	 	3.17E-02	ABCA1	 	
Observation 1	 	BQ-788	 	biologic drug	 	 	 	 	 	3.17E-02	AQP9	 	
Observation 1	 	FFAR1	 	g-protein coupled receptor	 	 	 	 	 	3.17E-02	SLC2A1	 	
Observation 1	 	IFNL4	 	cytokine	 	 	 	 	 	3.17E-02	OAS2	 	
Observation 1	 	KDM8	 	enzyme	 	 	 	 	 	3.17E-02	SLC2A1	 	
Observation 1	 	LIPA	 	enzyme	 	 	 	 	 	3.17E-02	ABCA1	 	
Observation 1	 	METRNL	 	other	 	 	 	 	 	3.17E-02	ACSL1	 	
Observation 1	 	PF-3084014	 	chemical drug	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	PIM3	 	kinase	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	PPM1D	 	phosphatase	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	RELN	 	peptidase	 	 	 	 	 	3.17E-02	ABCA1	 	
Observation 1	 	SLC6A1	 	transporter	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	Shc	 	group	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	USP9X	 	peptidase	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	allyl isothiocyanate	 	chemical toxicant	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	astressin 2B	 	biologic drug	 	 	 	 	 	3.17E-02	SLC2A1	 	
Observation 1	 	doxazosin	 	chemical drug	 	 	 	 	 	3.17E-02	ABCA1	 	
Observation 1	 	gossypol	 	chemical drug	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	mastoparan	 	chemical toxicant	 	 	 	 	 	3.17E-02	ABCA1	 	
Observation 1	 	pCPT-cAMP	 	chemical - kinase inhibitor	 	 	 	 	 	3.17E-02	ABCA1	 	
Observation 1	 	pevonedistat	 	chemical drug	 	 	 	 	 	3.17E-02	BCL2L1	 	
Observation 1	 	retinol acetate	 	chemical drug	 	 	 	 	 	3.17E-02	ALPL	 	
Observation 1	 	urea	 	chemical - endogenous mammalian	 	 	 	 	 	3.17E-02	GYPC	 	
Observation 1	 	P38 MAPK	 	group	 	1.944	bias	0.813	 	3.19E-02	ABCA1,ANK1,BCL2L1,BNIP3L	 	
Observation 1	 	CCL2	 	cytokine	 	 	 	 	 	3.20E-02	ABCA1,BCL2L1	 	
Observation 1	 	FAS	 	transmembrane receptor	 	 	 	 	 	3.22E-02	BCL2L1,MME,OPTN,SIAH2	 	
Observation 1	 	AREG	 	growth factor	 	 	 	 	 	3.27E-02	BCL2L1,BSG	 	
Observation 1	 	SOCS3	 	phosphatase	 	 	 	 	 	3.27E-02	ABCA1,OAS2	 	
Observation 1	 	COL18A1	 	other	 	 	 	 	 	3.34E-02	BCL2L1,MXI1	 	
Observation 1	 	garcinol	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.34E-02	BCL2L1,BCL6	 	
Observation 1	 	Pkc(s)	 	group	 	 	 	 	 	3.36E-02	ABCA1,BCL2L1,CTSB	 	
Observation 1	 	CDKN1A	 	kinase	 	 	 	 	 	3.40E-02	BCL2L1,CTSB,YBX1	 	
Observation 1	 	palmitic acid	 	chemical - endogenous mammalian	 	 	 	 	 	3.44E-02	ACSL1,BCL2L1,CTSB	 	
Observation 1	 	TAF4	 	transcription regulator	 	 	 	 	 	3.48E-02	BCL2L1,BCL6	 	
Observation 1	 	TCF	 	group	 	 	 	 	 	3.48E-02	BCL2L1,MME	 	
Observation 1	 	phosphate	 	chemical - endogenous mammalian	 	 	 	 	 	3.48E-02	ALPL,MAP2K3	 	
Observation 1	 	AIMP2	 	other	 	 	 	 	 	3.48E-02	SLC2A1	 	
Observation 1	 	APOA2	 	transporter	 	 	 	 	 	3.48E-02	ABCA1	 	
Observation 1	 	CA074-methyl ester	 	chemical reagent	 	 	 	 	 	3.48E-02	CTSB	 	
Observation 1	 	CCNT1	 	transcription regulator	 	 	 	 	 	3.48E-02	SLC2A1	 	
Observation 1	 	IGFBP1	 	other	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	KMUP-1	 	chemical reagent	 	 	 	 	 	3.48E-02	ABCA1	 	
Observation 1	 	LXR ligand-LXR-Retinoic acid-RXRα	 	complex	 	 	 	 	 	3.48E-02	ABCA1	 	
Observation 1	 	MXD1	 	transcription regulator	 	 	 	 	 	3.48E-02	BCL6	 	
Observation 1	 	NLRX1	 	other	 	 	 	 	 	3.48E-02	SLC2A1	 	
Observation 1	 	OSTM1	 	other	 	 	 	 	 	3.48E-02	BCL6	 	
Observation 1	 	PNPT1	 	enzyme	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	SH3KBP1	 	other	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	ST3-Hel2A-2	 	chemical reagent	 	 	 	 	 	3.48E-02	BCL6	 	
Observation 1	 	VEGFC	 	growth factor	 	 	 	 	 	3.48E-02	BAG1	 	
Observation 1	 	cinnamaldehyde	 	chemical toxicant	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	delphinidin	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	hesperetin	 	chemical drug	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	lidocaine	 	chemical drug	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	pimozide	 	chemical drug	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	sorbitol	 	chemical - endogenous mammalian	 	 	 	 	 	3.48E-02	BCL2L1	 	
Observation 1	 	teriflunomide	 	chemical drug	 	 	 	 	 	3.48E-02	BSG	 	
Observation 1	 	ethanol	 	chemical - endogenous mammalian	 	1.011	bias	0.285	0.455	3.52E-02	ABCA1,ADIPOR1,BCL2L1,MME	 	
Observation 1	 	STAT4	 	transcription regulator	 	 	 	 	 	3.60E-02	BCL2L1,BSG,PYGL	 	
Observation 1	 	TAL1	 	transcription regulator	 	 	 	 	 	3.60E-02	BCL6,NTNG2,UBE2H	 	
Observation 1	 	CALCA	 	other	 	 	 	 	 	3.62E-02	MME,SNX3	 	
Observation 1	 	desmopressin	 	biologic drug	 	 	 	 	 	3.62E-02	MME,SNX3	 	
Observation 1	 	ERBB2	 	kinase	 	0.774	bias	0.480	-0.269	3.63E-02	BCL2L1,CTSB,MAP2K3,MME,MXI1,SLC2A1	 	
Observation 1	 	GATA3	 	transcription regulator	 	 	 	 	 	3.68E-02	BCL2L1,BLVRB,GLUL	 	
Observation 1	 	GPD1	 	enzyme	 	 	 	 	 	3.69E-02	ALPL,BCL6	 	
Observation 1	 	PDLIM2	 	other	 	 	 	 	 	3.69E-02	CRISPLD2,MME	 	
Observation 1	 	okadaic acid	 	chemical toxicant	 	 	 	 	 	3.69E-02	BCL2L1,BCL6	 	
Observation 1	 	PSEN1	 	peptidase	 	 	 	 	 	3.78E-02	ACSL1,BSG,MME,SNCA	 	
Observation 1	 	BAG3	 	other	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	CCR7	 	g-protein coupled receptor	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	FCMR	 	other	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	IL16	 	cytokine	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	Il8r	 	group	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	KRT8	 	other	 	 	 	 	 	3.79E-02	SLC4A1	 	
Observation 1	 	MAPK10	 	kinase	 	 	 	 	 	3.79E-02	FOXO4	 	
Observation 1	 	NRG4	 	growth factor	 	 	 	 	 	3.79E-02	ABCA1	 	
Observation 1	 	PAX4	 	transcription regulator	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	PIK3CB	 	kinase	 	 	 	 	 	3.79E-02	SLC2A1	 	
Observation 1	 	PIK3R2	 	kinase	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	PRAME	 	other	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	SORT1	 	g-protein coupled receptor	 	 	 	 	 	3.79E-02	SLC2A1	 	
Observation 1	 	STAR	 	transporter	 	 	 	 	 	3.79E-02	ABCA1	 	
Observation 1	 	buthionine sulfoximine	 	chemical drug	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	cantharidin	 	chemical drug	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	cucurbitacin B	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	embelin	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	glycerol	 	chemical - endogenous mammalian	 	 	 	 	 	3.79E-02	ABCA1	 	
Observation 1	 	quinacrine	 	chemical drug	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	rhein	 	chemical - endogenous non-mammalian	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	ulipristal acetate	 	chemical drug	 	 	 	 	 	3.79E-02	BCL2L1	 	
Observation 1	 	Growth hormone	 	group	 	 	 	 	 	3.80E-02	ACSL1,BCL6,SLC2A1	 	
Observation 1	 	SLC25A13	 	transporter	 	 	 	 	 	3.83E-02	ALPL,BCL6	 	
Observation 1	 	STAT5a/b	 	group	 	 	 	 	 	3.90E-02	BCL2L1,BCL6	 	
Observation 1	 	CD40LG	 	cytokine	 	 	 	 	 	3.93E-02	BCL2L1,BCL6,LYL1,MAP2K3	 	
Observation 1	 	GATA2	 	transcription regulator	 	 	 	 	 	3.96E-02	AQP9,LYL1,SLC4A1,SNCA	 	
Observation 1	 	TLR9	 	transmembrane receptor	 	 	 	 	 	3.97E-02	ABCA1,BCL2L1,OAS2	 	
Observation 1	 	EIF2AK2	 	kinase	 	 	 	 	 	3.98E-02	BCL2L1,PARP9	 	
Observation 1	 	Ifn gamma	 	complex	 	 	 	 	 	3.98E-02	BAG1,BCL2L1	 	
Observation 1	 	TBK1	 	kinase	 	 	 	 	 	3.98E-02	BCL2L1,OAS2	 	
Observation 1	 	aspirin	 	chemical drug	 	 	 	 	 	4.05E-02	ABCA1,BCL2L1	 	
Observation 1	 	clofibrate	 	chemical drug	 	 	 	 	 	4.05E-02	ABCA1,BSG	 	
Observation 1	 	ALK	 	kinase	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	D-alpha-tocopheryl succinate	 	chemical reagent	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	EN1	 	transcription regulator	 	 	 	 	 	4.10E-02	SNCA	 	
Observation 1	 	FABP2	 	transporter	 	 	 	 	 	4.10E-02	ABCA1	 	
Observation 1	 	FH	 	enzyme	 	 	 	 	 	4.10E-02	BLVRB	 	
Observation 1	 	HIF3A	 	transcription regulator	 	 	 	 	 	4.10E-02	SLC2A1	 	
Observation 1	 	IgG2a	 	complex	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	MAPKAP1	 	other	 	 	 	 	 	4.10E-02	OAS2	 	
Observation 1	 	PON1	 	phosphatase	 	 	 	 	 	4.10E-02	ABCA1	 	
Observation 1	 	PPIA	 	enzyme	 	 	 	 	 	4.10E-02	BSG	 	
Observation 1	 	SIRPA	 	phosphatase	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	UGCG	 	enzyme	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	amiloride	 	chemical drug	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	gambogic acid	 	chemical - endogenous non-mammalian	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	harmine	 	chemical - endogenous non-mammalian	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	irinotecan	 	chemical drug	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	ladostigil	 	chemical drug	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	maxacalcitol	 	chemical drug	 	 	 	 	 	4.10E-02	ALPL	 	
Observation 1	 	mir-127	 	microrna	 	 	 	 	 	4.10E-02	BCL6	 	
Observation 1	 	palmitoleic acid	 	chemical - endogenous mammalian	 	 	 	 	 	4.10E-02	ABCA1	 	
Observation 1	 	phencyclidine	 	chemical drug	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	spermine nitric oxide complex	 	chemical toxicant	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	thermozymocidin	 	chemical reagent	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	vatalanib	 	chemical drug	 	 	 	 	 	4.10E-02	BCL2L1	 	
Observation 1	 	TNFSF10	 	cytokine	 	 	 	 	 	4.12E-02	BCL2L1,CTSB	 	
Observation 1	 	TRIM24	 	transcription regulator	 	 	 	 	 	4.12E-02	GLUL,SAMD9L	 	
Observation 1	 	IL17A	 	cytokine	 	 	 	 	 	4.18E-02	BCL2L1,MAP2K3,SLC2A1	 	
Observation 1	 	FGF2	 	growth factor	 	0.192	bias	0.501	 	4.24E-02	BCL2L1,BCL6,FOXO4,SLC2A1	 	
Observation 1	 	ERK	 	group	 	 	 	 	 	4.31E-02	ABCA1,BCL2L1,SLC2A1	 	
Observation 1	 	GW501516	 	chemical drug	 	 	 	 	 	4.35E-02	ABCA1,ACSL1	 	
Observation 1	 	TFAP2A	 	transcription regulator	 	 	 	 	 	4.35E-02	ABCA1,BCL2L1	 	
Observation 1	 	indomethacin	 	chemical drug	 	 	 	 	 	4.40E-02	ACSL1,BCL2L1,BSG	 	
Observation 1	 	methotrexate	 	chemical drug	 	 	 	 	 	4.40E-02	ABCA1,ADIPOR1,BNIP3L	 	
Observation 1	 	BET	 	group	 	 	 	 	 	4.41E-02	SLC4A1	 	
Observation 1	 	Betacatenin/TCF	 	complex	 	 	 	 	 	4.41E-02	ALPL	 	
Observation 1	 	CCL19	 	cytokine	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	DEFB103A/DEFB103B	 	other	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	GADD45B	 	other	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	NDUFA13	 	enzyme	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	NFKBID	 	transcription regulator	 	 	 	 	 	4.41E-02	MAP2K3	 	
Observation 1	 	NPFF	 	other	 	 	 	 	 	4.41E-02	SLC2A1	 	
Observation 1	 	PECAM1	 	other	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	PIAS3	 	transcription regulator	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	RALA	 	enzyme	 	 	 	 	 	4.41E-02	FOXO4	 	
Observation 1	 	SMPD1	 	enzyme	 	 	 	 	 	4.41E-02	CTSB	 	
Observation 1	 	SP7	 	transcription regulator	 	 	 	 	 	4.41E-02	ALPL	 	
Observation 1	 	Tnfsf9	 	other	 	 	 	 	 	4.41E-02	BCL6	 	
Observation 1	 	belnacasan	 	chemical drug	 	 	 	 	 	4.41E-02	SNCA	 	
Observation 1	 	cetuximab	 	biologic drug	 	 	 	 	 	4.41E-02	BNIP3L	 	
Observation 1	 	gamma-tocotrienol	 	chemical drug	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	growth factor	 	group	 	 	 	 	 	4.41E-02	GLUL	 	
Observation 1	 	ibrutinib	 	chemical drug	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	mirtazapine	 	chemical drug	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	noscapine	 	chemical drug	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	selenite	 	chemical toxicant	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	xanthine	 	chemical - endogenous mammalian	 	 	 	 	 	4.41E-02	SLC2A1	 	
Observation 1	 	zeranol	 	chemical - endogenous mammalian	 	 	 	 	 	4.41E-02	BCL2L1	 	
Observation 1	 	ELAVL1	 	other	 	 	 	 	 	4.50E-02	ABCA1,BCL2L1	 	
Observation 1	 	doxorubicin	 	chemical drug	 	 	 	 	 	4.54E-02	BCL2L1,BNIP3L,CTSB,YBX1	 	
Observation 1	 	camptothecin	 	chemical drug	 	 	 	 	 	4.62E-02	BCL2L1,BNIP3L,GRINA,OPTN,SIAH2	 	
Observation 1	 	Esrra	 	transcription regulator	 	 	 	 	 	4.66E-02	PYGL,SLC2A1	 	
Observation 1	 	phenethyl isothiocyanate	 	chemical drug	 	 	 	 	 	4.66E-02	BCL2L1,MAP2K3	 	
Observation 1	 	OGA	 	enzyme	 	0.000	 	-0.090	0.180	4.70E-02	BCL2L1,CREB5,GLUL,PYGL	 	
Observation 1	 	1'-acetoxychavicol acetate	 	chemical reagent	 	 	 	 	 	4.72E-02	BCL2L1	 	
Observation 1	 	24-hydroxycholesterol	 	chemical - endogenous mammalian	 	 	 	 	 	4.72E-02	ABCA1	 	
Observation 1	 	ADP	 	chemical - endogenous mammalian	 	 	 	 	 	4.72E-02	BSG	 	
Observation 1	 	AURKA	 	kinase	 	 	 	 	 	4.72E-02	BCL2L1	 	
Observation 1	 	BDKRB2	 	g-protein coupled receptor	 	 	 	 	 	4.72E-02	SNCA	 	
Observation 1	 	CLCN5	 	ion channel	 	 	 	 	 	4.72E-02	CTSB	 	
Observation 1	 	EHHADH	 	enzyme	 	 	 	 	 	4.72E-02	ACSL1	 	
Observation 1	 	ENPP2	 	enzyme	 	 	 	 	 	4.72E-02	SLC2A1	 	
Observation 1	 	FNDC5	 	other	 	 	 	 	 	4.72E-02	ALPL	 	
Observation 1	 	PPARα-RXRα	 	complex	 	 	 	 	 	4.72E-02	ABCA1	 	
Observation 1	 	TNFSF9	 	cytokine	 	 	 	 	 	4.72E-02	BCL2L1	 	
Observation 1	 	U18666A	 	chemical reagent	 	 	 	 	 	4.72E-02	ABCA1	 	
Observation 1	 	ZBTB33	 	transcription regulator	 	 	 	 	 	4.72E-02	BCL6	 	
Observation 1	 	ZNF148	 	transcription regulator	 	 	 	 	 	4.72E-02	BCL2L1	 	
Observation 1	 	deguelin	 	chemical drug	 	 	 	 	 	4.72E-02	BCL2L1	 	
Observation 1	 	leupeptin	 	chemical - protease inhibitor	 	 	 	 	 	4.72E-02	ABCA1	 	
Observation 1	 	fatty acid	 	chemical - endogenous mammalian	 	 	 	 	 	4.74E-02	ABCA1,SLC2A1	 	
Observation 1	 	pyrrolidine dithiocarbamate	 	chemical reagent	 	 	 	 	 	4.74E-02	BCL2L1,SLC2A1	 	
Observation 1	 	SREBF1	 	transcription regulator	 	 	 	 	 	4.77E-02	ABCA1,ACSL1,BCL2L1	 	
Observation 1	 	methylselenic acid	 	chemical reagent	 	 	 	 	 	4.77E-02	BCL2L1,BLVRB,MAP2K3	 	
Observation 1	 	plicamycin	 	chemical drug	 	 	 	 	 	4.82E-02	ABCA1,BNIP3L	 	

Causal Networks for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Master Regulator	Molecule Type	Expr Log Ratio	Depth	Predicted Activation State	Notes	Activation z-score	p-value of overlap	Network bias-corrected p-value	Participating regulators	Target molecules in dataset	Causal network	Target-connected regulators	Relationships Between Master Regulators(Increases/Downstream)	Relationships Between Master Regulators(Decreases/Downstream)	Relationships Between Master Regulators(Affects/Downstream)	Relationships Between Master Regulators(Increases/Upstream)	Relationships Between Master Regulators(Decreases/Upstream)	Relationships Between Master Regulators(Affects/Upstream)	Relationships Between Master Regulators(Increases/Both)	Relationships Between Master Regulators(Decreases/Both)	Relationships Between Master Regulators(Affects/Both)	
magnesium-adenosine triphosphate	chemical - endogenous mammalian	 	2	 	 	-1.265	3.83E-08	2.00E-04	magnesium-adenosine triphosphate,SRC,TGM2	ALPL,AQP9,BCL2L1,BCL6,CTSB,DDX60L,OAS2,PARP9,SAMD9L,SLC2A1	10 (3)	2	 	 	 	 	TGM2	 	 	 	 	
Immunoglobulin	complex	 	1	Inhibited	 	-2.530	5.89E-08	2.00E-04	Immunoglobulin	ACSL1,ADIPOR1,AQP9,BCL2L1,BCL6,BLVRB,CRISPLD2,GMPR,SLC25A37,SLC2A1	10 (1)	1	BTK,CRLF2,HLA-B,IL13RA1	 	 	IL10RA,IL21,PI3K (family),PRDM1,TNFRSF11A	IGL,IRF7,LILRB3	 	 	 	 	
CD 437	chemical drug	 	2	Activated	 	2.324	1.37E-07	9.00E-04	caspase,CD 437,MAPK14,MAPK8,P38 MAPK,TGM2	ABCA1,ALPL,ANK1,AQP9,BCL6,BNIP3L,DDX60L,FOXO4,GLUL,OAS2,PARP9,SAMD9L,SLC25A37,UBA52,YBX1	15 (6)	6	 	 	 	TGM2	ENO1,SAP18,SET	 	 	 	 	
cysteamine	chemical drug	 	2	 	biased	-0.302	1.97E-07	4.00E-04	CA4,cysteamine,STAT3	ANK1,BCL2L1,BCL6,BNIP3L,CTSB,GBP5,MXI1,OAS2,SLC2A1,SLC4A1,SPTB	11 (3)	3	 	 	 	CA4,PRL	 	 	 	 	 	
WT1	transcription regulator	 	3	 	 	0.365	2.52E-07	7.00E-03	AR,CASP3,caspase,CDK2,CDK4,CDX2,CTNNB1,DICER1,E2F1,EIF2AK2,FGFR1,FOS,FOXO1,mir-21,MYC,PGR,PI3K (complex),PRKCD,PTEN,RALA,RB1,RBL2,SDC1,SMARCA4,SOX2,STAT1,STAT3,TERT,TP53,TP63,WT1	ADIPOR1,ALPL,ANK1,APOBEC3A,BAG1,BCL2L1,BCL6,BNIP3L,FOXO4,GBP5,GLUL,GRINA,IGF2BP2,KCNJ15,MAP2K3,MPP1,MXI1,NUCB1,OAS2,PARP9,PYGL,RBM38,SAMD9L,SLC25A37,SLC2A1,SLC38A5,SNX3,ST6GALNAC4,UBE2H,YBX1	30 (31)	26	bortezomib,enterotoxin B,tretinoin	 	 	BTK,EPO,NR5A1	LSS	 	 	 	 	
Gata	group	 	3	 	 	0.209	3.17E-07	7.60E-03	26s Proteasome,Gata,GATA1,GATA2,GATA3,GATA4,IFNG,IL10,RORA,SPI1,STAT1,STAT3,STAT4	ADIPOR1,ANK1,AQP9,BCL2L1,BLVRB,BNIP3L,BSG,CTSB,DDX60L,GLUL,GMPR,LYL1,MME,MXI1,OAS2,OPTN,PARP9,PYGL,SAMD9L,SLC4A1,SNCA,SPTB,UBE2H	23 (13)	12	 	 	 	 	 	 	 	 	 	
GATA1	transcription regulator	 	2	Activated	biased	2.138	3.47E-07	1.40E-03	GATA1,SPI1,STAT1,STAT3	ABCA1,ANK1,BCL2L1,BLVRB,BNIP3L,LYL1,MME,MXI1,OAS2,SAMD9L,SLC2A1,SLC4A1,SNCA,SPTB	14 (4)	4	KLF13	filgrastim	 	MYCN,STAT4	 	 	 	 	 	
PRDM1	transcription regulator	 	3	 	 	-1.414	5.43E-07	3.60E-03	BAX,BID,CASP3,CASP9,caspase,DICER1,EIF2AK2,IL18,PDCD1,PI3K (family),PRDM1,PRKCD,PTEN,STAT1	ACSL1,ALPL,APOBEC3A,BCL2L1,BCL6,BSG,CRISPLD2,CTSB,FOXO4,GBP5,GLUL,IGF2BP2,PARP9,PYGL,RBM38,SAMD9L,SIAH2,SLC25A37	18 (14)	12	IL21,Immunoglobulin,PRMT7,STAT4,TCR	bortezomib,miR-127-3p (miRNAs w/seed CGGAUCC),TCF7	 	ATG7	BTK,REG1A	 	 	 	 	
EGR3	transcription regulator	 	3	Inhibited	 	-2.043	5.85E-07	2.05E-02	AR,CEBPA,E2F1,EGR3,EIF2AK2,GATA1,HIF1A,Ifn,JUN,mir-21,P38 MAPK,PI3K (complex),RALA,RB1,SPI1,STAT1,STAT3,TGFB1,TP53,TP63	ABCA1,ADIPOR1,ALPL,ANK1,APOBEC3A,AQP9,BAG1,BCL2L1,BCL6,BLVRB,BNIP3L,BSG,FOXO4,HDGF,LYL1,MAP2K3,MME,MXI1,OAS2,PARP9,SAMD9L,SLC25A37,SLC2A1,SLC38A5,SLC4A1,SNCA,SPTB,UBE2H,YBX1	29 (20)	19	 	filgrastim	 	 	 	 	 	 	 	
cucurbitacin B	chemical - endogenous non-mammalian	 	3	 	biased	-0.192	6.71E-07	1.67E-02	AR,BTK,Calmodulin,CASP3,CASP9,caspase,CEBPA,CTNNB1,cucurbitacin B,DICER1,EIF2AK2,ERBB2,FOS,HOXA10,IL18,IRS1,JAK2,mir-21,P38 MAPK,PI3K (complex),PRKCD,PTEN,RALA,SHC1,STAT3,STAT4,TP63	ADIPOR1,ALPL,ANK1,AP2A1,APOBEC3A,BAG1,BCL2L1,BNIP3L,BSG,FOXO4,GBP5,GLUL,IGF2BP2,LYL1,MAP2K3,MME,MXI1,OAS2,PARP9,PHOSPHO1,PYGL,RBM38,SLC25A37,SLC2A1,SLC38A5,SNX3,UBE2H	27 (27)	24	 	 	 	 	 	 	 	 	 	
EPO	cytokine	 	1	 	biased	0.378	7.93E-07	5.00E-04	EPO	ANK1,BCL2L1,BCL6,BNIP3L,SLC4A1,STRADB,YBX1	7 (1)	1	TGM2,tretinoin,WT1	bortezomib	 	Ciap	 	 	 	 	 	
GW501516	chemical drug	 	3	Inhibited	 	-2.117	8.70E-07	1.60E-03	Akt,AMPK,CASP3,CEBPA,CREB1,CREM,DICER1,EIF2AK2,EP300,ERK1/2,EZH2,FOS,GATA1,GW501516,HMGA1,Insulin,IRF3,IRS1,KLF13,MAPK8IP1,mir-21,MITF,PDPK1,PLK3,PRKAA,PRKCQ,RELA,STAT1,STAT3,TNF	ABCA1,AP2A1,BCL6,BNIP3L,CRISPLD2,CTSB,FKBP8,GBP5,GMPR,GYPC,IGF2BP2,LYL1,MME,MXI1,NFIX,OPTN,PARP9,RBM38,SAMD9L,SIAH2,SLC25A37,SLC4A1,SLC6A8,SNCA,SNX3,SPTB,YBX1	27 (30)	27	 	 	 	 	 	 	 	 	 	
bupropion	chemical drug	 	3	 	 	0.243	9.10E-07	5.40E-03	BAX,BID,bupropion,CASP3,caspase,CYP2D6,DICER1,EIF2AK2,IL18,PRKCD,PTEN,SLC18A2,SLC6A4,STAT3,tamoxifen	ACSL1,APOBEC3A,AQP9,BCL2L1,BNIP3L,BSG,CTSB,GBP5,GLUL,IGF2BP2,MXI1,OAS2,PARP9,PYGL,RBM38,SLC2A1,SNCA	17 (15)	12	 	 	 	 	 	 	 	 	 	
IL13RA1	transmembrane receptor	 	3	 	biased	1.347	1.21E-06	2.64E-02	AR,BTK,Calmodulin,ERBB2,FOS,HOXA10,IFNG,IL13RA1,IRS1,JAK2,mir-21,P38 MAPK,PI3K (complex),SHC1,STAT3,STAT4,STAT6,TP63,TYK2	ACSL1,ADIPOR1,ALPL,ANK1,AP2A1,AQP9,BAG1,BCL6,BNIP3L,BSG,CTSB,DDX60L,GBP5,GMPR,MAP2K3,MME,MXI1,OAS2,OPTN,PARP9,PHOSPHO1,PYGL,SLC25A37,SLC2A1,SLC38A5,SNX3,UBE2H	27 (19)	16	 	 	 	Immunoglobulin	 	 	 	 	 	
filgrastim	biologic drug	 	3	 	 	1.604	1.31E-06	3.50E-03	CSF3R,filgrastim,STAT3	ACSL1,ADGRG3,ALPL,BCL2L1,BCL6,BNIP3L,GBP5,GRINA,IGF2BP2,MGAM,MME,MXI1,OAS2,SLC2A1	14 (3)	2	 	 	 	CSF3R,ENO1,FCER1G,GAPDH,HIPK2,TRPS1	CLC,CST5,CYP27A1,EGR3,GATA1,MMP12	 	 	 	 	
TCF/LEF	group	 	3	 	 	1.225	1.33E-06	1.99E-02	Alp,AR,C5,CEBPA,GATA3,HNF1A,LEF1,MYC,MYOD1,PI3K (family),PRDM1,PRL,TCF/LEF,TCF3,TCF7,TCF7L1,TCF7L2	ACSL1,ADIPOR1,ALPL,AQP9,BAG1,BCL2L1,BCL6,BLVRB,CREB5,CRISPLD2,DDX60L,FOXO4,GLUL,GMPR,LYL1,MME,NFIX,NUCB1,SAMD9L,SIAH2,SLC25A37,SLC2A1,SLC38A5,YBX1	24 (17)	12	 	 	 	 	 	 	 	 	 	
MMP12	peptidase	 	3	 	 	0.626	1.66E-06	1.77E-02	APP,AR,CEBPA,CTNNB1,CXCL3,F12,F2,FOS,IGF1R,IL1,IRS1,mir-21,MMP12,MMP2,MMP3,P38 MAPK,PI3K (complex),SERPINA1,STAT1,STAT3,TFPI,TP63	ACSL1,ADIPOR1,ANK1,AP2A1,BCL2L1,BCL6,BNIP3L,BSG,GBP5,GLUL,IGF2BP2,LYL1,MAP2K3,MME,MXI1,OAS2,SAMD9L,SLC25A37,SLC2A1,SLC38A5,SNX3,UBE2H,YBX1	23 (22)	17	IL21,PI3K (family)	filgrastim,N-cor	 	 	 	 	 	 	 	
SRT1720	chemical drug	 	2	 	 	-1.508	1.74E-06	2.30E-03	AMPK,bortezomib,SIRT1,SRT1720	ABCA1,ALPL,BCL2L1,BNIP3L,DCAF12,OAS2,SLC25A37,SLC2A1,SLC6A8,SNCA,YBX1	11 (4)	3	 	 	 	bortezomib	 	 	 	 	 	
HIPK2	kinase	 	1	 	biased	1.342	2.12E-06	1.00E-04	HIPK2	ANK1,BCL2L1,SLC25A37,SLC4A1,SPTB	5 (1)	1	filgrastim	 	 	 	 	 	 	 	 	
propolis	biologic drug	 	3	 	 	1.300	2.53E-06	2.90E-03	26s Proteasome,AMPK,CASP3,CAT,CEBPA,CREB1,DICER1,EIF2AK2,EP300,ESR1,FGFR1,FOS,HIF1A,HNF4A,HSF1,hydrogen peroxide,IL18,ILK,Insulin,IRF3,IRS1,KRAS,mir-21,MLXIPL,MYC,NFE2L2,PI3K (complex),PRKCD,propolis,PTEN,STAT1,STAT3,TP63	ABCA1,ADIPOR1,AP2A1,APOBEC3A,AQP9,BCL6,BNIP3L,BSG,FKBP8,GBP5,GRINA,IGF2BP2,LYL1,MME,MXI1,NUCB1,OAS2,PARP9,PYGL,RBM38,SAMD9L,SIAH2,SLC25A37,SLC4A1,SLC6A8,SNX3,UBB,UBE2H,YBX1	29 (33)	30	 	 	 	 	cholesterol	 	 	 	 	
Ciap	group	 	3	 	 	-1.461	2.56E-06	3.12E-02	AR,CASP3,CEBPA,Ciap,DICER1,E2F1,EIF2AK2,EP300,ERBB2,FOS,HIF1A,HNF4A,IL18,IRS1,mir-21,mir-23,PI3K (complex),PRKCD,STAT1,STAT3,TP53,TP63,TRAF2	ADIPOR1,ALPL,ANK1,AP2A1,APOBEC3A,AQP9,BCL2L1,BCL6,BLVRB,BNIP3L,BSG,CTSB,GBP5,GLUL,IGF2BP2,LYL1,MME,MXI1,OAS2,PARP9,PYGL,RBM38,SAMD9L,SLC25A37,SLC2A1,SLC38A5,SNCA,SNX3,UBE2H,YBX1	30 (23)	22	EPO	 	 	 	 	 	 	 	 	
PRL	cytokine	 	1	 	biased	1.414	2.67E-06	1.10E-03	PRL	BCL2L1,BCL6,CTSB,DDX60L,GMPR,MME,OAS2,SAMD9L	8 (1)	1	cysteamine,Pka catalytic subunit,PREB,tretinoin	L-dopa	 	cholesterol,CTSD,ENO1,ERBB4,IDE,IRF7,SCP2,STAR	AKR1C3	 	 	 	 	
methimazole	chemical drug	 	3	Inhibited	biased	-3.710	2.81E-06	2.14E-02	acetaminophen,AR,benzo(a)pyrene,carbon tetrachloride,CYP1A2,CYP2A6 (includes others),CYP2C9,CYP2D6,CYP2E1,DIO3,EIF2AK2,ethanol,Ifn,IRS1,L-triiodothyronine,LPL,MAPK8,methimazole,P38 MAPK,STAT1,tamoxifen	ABCA1,ACSL1,ANK1,AP2A1,APOBEC3A,AQP9,BAG1,BCL2L1,BCL6,FOXO4,GBP5,GLUL,HDGF,MAP2K3,MME,PARP9,PHOSPHO1,PYGL,SAMD9L,SLC2A1,SLC38A5	21 (21)	15	 	 	 	 	 	 	 	 	 	
bufalin	chemical reagent	 	3	Activated	 	2.200	2.95E-06	1.90E-03	AMPK,APP,AR,bufalin,CASP3,CDK4,DICER1,EIF2AK2,EIF2AK3,ERK1/2,FLT1,GATA1,HIF1A,HNF4A,Insulin,IRF3,IRF7,IRS1,MAPK8,MITF,MLXIPL,PPARA,PRKCD,PTEN,RAC1,STAT1,TNF,WT1	AP2A1,APOBEC3A,AQP9,BCL2L1,BNIP3L,CRISPLD2,CTSB,FKBP8,FOXO4,GMPR,IGF2BP2,MPP1,OPTN,PARP9,PYGL,RBM38,SAMD9L,SLC2A1,SLC38A5,SLC4A1,SLC6A8,SNCA,SPTB,UBE2H,YBX1	25 (28)	24	 	 	 	 	 	 	 	 	 	
CLC	enzyme	 	3	 	biased	1.177	3.06E-06	2.85E-02	AR,BTK,Calmodulin,CEBPA,CLC,CTNNB1,EIF2AK2,ERBB2,FOS,FOXO3,HOXA10,Ifn,IL6ST,IRS1,JAK1,JAK2,MAP3K7,mir-21,MITF,PI3K (complex),RALA,SHC1,STAT1,STAT3,STAT4,TP63,TYK2	ABCA1,ADIPOR1,ALPL,AP2A1,APOBEC3A,BAG1,BCL6,BNIP3L,BSG,FOXO4,GLUL,GMPR,LYL1,MAP2K3,MME,MXI1,OAS2,PARP9,PHOSPHO1,SAMD9L,SLC25A37,SLC2A1,SLC38A5,SNX3,UBE2H,YBX1	26 (27)	22	TGM2,tretinoin	filgrastim	 	 	 	 	 	 	 	
AGO2	translation regulator	 	3	 	 	0.218	3.10E-06	2.99E-02	AGO2,Akt,AR,FOS,FOXO1,GATA1,GATA3,IRS1,LPL,MAPK8,MITF,NFATC1,NFE2L2,RB1,SPI1	ACSL1,ADIPOR1,ANK1,AP2A1,BCL6,BLVRB,CTSB,FOXO4,GLUL,GMPR,LYL1,MAP2K3,MME,MXI1,SLC2A1,SLC38A5,SLC4A1,SNCA,SNX3,SPTB,UBB	21 (15)	13	 	 	 	mir-19,mir-216,miR-30c-5p (and other miRNAs w/seed GUAAACA),miR-339-5p (and other miRNAs w/seed CCCUGUC)	 	 	 	 	 	
CRLF1	other	 	3	 	biased	1.177	3.21E-06	2.97E-02	AR,BTK,Calmodulin,CEBPA,CRLF1,CTNNB1,EIF2AK2,ERBB2,FOS,FOXO3,HOXA10,Ifn,IL6ST,IRS1,JAK1,JAK2,MAP3K7,mir-21,MITF,PI3K (complex),RALA,SHC1,STAT,STAT1,STAT3,STAT4,TP63,TYK2	ABCA1,ADIPOR1,ALPL,AP2A1,APOBEC3A,BAG1,BCL6,BNIP3L,BSG,FOXO4,GLUL,GMPR,LYL1,MAP2K3,MME,MXI1,OAS2,PARP9,PHOSPHO1,SAMD9L,SLC25A37,SLC2A1,SLC38A5,SNX3,UBE2H,YBX1	26 (28)	22	 	valproic acid	 	 	 	 	 	 	 	
KCND2	ion channel	 	3	Activated	biased	2.828	3.55E-06	1.84E-02	APP,AR,Calcineurin protein(s),CEBPA,CREB1,CREM,ERK1/2,ESR1,FOS,GATA1,HIF1A,IRS1,KCND2,mir-21,MITF,MYC,NFE2L2,PPARA,PPP1R1B,RALA,Secretase gamma,SMAD1,STAT1,STAT3,TNF,TP53,TP63	ABCA1,ALPL,ANK1,AP2A1,AQP9,BCL2L1,BCL6,BLVRB,BNIP3L,CRISPLD2,CTSB,FOXO4,GBP5,GMPR,IGF2BP2,LYL1,MME,MXI1,NUCB1,OAS2,OPTN,SAMD9L,SIAH2,SLC25A37,SLC2A1,SLC38A5,SLC4A1,SNCA,SNX3,SPTB,UBB,UBE2H	32 (27)	25	L-dopa	 	 	 	 	 	 	 	 	
PXR ligand-PXR-Retinoic acid-RXRα	complex	 	2	 	 	0.943	4.01E-06	2.31E-02	alitretinoin,FOXO1,NR1I2,PXR ligand-PXR-Retinoic acid-RXRα,RXRA,tretinoin	ABCA1,ACSL1,ADIPOR1,ALPL,AQP9,BCL2L1,BCL6,CTSB,DDX60L,GLUL,HDGF,MAP2K3,MXI1,OAS2,PARP9,RNF10,SAMD9L,YBX1	18 (6)	5	 	 	 	GSTA1	 	 	 	 	 	
HNF1A	transcription regulator	 	3	 	biased	1.671	4.18E-06	2.38E-02	AR,C5,CASP3,CREBBP,D-glucose,DICER1,EIF2AK2,ESR1,FOXO1,G6PC,GATA1,HNF1A,HNF4A,IRF4,KAT2B,KLF13,NFE2L2,P38 MAPK,PI3K (complex),PPARA,PRKCD,PTEN,RB1,RBL2,RELA,STAT3,TP53	ADIPOR1,ALPL,APOBEC3A,AQP9,BAG1,BCL2L1,BCL6,BLVRB,BNIP3L,FOXO4,GLUL,GYPC,IGF2BP2,LYL1,MAP2K3,MXI1,NFIX,NUCB1,PARP9,PYGL,RBM38,SLC38A5,SLC4A1,SLC6A8,SNCA,SPTB,UBB,UBE2H,YBX1	29 (27)	23	 	tretinoin	 	GSTA1,INS,Muc4,SOAT2	cholesterol	 	 	 	 	
DUOX1	enzyme	 	3	 	biased	1.461	4.30E-06	3.54E-02	AGT,AR,CREB1,DUOX1,EGFR,EPB41,ERBB2,ERBB4,ESR1,FOS,FOXO3,IFNG,Insulin,IRS1,KRAS,mir-21,P38 MAPK,PI3K (family),PRKCD,PTPN1,SHC1,STAT3,STAT6,TP63	ACSL1,ANK1,AP2A1,APOBEC3A,BAG1,BCL2L1,BCL6,BNIP3L,CREB5,CTSB,DDX60L,FKBP8,GBP5,GMPR,GYPC,IGF2BP2,MAP2K3,NUCB1,OAS2,OPTN,PARP9,SIAH2,SLC25A37,SLC2A1,SLC38A5,SLC6A8,SNCA,SNX3,UBE2H,YBX1	30 (24)	22	 	 	 	 	 	 	 	 	 	
ruthenium red	chemical reagent	 	3	Inhibited	biased	-2.683	4.69E-06	3.20E-02	ABCG1,AKT1,calpain,CASP3,CASP8,caspase,DICER1,EIF2AK2,IL18,IL1B,MAPK8,NFkB (complex),P38 MAPK,PRKCD,PTEN,RB1,ruthenium red,STAT1,TAC1	ACSL1,ALPL,ANK1,APOBEC3A,BCL2L1,BNIP3L,BSG,FOXO4,GBP5,GLUL,IGF2BP2,MAP2K3,MME,OAS2,PARP9,PYGL,RBM38,SAMD9L,SLC2A1,SNCA	20 (19)	16	 	 	 	 	 	 	 	 	 	
palmitoleic acid	chemical - endogenous mammalian	 	3	 	 	0.784	5.13E-06	4.50E-03	APP,AR,CASP3,CEBPA,CREB1,CREM,DICER1,E2F1,EIF2AK2,ERK1/2,FFAR4,FOS,FOXO1,GATA1,HNF4A,IDE,Insulin,IRF3,IRF7,MAPK8,MITF,palmitoleic acid,PEBP1,PRKCD,PTEN,SMAD1,TNF	ABCA1,ADIPOR1,ALPL,APOBEC3A,BCL2L1,BLVRB,CRISPLD2,CTSB,FKBP8,FOXO4,GMPR,IGF2BP2,LYL1,MXI1,OPTN,PARP9,PYGL,RBM38,SAMD9L,SIAH2,SLC38A5,SLC4A1,SNCA,SNX3,SPTB,UBE2H	26 (27)	26	 	 	 	 	IDE	 	 	 	 	
IL-2R	complex	 	3	 	biased	1.768	5.23E-06	1.78E-02	AR,CREB1,EIF2AK2,EP300,ESR1,EZH2,FGFR1,FOS,GATA3,HIF1A,Ifn,IFNG,IKZF1,IL-2R,IL10RA,IL2,IL2RA,ILK,IRS1,JAK1,JAK3,KRAS,LCK,mir-21,MYC,NFE2L2,PI3K (complex),PI3K (family),PIK3CA,PIK3CB,PIK3CD,PRKCD,PTEN,STAT1,STAT3,STAT4,STAT5a/b,STAT6,SYK,TCR,ZAP70	ACSL1,ADIPOR1,ALPL,AP2A1,APOBEC3A,AQP9,BCL2L1,BLVRB,BNIP3L,CRISPLD2,CTSB,DDX60L,GMPR,GRINA,IGF2BP2,MME,MXI1,NFIX,NUCB1,OAS2,OPTN,PARP9,PYGL,SAMD9L,SIAH2,SLC25A37,SLC2A1,SLC38A5,SLC4A1,SNX3,UBA52,UBB	32 (41)	33	TCR	 	 	 	 	 	 	 	 	
GATA1	transcription regulator	 	1	 	biased	1.890	5.54E-06	9.00E-04	GATA1	ANK1,BCL2L1,BLVRB,LYL1,SLC4A1,SNCA,SPTB	7 (1)	1	KLF13	filgrastim	 	MYCN,STAT4	 	 	 	 	 	
IL22RA2	transmembrane receptor	 	3	 	 	-1.964	5.70E-06	4.66E-02	AR,CEBPA,CTNNB1,EIF2AK2,FOS,Ifn,IL22,IL22RA2,mir-21,P38 MAPK,PI3K (complex),RALA,STAT1,STAT3,TP63	ABCA1,ACSL1,ADIPOR1,ANK1,APOBEC3A,BAG1,BCL2L1,BCL6,BNIP3L,FOXO4,GLUL,LYL1,MXI1,OAS2,PARP9,SAMD9L,SLC25A37,SLC2A1,SLC38A5,SNX3,UBE2H	21 (15)	14	 	 	 	 	HLA-B	 	 	 	 	
STAT4	transcription regulator	 	2	 	biased	1.698	6.32E-06	2.83E-02	DDX58,GATA3,IFNG,STAT3,STAT4	ABCA1,ALPL,AQP9,BCL2L1,BCL6,BLVRB,BNIP3L,BSG,CTSB,DDX60L,GLUL,GMPR,MXI1,OPTN,PARP9,PYGL,SLC2A1	17 (5)	5	GATA1,Ifn,SET,TCR	IL21,NPC2,progesterone	 	IL10RA,PRDM1,SRPK1	 	 	 	 	 	
TCR	complex	 	2	 	biased	1.732	6.50E-06	4.15E-02	AMPK,CD5,CREB1,FOS,HSF1,IFNG,IL2,JINK1/2,MAP3K7,MAPK10,MAPK8,P38 MAPK,PI3K (complex),PRKCA,RELA,SHC1,STAT1,STAT3,STAT4,STAT6,TCR	ACSL1,ADIPOR1,ANK1,AQP9,BAG1,BCL2L1,BNIP3L,BSG,CTSB,DDX60L,FOXO4,GLUL,GMPR,MAP2K3,MME,MXI1,OPTN,PARP9,PYGL,SAMD9L,SIAH2,SLC2A1,SLC6A8,SNX3,UBA52,UBB,YBX1	27 (21)	21	antigen	 	 	CTSD,IL-2R,PRDM1,STAT4,USP21	 	 	 	 	 	
TGM2	enzyme	 	1	Activated	biased	2.646	7.06E-06	7.00E-04	TGM2	ALPL,AQP9,BCL6,DDX60L,OAS2,PARP9,SAMD9L	7 (1)	1	CD 437,PI3K (family),TO-901317,tretinoin	magnesium-adenosine triphosphate,MYCN,valproic acid	 	cholesterol,CLC,EPO,FCER1G,HDL-cholesterol,HLA-B,NPC2,PARP9	 	 	 	 	 	
PRMT1/PRMT2	group	 	3	Activated	biased	2.294	7.72E-06	2.13E-02	ESR1,let-7,P38 MAPK,PRMT1,PRMT1/PRMT2,PRMT2,Retinoic acid-RAR-RXR,TP53,tretinoin	ABCA1,ACSL1,ALPL,ANK1,AQP9,BAG1,BCL6,BNIP3L,DDX60L,FOXO4,GLUL,HDGF,IGF2BP2,MAP2K3,MME,NUCB1,OAS2,PARP9,RBM38,RNF10,SAMD9L,SLC6A8,YBX1	23 (9)	5	 	 	 	 	 	 	 	 	 	
Prl3d1 (includes others)	other	 	2	 	biased	1.265	8.09E-06	8.00E-03	PRKCD,Prl3d1 (includes others),STAT3	ABCA1,APOBEC3A,BCL2L1,BCL6,BNIP3L,CTSB,GBP5,MXI1,OAS2,SLC2A1	10 (3)	2	 	 	 	 	 	 	 	 	 	
KA2237	chemical drug	 	3	 	biased	-0.500	8.70E-06	2.46E-02	Akt,AURKB,BTK,FOXO3,HRAS,KA2237,PI3K (complex),PI3K (family),PIK3CB,PIK3CD,PTEN	ABCA1,ACSL1,ADIPOR1,ANK1,BAG1,BCL2L1,BCL6,BNIP3L,CTSB,FOXO4,MXI1,OAS2,PYGL,SIAH2,SLC2A1,YBX1	16 (11)	10	 	 	 	 	 	 	 	 	 	
acalisib	chemical drug	 	3	 	biased	-0.500	8.70E-06	2.46E-02	acalisib,Akt,AURKB,BTK,FOXO3,HRAS,PI3K (complex),PI3K (family),PIK3CB,PIK3CD,PTEN	ABCA1,ACSL1,ADIPOR1,ANK1,BAG1,BCL2L1,BCL6,BNIP3L,CTSB,FOXO4,MXI1,OAS2,PYGL,SIAH2,SLC2A1,YBX1	16 (11)	10	 	 	 	 	 	 	 	 	 	
terfenadine	chemical drug	 	3	Inhibited	biased	-2.183	1.01E-05	2.28E-02	acetaminophen,AMPK,AR,benzo(a)pyrene,carbon tetrachloride,CYP1A2,CYP2C8,CYP2C9,CYP2D6,CYP2E1,CYP2J2,CYP3A4,ERK1/2,ethanol,FOXO1,HRH1,IRS1,MAPK8,P38 MAPK,paclitaxel,PRKAA2,STAT3,tamoxifen,terfenadine	ANK1,AP2A1,AQP9,BCL2L1,BNIP3L,CTSB,FOXO4,GBP5,GLUL,HDGF,MAP2K3,MME,MXI1,OAS2,SLC38A5,SLC6A8,YBX1	17 (24)	16	 	 	 	 	 	 	 	 	 	
DDB2	other	 	3	 	 	-0.600	1.05E-05	3.42E-02	AR,CDKN1A,CEBPA,CREB1,CSF2,DDB2,EP300,FOS,GATA3,HIF1A,HNF4A,IL1B,IRF3,IRF4,MYC,NFE2L2,NFkB (complex),PARP1,PRKCD,RB1,STAT1,STAT3,STAT4	ABCA1,ADIPOR1,ALPL,APOBEC3A,AQP9,BAG1,BCL2L1,BLVRB,CTSB,GBP5,LYL1,MAP2K3,MME,MXI1,NUCB1,PYGL,SAMD9L,SIAH2,SLC2A1,SLC38A5,SNCA,SNX3,UBB,UBE2H,YBX1	25 (23)	22	tretinoin	 	 	 	 	 	 	 	 	
Caspase 8/10	group	 	3	Activated	biased	2.982	1.07E-05	4.02E-02	BID,CASP10,CASP3,CASP8,caspase,Caspase 8/10,DICER1,EIF2AK2,IL18,IL1B,MAPK8,NFkB (complex),P38 MAPK,PRKCD,PTEN,STAT1	ACSL1,ALPL,ANK1,APOBEC3A,BCL2L1,BNIP3L,BSG,CTSB,FOXO4,GBP5,GLUL,IGF2BP2,OAS2,PARP9,PYGL,RBM38,SAMD9L,SLC2A1,SNCA	19 (16)	13	 	 	 	 	 	 	 	 	 	
filgrastim	biologic drug	 	1	 	 	1.000	1.18E-05	1.60E-03	filgrastim	ACSL1,ADGRG3,ALPL,BCL2L1,GBP5,GRINA,IGF2BP2,MGAM,MME	9 (1)	1	 	 	 	CSF3R,ENO1,FCER1G,GAPDH,HIPK2,TRPS1	CLC,CST5,CYP27A1,EGR3,GATA1,MMP12	 	 	 	 	
protriptyline	chemical drug	 	3	 	biased	-0.905	1.24E-05	1.55E-02	AMPK,HRH1,P38 MAPK,protriptyline,SLC6A4,STAT3	ABCA1,ANK1,BCL2L1,BCL6,BNIP3L,GBP5,MXI1,OAS2,SLC2A1,SLC6A8,YBX1	11 (6)	3	 	 	 	 	 	 	 	 	 	
vanadium pentoxide	chemical toxicant	 	2	 	biased	1.265	1.38E-05	8.90E-03	AMPK,MAPK1,STAT1,vanadium pentoxide	ABCA1,BCL2L1,BCL6,CTSB,GBP5,OAS2,SAMD9L,SLC2A1,SLC6A8,YBX1	10 (4)	3	 	 	 	 	 	 	 	 	 	
NR5A1	ligand-dependent nuclear receptor	 	3	 	biased	0.632	1.75E-05	1.46E-02	Akt,AMPK,BAX,FSHR,LIPE,Mapk,NR5A1,PI3K (complex),STAR	ABCA1,ACSL1,ADIPOR1,BCL2L1,BCL6,CTSB,SLC2A1,SLC38A5,SLC6A8,YBX1	10 (9)	7	WT1	 	 	GSTA1,progesterone,STAR	 	 	 	 	 	
decursin	chemical - endogenous non-mammalian	 	3	 	 	-0.200	1.82E-05	8.90E-03	CASP3,caspase,CCND1,CDK2,CDK4,CDK6,CDX2,CEBPA,Cyclin E,decursin,DICER1,EIF2AK2,ERK,GATA3,HSF1,IL18,mir-21,MITF,NFE2L2,P38 MAPK,PPARA,PRKCD,PTEN,SMARCA4,SNAI2,STAT3,TNF,WT1	ABCA1,ANK1,APOBEC3A,AQP9,BCL6,BLVRB,BNIP3L,BSG,GBP5,GLUL,GMPR,IGF2BP2,KCNJ15,LYL1,MPP1,MXI1,OAS2,OPTN,PARP9,PYGL,RBM38,SLC25A37,SLC2A1,ST6GALNAC4,UBB	25 (28)	20	 	 	 	 	 	 	 	 	 	
3-methyladenine	chemical toxicant	 	3	 	 	1.347	1.89E-05	8.90E-03	26s Proteasome,3-methyladenine,Akt,AMPK,AR,beta-estradiol,CASP3,caspase,CEBPA,DICER1,EZH2,FGFR1,FOS,HMGA1,ILK,Insulin,IRF3,IRS1,MITF,NFE2L2,NFkB (complex),P38 MAPK,p70 S6k,PI3K (complex),RELA,RPS6KB1,TNF	ADIPOR1,ANK1,AP2A1,BCL6,BNIP3L,CRISPLD2,CTSB,FKBP8,GBP5,GLUL,GMPR,GRINA,HDGF,LYL1,NFIX,OPTN,RBM38,SAMD9L,SLC38A5,SLC4A1,SLC6A8,SNCA,SNX3,ST6GALNAC4,UBB,UBE2H,YBX1	27 (27)	23	 	 	 	 	 	 	 	 	 	
Z-Asp-2,6-dichlorobenzoyl-oxymethylketone	chemical toxicant	 	3	 	 	-1.500	2.22E-05	4.18E-02	BAX,BID,CASP3,caspase,DICER1,EIF2AK2,IL18,LPL,PI3K (complex),PRKCD,PTEN,RELA,STAT1,Z-Asp-2,6-dichlorobenzoyl-oxymethylketone	ACSL1,ADIPOR1,APOBEC3A,BCL2L1,BNIP3L,BSG,CTSB,GBP5,GLUL,IGF2BP2,OAS2,PARP9,PYGL,RBM38,SAMD9L,SLC2A1	16 (14)	13	 	 	 	 	 	 	 	 	 	
tretinoin	chemical - endogenous mammalian	 	1	 	biased	1.807	2.22E-05	3.73E-02	tretinoin	ABCA1,ACSL1,ALPL,AQP9,BCL2L1,BCL6,CTSB,DDX60L,HDGF,MAP2K3,OAS2,PARP9,RNF10,SAMD9L,YBX1	15 (1)	1	 	 	 	CDX1,CLC,CSF3R,CTSD,DDB2,EPO,FCER1G,HLA-B,IDE,IL10RA,MSLN,NDUFA13,NPC2,PARP9,PPP1R1B,PRL,progesterone,RBM8A,STAR,SYCP3,TGM2,Timp,WT1	HNF1A,IRF4,mir-19,mir-216,MYCN,PLK3,ROR,TNFRSF11A	 	 	 	 	
HDL-cholesterol	complex	 	2	 	 	1.134	2.34E-05	5.30E-03	cholesterol,EIF4EBP1,HDL,HDL-cholesterol	ABCA1,ACSL1,AQP9,BSG,MME,SIAH2,SLC2A1	7 (4)	3	TGM2	SCP2,SOAT2	 	 	 	 	 	 	 	
SRPK1	kinase	 	2	 	biased	1.000	2.77E-05	4.56E-02	Akt,CHUK,ERBB2,FLT1,FOS,H2AFY,IRF3,IRF7,MAPK14,PAK4,PPIA,SRPK1,TFEB,UBD	ABCA1,ACSL1,BCL2L1,BCL6,BNIP3L,BSG,CTSB,GBP5,MAP2K3,MME,MXI1,OAS2,SAMD9L,SLC2A1,SNX3,UBE2H	16 (14)	14	STAT4,TCF7	 	 	FLOT1,IRF7,PAK4,RBM8A	 	 	 	 	 	
CST5	other	 	3	Activated	 	2.982	3.07E-05	4.80E-02	CASP3,CASP8,CASP9,caspase,CST5,CTSH,DICER1,EIF2AK2,IL18,IL1B,MAPK8,MMP3,P38 MAPK,PRKCD,PTEN,STAT1	ACSL1,ALPL,ANK1,APOBEC3A,BCL2L1,BNIP3L,BSG,CTSB,FOXO4,GBP5,GLUL,IGF2BP2,OAS2,PARP9,PYGL,RBM38,SAMD9L,SNCA,YBX1	19 (16)	13	 	filgrastim	 	SGPL1	ACAT2	 	 	 	 	
USP21	peptidase	 	3	 	 	-0.784	3.11E-05	4.69E-02	AR,CEBPA,CSF2,DDX58,FOXO3,GATA3,HIF1A,HNF4A,Ifn,IFNA2,IFNG,IKBKB,IL1B,IRF3,IRF4,IRS1,MAPK10,MAPK8,NEDD8,NFkB (complex),PRKCD,RELA,RIPK1,RORA,STAT4,TP53,TP73,USP21	ABCA1,ADIPOR1,ALPL,AP2A1,APOBEC3A,AQP9,BAG1,BLVRB,BNIP3L,CTSB,DDX60L,FOXO4,GLUL,GMPR,LYL1,MME,OAS2,OPTN,PARP9,PYGL,SAMD9L,SLC2A1,SLC38A5,SNCA,UBE2H,YBX1	26 (28)	25	TCR	 	 	 	 	 	 	 	 	
desmethylazelastine	chemical - endogenous mammalian	 	3	 	biased	-1.387	3.71E-05	4.36E-02	AMPK,benzo(a)pyrene,CYP2C9,CYP2D6,CYP3A4,desmethylazelastine,HRH1,losartan potassium,MAPK8,P38 MAPK,STAT3,tamoxifen	ABCA1,ADIPOR1,ANK1,AQP9,BNIP3L,FOXO4,GBP5,MAP2K3,MXI1,OAS2,SLC2A1,SLC6A8,YBX1	13 (12)	7	 	 	 	 	 	 	 	 	 	
vidarabine	chemical drug	 	2	 	biased	-0.707	3.88E-05	1.43E-02	AMPK,GAPDH,P38 MAPK,vidarabine	ABCA1,ANK1,BCL2L1,BNIP3L,OAS2,SLC2A1,SLC6A8,YBX1	8 (4)	3	 	 	 	 	GAPDH	 	 	 	 	
FLOT1	other	 	2	 	biased	-0.632	3.95E-05	2.78E-02	ALK,ERK1/2,FLOT1,FOXO3,STAT3	ABCA1,BCL2L1,BCL6,BNIP3L,CTSB,GBP5,MXI1,OAS2,SLC2A1,YBX1	10 (5)	4	SRPK1	 	 	cholesterol	 	 	 	 	 	
TCF7	transcription regulator	 	2	 	 	1.265	4.05E-05	1.38E-02	CEBPA,GATA3,PRDM1,TCF7	ACSL1,ALPL,BCL2L1,BCL6,BLVRB,CRISPLD2,GLUL,LYL1,OAS2,SLC25A37	10 (4)	4	 	IRF4	 	SRPK1	PRDM1	 	 	 	 	
24-hydroxycholesterol	chemical - endogenous mammalian	 	2	 	 	1.265	4.67E-05	3.45E-02	24-hydroxycholesterol,Beta Secretase,NR1H3,Pkc(s),STAT3	ABCA1,BCL2L1,BCL6,BNIP3L,CTSB,GBP5,MME,MXI1,OAS2,SLC2A1	10 (5)	5	 	ACAT1,CYP27A1	 	 	Beta Secretase	 	 	 	 	
IL10RA	transmembrane receptor	 	2	 	biased	0.302	5.00E-05	2.88E-02	IL10RA,STAT1,STAT3	ABCA1,ACSL1,BCL2L1,BCL6,BNIP3L,GBP5,MXI1,OAS2,PYGL,SAMD9L,SLC2A1	11 (3)	3	Ifn,Immunoglobulin,STAT4,tretinoin	BTK	 	REG4	CSF3R,IRF7	 	 	 	 	
CSF3R	transmembrane receptor	 	3	Activated	biased	2.200	5.11E-05	4.86E-02	APP,AR,BMX,BTK,CEBPA,CSF3R,FOS,HCK,IRS1,Jnk,KRT8,LYN,MAPK10,MAPK7,MAPK8,mir-21,MYC,PRKCD,RALA,RICTOR,SGK1,STAT,STAT3,STAT4,TNF,TP63,TWIST1	AP2A1,APOBEC3A,AQP9,BAG1,BCL6,BNIP3L,BSG,CRISPLD2,FOXO4,GBP5,IGF2BP2,LYL1,MME,MXI1,NUCB1,OAS2,OPTN,PYGL,SLC25A37,SLC2A1,SLC38A5,SLC4A1,SLC6A8,SNX3,UBE2H	25 (27)	20	filgrastim,tretinoin	IL10RA	 	 	 	 	 	 	 	
MSLN	other	 	2	 	biased	1.667	5.41E-05	3.27E-02	MSLN,PI3K (complex),STAT3	ABCA1,ADIPOR1,BCL2L1,BCL6,BNIP3L,GBP5,MXI1,OAS2,SLC2A1	9 (3)	2	progesterone,tretinoin	 	 	 	 	 	 	 	 	
FCER1G	transmembrane receptor	 	3	Activated	 	2.268	5.43E-05	2.52E-02	26s Proteasome,CBL,CDK2,CDK4,CDK6,CDX2,CEBPB,CEBPD,CREB1,EIF2AK2,EP300,ERBB2,ERK,ESR1,EZH2,FCER1G,FGFR1,FLT1,FOS,GATA3,HIF1A,Ifn,IKZF1,IRS1,KRAS,MAPK1,PI3K (complex),PRKCD,PTEN,RB1,SMARCA4,STAT1,SYK,TCR,TGFB1,TWIST1,WT1,ZAP70	ABCA1,ADIPOR1,AP2A1,APOBEC3A,AQP9,BCL2L1,BCL6,BLVRB,CRISPLD2,CTSB,GBP5,GRINA,HDGF,IGF2BP2,KCNJ15,MAP2K3,MME,MPP1,NFIX,OAS2,PARP9,PYGL,SAMD9L,SIAH2,SNX3,ST6GALNAC4,UBA52,UBE2H	28 (38)	30	filgrastim,IL21,TGM2,tretinoin	BTK,GAPDH,LILRB3	 	 	 	 	 	 	 	
propolis	biologic drug	 	2	 	 	-0.333	6.07E-05	2.24E-02	AMPK,PI3K (complex),propolis,STAT3	ABCA1,ADIPOR1,BCL6,BNIP3L,GBP5,MXI1,OAS2,SLC6A8,YBX1	9 (4)	3	 	 	 	 	cholesterol	 	 	 	 	
AR-A014418	chemical reagent	 	3	 	 	-0.392	6.49E-05	1.82E-02	AMPK,APP,AR,AR-A014418,Betacatenin/TCF,CDK2,CDX2,CEBPA,CREB1,Cyclin A,E2F1,FOXO1,Gsk3,GSK3B,Hsp70,IRS1,MITF,MYC,P38 MAPK,PI3K (complex),PRKCD,PSEN1,PTEN,RB1,RBL2,SMARCA4,SNAI2,STAT1,TNF,TP53,WT1	ADIPOR1,ALPL,ANK1,AP2A1,APOBEC3A,BAG1,BCL2L1,BSG,CRISPLD2,GMPR,IGF2BP2,KCNJ15,LYL1,MAP2K3,MME,MPP1,NUCB1,OPTN,PYGL,SAMD9L,SIAH2,SLC38A5,SLC6A8,SNCA,ST6GALNAC4,UBE2H	26 (31)	27	 	 	 	 	 	 	 	 	 	
IRF4	transcription regulator	 	1	 	biased	-1.342	6.96E-05	4.30E-03	IRF4	ALPL,BCL6,SLC2A1,UBE2H,YBX1	5 (1)	1	PRMT7	bortezomib,BTK,tretinoin	 	 	IRF7,TCF7	 	 	 	 	
CA4	enzyme	 	1	 	biased	-1.732	6.97E-05	5.00E-04	CA4	ANK1,SLC4A1,SPTB	3 (1)	1	cysteamine	 	 	 	 	 	 	 	 	
CYP27A1	enzyme	 	2	 	biased	0.707	7.39E-05	2.95E-02	CYP27A1,STAT3	ABCA1,BCL2L1,BCL6,BNIP3L,GBP5,MXI1,OAS2,SLC2A1	8 (2)	2	 	filgrastim	 	 	24-hydroxycholesterol	 	 	 	 	
Il18r	complex	 	2	Activated	biased	2.646	7.55E-05	1.72E-02	Il18r,MAP3K7,PI3K (complex),SRC	ABCA1,ADIPOR1,BCL2L1,CTSB,MAP2K3,OAS2,SLC2A1	7 (4)	3	 	 	 	 	 	 	 	 	 	
7beta-hydroxycholesterol	chemical - endogenous mammalian	 	2	 	biased	-1.633	7.62E-05	1.33E-02	7beta-hydroxycholesterol,LPL,PRKCA,RORA	ABCA1,ADIPOR1,BCL2L1,BNIP3L,CTSB,SLC2A1	6 (4)	3	 	 	 	 	 	 	 	 	 	
bortezomib	chemical drug	 	1	 	 	-1.633	7.82E-05	9.70E-03	bortezomib	ALPL,BCL2L1,BNIP3L,DCAF12,SLC25A37,SNCA	6 (1)	1	SRT1720	 	 	WT1	EPO,IGL,IRF4,PRDM1	 	 	 	 	
MIRLET7	group	 	2	 	biased	-1.667	8.55E-05	3.18E-02	let-7,MIRLET7,STAT3	BCL2L1,BCL6,BNIP3L,GBP5,IGF2BP2,MXI1,OAS2,RBM38,SLC2A1	9 (3)	2	 	 	 	 	 	 	 	 	 	
hematoporphyrin derivative	chemical drug	 	2	 	biased	-1.000	8.90E-05	4.79E-02	ERK1/2,hematoporphyrin derivative,STAT3	ABCA1,BCL2L1,BCL6,BNIP3L,CTSB,GBP5,MXI1,OAS2,SLC2A1	9 (3)	2	 	 	 	 	 	 	 	 	 	
WT1	transcription regulator	 	2	 	biased	1.667	9.26E-05	4.07E-02	STAT3,WT1	BCL2L1,BCL6,BNIP3L,GBP5,MPP1,MXI1,OAS2,SLC2A1,YBX1	9 (2)	2	bortezomib,enterotoxin B,tretinoin	 	 	BTK,EPO,NR5A1	LSS	 	 	 	 	
enterotoxin B	biologic drug	 	1	Activated	biased	2.000	9.53E-05	4.70E-03	enterotoxin B	BNIP3L,DCAF12,SLC25A37,SNCA	4 (1)	1	 	 	 	IL21,WT1	 	 	 	 	 	
CA074-methyl ester	chemical reagent	 	3	 	 	-1.043	9.80E-05	1.98E-02	AGT,AR,BAX,CA074-methyl ester,CASP3,CEBPA,DICER1,EGFR,EIF2AK2,EPB41,GATA3,IGF1R,Jnk,KRT8,MITF,NFE2L2,P38 MAPK,PTEN,SHC1,TNF,TP63,TRAF2	ABCA1,ACSL1,ANK1,BCL6,BLVRB,BNIP3L,CREB5,CRISPLD2,CTSB,GMPR,GYPC,LYL1,MAP2K3,MXI1,OPTN,PARP9,PYGL,RBM38,SLC2A1,SLC38A5,SLC4A1,UBB,UBE2H	23 (22)	19	 	 	 	 	 	 	 	 	 	
everolimus	chemical drug	 	1	 	biased	-0.577	9.86E-05	2.10E-03	everolimus	ABCA1,BCL2L1,SLC2A1	3 (1)	1	 	 	 	 	 	 	 	 	 	
temsirolimus	chemical drug	 	1	 	biased	-1.414	1.01E-04	7.00E-04	temsirolimus	BCL2L1,SLC2A1	2 (1)	1	 	 	 	 	 	 	 	 	 	
NDUFA13	enzyme	 	2	 	biased	-0.707	1.19E-04	3.73E-02	caspase,NDUFA13,STAT3	BCL2L1,BCL6,BNIP3L,GBP5,GLUL,MXI1,OAS2,SLC2A1	8 (3)	3	tretinoin	 	 	 	 	 	 	 	 	
zinc protoporphyrin IX	chemical - endogenous mammalian	 	2	 	biased	-1.414	1.23E-04	4.27E-02	HMOX1,STAT3,zinc protoporphyrin IX	ABCA1,BCL2L1,BCL6,BNIP3L,GBP5,MXI1,OAS2,SLC2A1	8 (3)	2	 	 	 	 	 	 	 	 	 	
WEE1	kinase	 	3	 	 	-0.243	1.53E-04	3.00E-02	APP,AR,Cdc2,CDK1,CDK2,CDX2,E2F1,EZH2,FOS,HMGA1,KRT8,PGR,SMARCA4,SNAI2,SOX2,SP1,STAT3,WEE1,WT1	ACSL1,ALPL,BNIP3L,BSG,CRISPLD2,FOXO4,GBP5,IGF2BP2,KCNJ15,MME,MPP1,NFIX,OAS2,SLC38A5,SLC4A1,SNX3,ST6GALNAC4	17 (19)	15	 	BTRC	 	 	 	 	 	 	 	
NEK6	kinase	 	2	 	biased	1.414	1.76E-04	4.74E-02	NEK6,RPS6KB1,SGK1,STAT3	BCL2L1,BCL6,BNIP3L,GBP5,MXI1,OAS2,SLC2A1,SLC6A8	8 (4)	3	 	 	 	 	 	 	 	 	 	
progesterone	chemical - endogenous mammalian	 	1	 	 	0.707	1.78E-04	3.53E-02	progesterone	ACSL1,BCL2L1,BCL6,BSG,GRINA,MAP2K3,MME,SLC2A1	8 (1)	1	GSTA1,INS,NR5A1,STAR,tretinoin	tyrphostin AG 1478,valproic acid	 	AKR1C3,cholesterol,ENPP1,IDE,MSLN,PPP1R1B,TJP2	ACAT1,IRF7,STAT4	 	 	 	 	
pinosylvin	chemical - endogenous non-mammalian	 	2	 	biased	-0.816	1.90E-04	2.84E-02	AMPK,CASP3,pinosylvin,Pkc(s)	ABCA1,BCL2L1,CTSB,SLC2A1,SLC6A8,YBX1	6 (4)	3	 	 	 	 	 	 	 	 	 	
ROR	group	 	2	 	biased	0.447	1.97E-04	1.84E-02	AMPK,ROR,RORA	ABCA1,ADIPOR1,SLC2A1,SLC6A8,YBX1	5 (3)	2	 	tretinoin	 	 	 	 	 	 	 	
IL21	cytokine	 	1	 	biased	1.342	2.08E-04	1.90E-02	IL21	BCL2L1,BCL6,BSG,GBP5,OAS2	5 (1)	1	enterotoxin B,Immunoglobulin,Secretase gamma	 	 	FCER1G,IRF7,MMP12,PRDM1	STAT4	 	 	 	 	
triazolam	chemical drug	 	3	 	 	0.378	2.29E-04	4.60E-02	Akt,CCKAR,CYP2C8,paclitaxel,PI3K (family),triazolam	ABCA1,BCL2L1,BCL6,FOXO4,SIAH2,SLC2A1,YBX1	7 (6)	3	 	 	 	 	 	 	 	 	 	
seocalcitol	chemical drug	 	3	Activated	 	2.132	2.35E-04	3.05E-02	CASP3,CDK2,CDX2,CEBPA,DICER1,EIF2AK2,ERK,GATA3,IL18,IRF3,MITF,NFE2L2,P38 MAPK,PPARA,PRKCD,PTEN,seocalcitol,SMARCA4,SNAI2,STAT1,TNF,TP63,VDR,WT1	ABCA1,ANK1,APOBEC3A,AQP9,BCL2L1,BLVRB,BNIP3L,BSG,CRISPLD2,GMPR,IGF2BP2,KCNJ15,LYL1,MPP1,OPTN,PARP9,PYGL,RBM38,SAMD9L,ST6GALNAC4,UBB,UBE2H	22 (24)	20	 	 	 	 	 	 	 	 	 	
ZSTK-474	chemical drug	 	2	 	biased	-1.633	2.42E-04	3.28E-02	PI3K (complex),PI3K (family),ZSTK-474	ABCA1,ADIPOR1,BCL2L1,FOXO4,SIAH2,SLC2A1	6 (3)	2	 	 	 	 	PI3K (family)	 	 	 	 	
APBA3	transporter	 	2	Activated	biased	2.828	2.52E-04	4.82E-02	APBA3,HIF1A,IRF3,TRAF3	AQP9,BCL2L1,BNIP3L,GBP5,OAS2,PYGL,SAMD9L,SLC2A1	8 (4)	4	 	 	 	 	 	 	 	 	 	
CRLF2	transmembrane receptor	 	2	 	 	-0.378	2.72E-04	4.42E-02	BTK,CRLF2,MAPK10,MAPK8,SRC,STAT5a/b	ABCA1,BAG1,BCL6,CTSB,FOXO4,OAS2,SLC2A1	7 (6)	5	 	 	 	Immunoglobulin	BTK	 	 	 	 	
LILRB3	transmembrane receptor	 	2	 	biased	-1.890	2.76E-04	3.98E-02	BTK,LILRB3,PTK2B,STAT1	ABCA1,BAG1,BCL2L1,BCL6,GBP5,OAS2,SAMD9L	7 (4)	3	 	Immunoglobulin	 	 	BTK,FCER1G	 	 	 	 	
CDX1	transcription regulator	 	3	Activated	 	2.558	2.95E-04	3.48E-02	26s Proteasome,Cdc42,CDK2,CDK4,CDK6,CDX1,CREB1,ESR1,EZH2,FGFR1,GATA3,HIF1A,HSF1,ILK,IRF3,IRS1,KRAS,NFE2L2,PI3K (complex),PRKCD,PTEN,RB1,RBL2,RHOA,SMARCA4,SNAI2,STAT1,WT1	ABCA1,ADIPOR1,AP2A1,APOBEC3A,AQP9,BLVRB,BSG,CRISPLD2,CTSB,GRINA,IGF2BP2,KCNJ15,MAP2K3,MME,MPP1,PYGL,SAMD9L,SIAH2,SLC4A1,ST6GALNAC4,UBB,UBE2H	22 (28)	24	tretinoin	 	 	 	 	 	 	 	 	
Ifn	group	 	1	 	biased	1.000	3.17E-04	1.68E-02	Ifn	APOBEC3A,BAG1,BCL6,OAS2	4 (1)	1	 	 	 	IL10RA,STAT4	STAR	 	 	 	 	
IFNL4	cytokine	 	2	Activated	biased	2.449	3.60E-04	3.68E-02	IFNL4,STAT1	ABCA1,BCL2L1,BCL6,GBP5,OAS2,SAMD9L	6 (2)	2	 	 	 	 	 	 	 	 	 	
orotic acid	chemical - endogenous mammalian	 	2	 	biased	0.000	3.74E-04	3.74E-02	AMPK,LPL,orotic acid,PRKAA,SREBF1	ABCA1,ACSL1,BCL2L1,SLC2A1,SLC6A8,YBX1	6 (5)	4	 	 	 	 	 	 	 	 	 	
PI3K (family)	group	 	1	 	biased	1.000	4.54E-04	2.18E-02	PI3K (family)	ABCA1,FOXO4,SIAH2,SLC2A1	4 (1)	1	Immunoglobulin,NKX2-3	ZSTK-474	 	CTSD,MMP12,TGM2	ATG7	 	 	 	 	
cholesterol	chemical - endogenous mammalian	 	1	 	biased	1.342	4.55E-04	2.89E-02	cholesterol	ABCA1,ACSL1,AQP9,BSG,MME	5 (1)	1	choline fenofibrate,FLOT1,linolenic acid,PRL,progesterone,SOAT2,TGM2,TO-901317	2-[[4-[(e)-styryl]phenoxy]methyl]oxirane,ascorbic acid,colestimide,HNF1A,hydroxypropyl-beta-cyclodextrin,miR-30c-5p (and other miRNAs w/seed GUAAACA),NPC2,propolis,SGPL1,sobetirome,STARD3	 	Beta Secretase,Secretase gamma,STX12	ERBB4	 	 	 	 	
PARP9	enzyme	0.549	2	Activated	biased	2.449	5.02E-04	4.98E-02	PARP9,STAT,STAT1	ABCA1,BCL2L1,BCL6,GBP5,OAS2,SAMD9L	6 (3)	3	TGM2,tretinoin	NKX2-3	 	IRF7	 	 	 	 	 	
antigen	group	 	2	Activated	biased	2.449	5.11E-04	4.11E-02	antigen,Fcer1,SPHK1,TCR	BCL2L1,BSG,CTSB,MAP2K3,SLC2A1,UBA52	6 (4)	3	 	 	 	TCR	 	 	 	 	 	
NCKAP1L	other	 	1	 	biased	1.414	5.51E-04	1.40E-03	NCKAP1L	MPP1,SLC4A1	2 (1)	1	 	 	 	 	 	 	 	 	 	
rotenone	chemical toxicant	 	1	 	 	1.732	6.29E-04	1.70E-02	rotenone	ADIPOR1,BSG,SNCA	3 (1)	1	 	 	 	 	 	 	 	 	 	
NKX2-3	transcription regulator	 	1	Inhibited	 	-2.236	6.87E-04	1.18E-02	NKX2-3	ALPL,DDX60L,GMPR,PARP9,SAMD9L	5 (1)	1	 	 	 	PI3K (family)	HLA-B,PARP9	 	 	 	 	
methylphenazonium methosulfate	chemical toxicant	 	2	 	 	1.000	6.89E-04	3.29E-02	AMPK,methylphenazonium methosulfate,MMP2	BCL2L1,SLC2A1,SLC6A8,YBX1	4 (3)	2	 	 	 	 	 	 	 	 	 	
RALGPS1	other	 	2	 	biased	0.577	7.03E-04	1.91E-02	FOXO4,RALA,RALGPS1	BCL2L1,BCL6,FOXO4	3 (3)	2	 	 	 	 	 	 	 	 	 	
pranlukast	chemical drug	 	2	 	 	0.000	7.53E-04	3.75E-02	AMPK,CASP3,pranlukast	BCL2L1,SLC2A1,SLC6A8,YBX1	4 (3)	2	 	 	 	 	 	 	 	 	 	
RV 538	chemical reagent	 	1	 	biased	0.000	7.78E-04	1.17E-02	RV 538	ABCA1,BCL2L1	2 (1)	1	 	 	 	 	TNFRSF11A	 	 	 	 	
tetrandrine	chemical drug	 	1	 	 	-1.414	7.78E-04	9.80E-03	tetrandrine	BCL2L1,YBX1	2 (1)	1	 	 	 	 	 	 	 	 	 	
valproic acid	chemical drug	 	1	 	 	0.000	8.12E-04	3.76E-02	valproic acid	BAG1,BCL2L1,CTSB,GLUL,MME,UBE2H	6 (1)	1	 	 	 	MAD1L1	BAG2,CRLF1,miR-30c-5p (and other miRNAs w/seed GUAAACA),MYCN,progesterone,TGM2	 	 	 	 	
2-aminobenzimidazole	chemical reagent	 	2	 	 	0.000	8.22E-04	3.51E-02	2-aminobenzimidazole,AMPK,IRS1	AP2A1,SLC2A1,SLC6A8,YBX1	4 (3)	2	 	 	 	 	 	 	 	 	 	
non-esterified fatty acid	chemical - endogenous mammalian	 	2	 	 	-1.000	8.22E-04	3.24E-02	AMPK,IRS1,non-esterified fatty acid	AP2A1,SLC2A1,SLC6A8,YBX1	4 (3)	2	TO-901317	 	 	 	 	 	 	 	 	
PNN	other	 	1	 	biased	-1.414	9.05E-04	1.01E-02	PNN	BCL2L1,BSG	2 (1)	1	 	 	 	 	 	 	 	 	 	
oleoyl-coenzyme A	chemical - endogenous mammalian	 	2	 	biased	-0.577	9.11E-04	1.42E-02	IDE,LIPE,oleoyl-coenzyme A	ABCA1,ACSL1,SNCA	3 (3)	2	 	 	 	 	IDE	 	 	 	 	
INS	other	 	1	 	 	0.000	9.46E-04	3.35E-02	INS	ADIPOR1,AQP9,BCL2L1,SLC2A1	4 (1)	1	CCNT1,HNF1A,TO-901317	miR-30c-5p (and other miRNAs w/seed GUAAACA)	 	progesterone	 	 	 	 	 	
dibucaine	chemical drug	 	2	 	 	0.000	1.04E-03	1.23E-02	dibucaine,SMPD1	BCL2L1,CTSB	2 (2)	2	 	 	 	 	 	 	 	 	 	
ATG7	enzyme	 	1	 	 	1.732	1.05E-03	2.03E-02	ATG7	ACSL1,CTSB,SLC2A1	3 (1)	1	PRDM1	PI3K (family)	 	ACAT1	 	 	 	 	 	
SCP2	transporter	 	3	 	 	0.577	1.05E-03	2.53E-02	SCARB1,SCP2,SOAT1	ABCA1,BSG,SIAH2	3 (3)	2	PRL	 	 	 	HDL-cholesterol	 	 	 	 	
TO-901317	chemical reagent	 	1	Activated	biased	2.000	1.30E-03	4.33E-02	TO-901317	ABCA1,ACSL1,ADIPOR1,BCL2L1	4 (1)	1	 	 	 	cholesterol,INS,non-esterified fatty acid,STAR,TGM2	Secretase gamma	 	 	 	 	
MYCN	transcription regulator	 	1	 	 	0.447	1.34E-03	3.52E-02	MYCN	ABCA1,BCL2L1,MXI1,NUCB1,SLC2A1	5 (1)	1	GATA1	tretinoin,valproic acid	 	CCNT1,GAPDH	TGM2	 	 	 	 	
PPP1R1B	phosphatase	 	1	 	biased	1.414	1.34E-03	5.60E-03	PPP1R1B	BCL2L1,SNCA	2 (1)	1	glucagon,L-dopa,progesterone,tretinoin	 	 	 	 	 	 	 	 	
tyrphostin AG 1478	chemical - kinase inhibitor	 	1	 	biased	-1.732	1.43E-03	3.65E-02	tyrphostin AG 1478	BCL2L1,MME,SLC2A1	3 (1)	1	 	 	 	 	ERBB4,progesterone	 	 	 	 	
KLF13	transcription regulator	 	1	 	biased	0.000	1.68E-03	2.10E-02	KLF13	BCL2L1,GYPC	2 (1)	1	 	 	 	GATA1	 	 	 	 	 	
PARP9	enzyme	0.549	1	 	biased	1.414	1.68E-03	1.00E-02	PARP9	BCL6,OAS2	2 (1)	1	TGM2,tretinoin	NKX2-3	 	IRF7	 	 	 	 	 	
trastuzumab	biologic drug	 	1	 	biased	0.000	1.68E-03	1.42E-02	trastuzumab	BCL2L1,BNIP3L	2 (1)	1	 	 	 	 	 	 	 	 	 	
6-hydroxydopamine	chemical toxicant	 	1	 	biased	0.577	1.69E-03	3.05E-02	6-hydroxydopamine	BCL2L1,BNIP3L,SNCA	3 (1)	1	 	 	 	 	L-dopa	 	 	 	 	
Il2 beta gamma receptor	complex	 	2	 	 	-0.577	1.75E-03	2.31E-02	Il2 beta gamma receptor,IL2RG,LCK	ABCA1,BCL2L1,BCL6	3 (3)	3	 	 	 	 	 	 	 	 	 	
IRF7	transcription regulator	 	1	Activated	biased	2.000	1.81E-03	4.05E-02	IRF7	BCL2L1,GBP5,OAS2,SAMD9L	4 (1)	1	IL21,PARP9,PRL,SRPK1	IL10RA,Immunoglobulin,IRF4,progesterone	 	 	 	 	 	 	 	
BTRC	enzyme	 	1	 	biased	-1.414	1.87E-03	9.50E-03	BTRC	BCL2L1,GLUL	2 (1)	1	 	 	 	 	WEE1	 	 	 	 	
TNFRSF11A	transmembrane receptor	 	1	 	biased	1.414	1.87E-03	2.15E-02	TNFRSF11A	BCL2L1,MME	2 (1)	1	Immunoglobulin	RV 538,tretinoin	 	 	 	 	 	 	 	
ammonium chloride	chemical drug	 	1	 	biased	1.414	1.87E-03	1.16E-02	ammonium chloride	CTSB,SNCA	2 (1)	1	 	 	 	 	 	 	 	 	 	
ascorbic acid	chemical - endogenous mammalian	 	1	 	 	0.577	1.89E-03	3.38E-02	ascorbic acid	ALPL,BCL2L1,SLC2A1	3 (1)	1	 	 	 	 	cholesterol	 	 	 	 	
Lysosomal Protease	group	 	2	 	biased	1.732	2.04E-03	4.52E-02	CTSB,CTSD,CTSE,Lysosomal Protease	ABCA1,BCL2L1,CTSB	3 (4)	3	 	 	 	 	 	 	 	 	 	
meldonium	chemical drug	 	2	 	biased	0.577	2.04E-03	3.16E-02	LIPE,LPL,meldonium	ABCA1,ACSL1,SLC2A1	3 (3)	2	 	 	 	 	 	 	 	 	 	
BTK	kinase	 	1	 	 	0.577	2.12E-03	4.95E-02	BTK	BAG1,BCL2L1,OAS2	3 (1)	1	WT1	CRLF2,IBTK,LILRB3,PRDM1	 	Immunoglobulin	FCER1G,IL10RA,IRF4	 	 	 	 	
PAPPA	peptidase	 	3	 	biased	-1.414	2.47E-03	1.74E-02	creatine,creatine kinase,PAPPA	ABCA1,SLC6A8	2 (3)	2	 	 	 	 	 	 	 	 	 	
SGPL1	enzyme	 	1	 	 	-1.414	2.47E-03	2.14E-02	SGPL1	ABCA1,BCL2L1	2 (1)	1	CST5	 	 	Secretase gamma	cholesterol	 	 	 	 	
TRPS1	transcription regulator	 	1	 	 	1.414	2.47E-03	7.00E-03	TRPS1	ALPL,PHOSPHO1	2 (1)	1	filgrastim	miR-30c-5p (and other miRNAs w/seed GUAAACA)	 	 	ENPP1	 	 	 	 	
ERBB4	kinase	 	1	 	 	0.577	2.52E-03	4.35E-02	ERBB4	MAP2K3,MXI1,SLC2A1	3 (1)	1	PRL	cholesterol,tyrphostin AG 1478	 	 	 	 	 	 	 	
UCN-01	chemical drug	 	1	 	biased	-1.414	2.69E-03	2.02E-02	UCN-01	BAG1,BCL2L1	2 (1)	1	 	 	 	 	 	 	 	 	 	
CSNK1G1	kinase	 	2	 	biased	-1.414	2.92E-03	3.02E-02	CHEK1,CSNK1G1,LRRK2	BCL2L1,SNCA	2 (3)	2	 	 	 	 	 	 	 	 	 	
choline fenofibrate	chemical drug	 	1	 	 	0.000	2.92E-03	2.44E-02	choline fenofibrate	ACSL1,ADIPOR1	2 (1)	1	 	 	 	cholesterol,NPC2	 	 	 	 	 	
Pka catalytic subunit	group	 	1	 	biased	1.414	3.15E-03	2.34E-02	Pka catalytic subunit	ABCA1,BCL2L1	2 (1)	1	 	 	 	PAK4,PRL,STAR	 	 	 	 	 	
linolenic acid	chemical - endogenous mammalian	 	1	 	 	1.414	3.15E-03	3.34E-02	linolenic acid	ACSL1,SNCA	2 (1)	1	 	 	 	cholesterol	IDE	 	 	 	 	
(+)-terpinen-4-ol	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	(+)-terpinen-4-ol	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
(-)-gossypol-enriched cottonseed oil	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	(-)-gossypol-enriched cottonseed oil	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
1-benzyl-2-phenylbenzimidazole	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	1-benzyl-2-phenylbenzimidazole	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
2,2-dichloroacetophenone	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	2,2-dichloroacetophenone	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
4-(3',5'-dimethoxybenzyloxy)-6-methoxyquinolin-2(1H)-one	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	4-(3',5'-dimethoxybenzyloxy)-6-methoxyquinolin-2(1H)-one	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
4-methoxyhonokiol	chemical - endogenous non-mammalian	 	1	 	biased	-1.000	3.22E-03	3.93E-02	4-methoxyhonokiol	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
6-azidomethyl-1-hydroxy-3,8-dimethoxy-9,10-anthraquinone	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	6-azidomethyl-1-hydroxy-3,8-dimethoxy-9,10-anthraquinone	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
7,8-dihydroxy-4-methylcoumarin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	7,8-dihydroxy-4-methylcoumarin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
8-hydrocalamenene	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	8-hydrocalamenene	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
AB1	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	AB1	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ACAT2	enzyme	 	1	 	biased	-1.000	3.22E-03	1.17E-02	ACAT2	ABCA1	1 (1)	1	 	CST5	 	 	 	 	 	 	 	
ARHGEF11	other	 	1	 	biased	1.000	3.22E-03	1.17E-02	ARHGEF11	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
AUH-6-96	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	AUH-6-96	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
CDC42BPB	kinase	 	1	 	biased	1.000	3.22E-03	9.70E-03	CDC42BPB	CTSB	1 (1)	1	 	 	 	 	 	 	 	 	 	
CLPTM1L	other	 	1	 	biased	1.000	3.22E-03	3.93E-02	CLPTM1L	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
CPEB4	other	 	1	 	biased	1.000	3.22E-03	3.93E-02	CPEB4	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
CPS49	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	CPS49	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
EAPB0203	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	EAPB0203	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
FBXO11	enzyme	 	1	 	biased	-1.000	3.22E-03	9.00E-03	FBXO11	BCL6	1 (1)	1	 	 	 	 	 	 	 	 	 	
GSTA1	enzyme	 	1	 	biased	1.000	3.22E-03	3.93E-02	GSTA1	BCL2L1	1 (1)	1	HNF1A,NR5A1,PXR ligand-PXR-Retinoic acid-RXRα	 	 	progesterone	 	 	 	 	 	
H9 extract	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	H9 extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
HO-3867	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	HO-3867	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
IGL	other	 	1	 	biased	1.000	3.22E-03	3.93E-02	IGL	BCL2L1	1 (1)	1	 	bortezomib,Immunoglobulin	 	 	 	 	 	 	 	
Il2 beta gamma receptor	complex	 	1	 	biased	1.000	3.22E-03	3.93E-02	Il2 beta gamma receptor	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
JOT01006	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	JOT01006	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
LRP1B	transmembrane receptor	 	1	 	biased	1.000	3.22E-03	1.17E-02	LRP1B	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
MAPK substrate-4	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	MAPK substrate-4	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
MCM8	enzyme	 	1	 	biased	1.000	3.22E-03	3.93E-02	MCM8	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
MI-319	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	MI-319	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
MPT0B169	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	MPT0B169	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
MPT0G009	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	MPT0G009	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
Muc4	other	 	1	 	biased	1.000	3.22E-03	3.93E-02	Muc4	BCL2L1	1 (1)	1	HNF1A	 	 	 	 	 	 	 	 	
N-[3-(trifluoromethyl)phenyl]retinamide	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	N-[3-(trifluoromethyl)phenyl]retinamide	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
NBR2	other	 	1	 	biased	1.000	3.22E-03	8.10E-03	NBR2	SLC2A1	1 (1)	1	phenformin	 	 	 	 	 	 	 	 	
NEK2	kinase	 	1	 	biased	-1.000	3.22E-03	3.93E-02	NEK2	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
PTPN13	phosphatase	 	1	 	biased	-1.000	3.22E-03	3.93E-02	PTPN13	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
REG1A	growth factor	 	1	 	biased	1.000	3.22E-03	3.93E-02	REG1A	BCL2L1	1 (1)	1	 	PRDM1	 	 	 	 	 	 	 	
REG4	other	 	1	 	biased	1.000	3.22E-03	3.93E-02	REG4	BCL2L1	1 (1)	1	IL10RA	 	 	 	 	 	 	 	 	
RNPS1	other	 	1	 	biased	-1.000	3.22E-03	3.93E-02	RNPS1	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
SNTB1	other	 	1	 	biased	1.000	3.22E-03	1.17E-02	SNTB1	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
SPI-112Me	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	SPI-112Me	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
STARD3	transporter	 	1	 	biased	1.000	3.22E-03	1.17E-02	STARD3	ABCA1	1 (1)	1	 	 	 	 	cholesterol	 	 	 	 	
STX12	other	 	1	 	biased	1.000	3.22E-03	1.17E-02	STX12	ABCA1	1 (1)	1	cholesterol	 	 	 	 	 	 	 	 	
TCEAL7	transcription regulator	 	1	 	biased	-1.000	3.22E-03	3.93E-02	TCEAL7	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
TL-77	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	TL-77	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
TMEM139	other	 	1	 	biased	1.000	3.22E-03	4.80E-03	TMEM139	SLC4A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
TRAPPC9	other	 	1	 	biased	1.000	3.22E-03	3.93E-02	TRAPPC9	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
Timp	group	 	1	 	biased	1.000	3.22E-03	3.93E-02	Timp	BCL2L1	1 (1)	1	tretinoin	 	 	 	 	 	 	 	 	
WJ9708012	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	WJ9708012	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ZSCAN21	transcription regulator	 	1	 	biased	-1.000	3.22E-03	8.90E-03	ZSCAN21	SNCA	1 (1)	1	 	 	 	 	 	 	 	 	 	
acetylapoaranotin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	acetylapoaranotin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
acetylaranotin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	acetylaranotin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
aloin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	aloin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
alpinetin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	alpinetin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
atractylenolide I	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	atractylenolide I	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
azide	chemical reagent	 	1	 	biased	1.000	3.22E-03	8.10E-03	azide	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
betulin	chemical - endogenous non-mammalian	 	1	 	biased	1.000	3.22E-03	3.93E-02	betulin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
bisindole-linked pyrrolo[2,1-c][1,4]benzodiazepine 5b	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	bisindole-linked pyrrolo[2,1-c][1,4]benzodiazepine 5b	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
bornyl caffeate	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	bornyl caffeate	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
cardiotoxin III	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	cardiotoxin III	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
colestimide	chemical drug	 	1	 	biased	1.000	3.22E-03	1.17E-02	colestimide	ABCA1	1 (1)	1	 	 	 	 	cholesterol	 	 	 	 	
danusertib	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	danusertib	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
deoxyapoaranotin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	deoxyapoaranotin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
depsipeptide	chemical - other	 	1	 	biased	-1.000	3.22E-03	3.93E-02	depsipeptide	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
dianthus chinensis l. ethanol extract	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	dianthus chinensis l. ethanol extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
farnesiferol C	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	farnesiferol C	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
flacourtia indica methanol extract	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	flacourtia indica methanol extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
fungal taxol	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	fungal taxol	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
galiximab	biologic drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	galiximab	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
gelam honey	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	gelam honey	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
gypenoside	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	gypenoside	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
hederagenin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	hederagenin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
heteronemin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	heteronemin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
hydroxyaminoindan	chemical reagent	 	1	 	biased	1.000	3.22E-03	3.93E-02	hydroxyaminoindan	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
icariin	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	icariin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ingenol mebutate	chemical drug	 	1	 	biased	1.000	3.22E-03	3.93E-02	ingenol mebutate	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
korean red ginseng extract	chemical reagent	 	1	 	biased	1.000	3.22E-03	3.93E-02	korean red ginseng extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
let-7c mimic	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	let-7c mimic	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
liriope platyphylla root part extract	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	liriope platyphylla root part extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
luffa echinata roxb fruit extract	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	luffa echinata roxb fruit extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
mansonone E	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	mansonone E	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
melamine	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	melamine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
miR-135a mimic	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	miR-135a mimic	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
miR-33-5p (and other miRNAs w/seed UGCAUUG)	mature microRNA	 	1	 	biased	-1.000	3.22E-03	1.17E-02	miR-33-5p (and other miRNAs w/seed UGCAUUG)	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
miR-4651 (and other miRNAs w/seed GGGGUGG)	mature microRNA	 	1	 	biased	-1.000	3.22E-03	3.93E-02	miR-4651 (and other miRNAs w/seed GGGGUGG)	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
mir-216	microRNA	 	1	 	biased	-1.000	3.22E-03	9.50E-03	mir-216	YBX1	1 (1)	1	AGO2	tretinoin	 	 	 	 	 	 	 	
mir-491	microRNA	 	1	 	biased	-1.000	3.22E-03	3.93E-02	mir-491	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
morusin	chemical - endogenous non-mammalian	 	1	 	biased	-1.000	3.22E-03	3.93E-02	morusin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
nitidine	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	nitidine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
norcantharidin	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	norcantharidin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
p-cuminaldehyde	chemical - endogenous non-mammalian	 	1	 	biased	-1.000	3.22E-03	3.93E-02	p-cuminaldehyde	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
pepleomycin	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	pepleomycin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
persea declinata (bl.) kosterm bark methanolic crude extract	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	persea declinata (bl.) kosterm bark methanolic crude extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
picolog	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	picolog	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
pien tze huang methanol extract	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	pien tze huang methanol extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
procyanidin B2-3'-O-gallate	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	procyanidin B2-3'-O-gallate	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
procyanidin B2-3,3'-di-O-gallate	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	procyanidin B2-3,3'-di-O-gallate	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
pseudolaric acid B	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	pseudolaric acid B	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
raddeanin A	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	raddeanin A	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
rifamycin SV	chemical drug	 	1	 	biased	1.000	3.22E-03	9.00E-03	rifamycin SV	BCL6	1 (1)	1	 	 	 	 	 	 	 	 	 	
rocaglaol	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	rocaglaol	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
sargramostim	biologic drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	sargramostim	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
silmitasertib	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	silmitasertib	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
solamargine	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	solamargine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
subditine	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	subditine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
sun ginseng extract	chemical reagent	 	1	 	biased	1.000	3.22E-03	3.93E-02	sun ginseng extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
tetraacetyl-phytosphingosine	chemical reagent	 	1	 	biased	1.000	3.22E-03	3.93E-02	tetraacetyl-phytosphingosine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
tetracaine	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	tetracaine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
tinostamustine	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	tinostamustine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
uncarinic acid E	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	uncarinic acid E	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
zinc-citrate	chemical reagent	 	1	 	biased	-1.000	3.22E-03	3.93E-02	zinc-citrate	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ziram	chemical toxicant	 	1	 	biased	1.000	3.22E-03	8.90E-03	ziram	SNCA	1 (1)	1	 	 	 	 	 	 	 	 	 	
zuo-jin-wan	chemical drug	 	1	 	biased	-1.000	3.22E-03	3.93E-02	zuo-jin-wan	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
betulinic acid	chemical drug	 	1	 	biased	0.000	3.40E-03	4.21E-02	betulinic acid	ABCA1,BCL2L1	2 (1)	1	 	 	 	 	DUB	 	 	 	 	
hydroxypropyl-beta-cyclodextrin	chemical drug	 	1	 	biased	0.000	3.40E-03	1.54E-02	hydroxypropyl-beta-cyclodextrin	ABCA1,CTSB	2 (1)	1	 	 	 	miR-127-3p (miRNAs w/seed CGGAUCC)	cholesterol,CTSD,NPC2	 	 	 	 	
STAR	transporter	 	2	 	biased	0.577	3.47E-03	4.85E-02	BAX,LIPE,STAR	ABCA1,ACSL1,CTSB	3 (3)	2	NR5A1,Pka catalytic subunit,PRL,TO-901317,tretinoin	Ifn	 	progesterone	 	 	 	 	 	
NPC2	transporter	 	1	 	biased	0.000	3.65E-03	1.91E-02	NPC2	CREB5,CTSB	2 (1)	1	choline fenofibrate,TGM2,tretinoin	hydroxypropyl-beta-cyclodextrin,L-dopa	 	 	AKR1C3,cholesterol,STAT4	 	 	 	 	
sobetirome	chemical drug	 	2	 	biased	1.414	3.65E-03	2.88E-02	CYP7A1,sobetirome	ABCA1,SLC4A1	2 (2)	2	 	 	 	 	cholesterol	 	 	 	 	
MAX	transcription regulator	 	1	 	 	0.000	4.47E-03	3.22E-02	MAX	BCL6,SLC2A1	2 (1)	1	 	 	 	 	 	 	 	 	 	
methylselenic acid	chemical reagent	 	1	 	biased	0.000	4.47E-03	3.09E-02	methylselenic acid	BCL2L1,BLVRB	2 (1)	1	 	 	 	 	 	 	 	 	 	
AMG 900	chemical drug	 	2	 	biased	0.000	4.75E-03	4.60E-02	AMG 900,AURKA,AURKB	ANK1,BCL2L1	2 (3)	2	 	 	 	 	 	 	 	 	 	
SNS 314	chemical drug	 	2	 	biased	0.000	4.75E-03	4.60E-02	AURKA,AURKB,SNS 314	ANK1,BCL2L1	2 (3)	2	 	 	 	 	 	 	 	 	 	
TTP607	chemical drug	 	2	 	biased	0.000	4.75E-03	4.60E-02	AURKA,AURKB,TTP607	ANK1,BCL2L1	2 (3)	2	 	 	 	 	 	 	 	 	 	
alvocidib	chemical drug	 	1	 	biased	-1.414	4.75E-03	4.50E-02	alvocidib	BAG1,BCL2L1	2 (1)	1	 	 	 	 	 	 	 	 	 	
GAPDH	enzyme	 	1	 	biased	0.000	5.05E-03	3.87E-02	GAPDH	BCL2L1,OAS2	2 (1)	1	filgrastim,L-dopa,MYCN	vidarabine	 	 	ENO1,ENPP1,FCER1G	 	 	 	 	
Secretase gamma	complex	 	1	 	biased	1.414	5.05E-03	4.85E-02	Secretase gamma	MME,SLC2A1	2 (1)	1	cholesterol,SGPL1	TO-901317	 	IL21	 	 	 	 	 	
N-cor	group	 	1	 	biased	0.000	5.35E-03	4.95E-02	N-cor	ABCA1,ACSL1	2 (1)	1	 	 	 	 	MMP12	 	 	 	 	
bardoxolone	chemical drug	 	1	 	biased	0.000	5.35E-03	3.67E-02	bardoxolone	BCL2L1,UBE2H	2 (1)	1	 	 	 	 	 	 	 	 	 	
miR-30c-5p (and other miRNAs w/seed GUAAACA)	mature microRNA	 	1	 	biased	-1.732	5.52E-03	3.10E-02	miR-30c-5p (and other miRNAs w/seed GUAAACA)	AP2A1,BCL6,NUCB1	3 (1)	1	AGO2	valproic acid	 	 	cholesterol,INS,TRPS1	 	 	 	 	
mir-19	microRNA	 	1	 	biased	-1.414	5.67E-03	2.56E-02	mir-19	ABCA1,MAP2K3	2 (1)	1	AGO2	tretinoin	 	 	 	 	 	 	 	
L-dopa	chemical - endogenous mammalian	 	1	 	 	1.134	5.82E-03	4.52E-02	L-dopa	ALPL,BCL2L1,CTSB,FAM210B,SIAH2,SLC2A1,UBXN6	7 (1)	1	 	6-hydroxydopamine	 	DAB1,GAPDH,KCND2,PPP1R1B	NPC2,PRL,PTPRT	 	 	 	 	
CRNDE	other	 	1	 	biased	1.414	5.99E-03	4.55E-02	CRNDE	BCL2L1,FOXO4	2 (1)	1	 	 	 	 	 	 	 	 	 	
SET	phosphatase	 	1	 	biased	-1.414	5.99E-03	1.25E-02	SET	BCL2L1,YBX1	2 (1)	1	 	CD 437	 	STAT4	 	 	 	 	 	
3830403N18Rik/Xlr	other	 	1	 	biased	1.000	6.42E-03	3.93E-02	3830403N18Rik/Xlr	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
8-aminoadenosine	chemical reagent	 	1	 	biased	-1.000	6.42E-03	1.54E-02	8-aminoadenosine	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ACAT1	enzyme	 	1	 	 	-1.000	6.42E-03	2.02E-02	ACAT1	ABCA1	1 (1)	1	ATG7	progesterone	 	 	24-hydroxycholesterol	 	 	 	 	
Alpha 1 antitrypsin	group	 	1	 	biased	-1.000	6.42E-03	4.66E-02	Alpha 1 antitrypsin	CTSB	1 (1)	1	 	 	 	 	 	 	 	 	 	
Beta Secretase	group	 	1	 	 	1.000	6.42E-03	1.76E-02	Beta Secretase	MME	1 (1)	1	cholesterol	24-hydroxycholesterol	 	 	 	 	 	 	 	
CANX	other	 	1	 	biased	1.000	6.42E-03	2.18E-02	CANX	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
Camkk	group	 	1	 	biased	1.000	6.42E-03	1.91E-02	Camkk	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
E. coli 011:B4 lipopolysaccharide	chemical - endogenous non-mammalian	 	1	 	 	1.000	6.42E-03	4.13E-02	E. coli 011:B4 lipopolysaccharide	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
GABBR2	G-protein coupled receptor	 	1	 	biased	1.000	6.42E-03	1.26E-02	GABBR2	GLUL	1 (1)	1	 	 	 	 	 	 	 	 	 	
Gm4836 (includes others)	other	 	1	 	biased	1.000	6.42E-03	3.93E-02	Gm4836 (includes others)	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
IBTK	other	 	1	 	biased	1.000	6.42E-03	4.76E-02	IBTK	BCL2L1	1 (1)	1	 	 	 	 	BTK	 	 	 	 	
IDE	peptidase	 	1	 	biased	-1.000	6.42E-03	1.94E-02	IDE	SNCA	1 (1)	1	PRL,progesterone,tretinoin	linolenic acid,oleoyl-coenzyme A,palmitoleic acid	 	 	 	 	 	 	 	
LGR5	transmembrane receptor	 	1	 	 	1.000	6.42E-03	4.65E-02	LGR5	BCL2L1	1 (1)	1	 	 	 	 	AKR1C3	 	 	 	 	
MLIP	other	 	1	 	 	1.000	6.42E-03	1.69E-02	MLIP	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
NEU2	enzyme	 	1	 	biased	-1.000	6.42E-03	3.93E-02	NEU2	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
PREB	transcription regulator	 	1	 	biased	1.000	6.42E-03	2.41E-02	PREB	ABCA1	1 (1)	1	 	 	 	PRL	 	 	 	 	 	
PTPRT	phosphatase	 	1	 	biased	-1.000	6.42E-03	5.00E-02	PTPRT	BCL2L1	1 (1)	1	 	L-dopa	 	 	 	 	 	 	 	
SAP18	transcription regulator	 	1	 	 	-1.000	6.42E-03	4.71E-02	SAP18	BCL2L1	1 (1)	1	 	CD 437	 	 	 	 	 	 	 	
SD-1008	chemical - kinase inhibitor	 	1	 	biased	-1.000	6.42E-03	4.94E-02	SD-1008	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
SNED1	other	 	1	 	biased	1.000	6.42E-03	1.54E-02	SNED1	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
SYCP3	other	 	1	 	biased	1.000	6.42E-03	3.93E-02	SYCP3	BCL2L1	1 (1)	1	tretinoin	 	 	 	 	 	 	 	 	
TJP2	kinase	 	1	 	 	-1.000	6.42E-03	4.42E-02	TJP2	BCL2L1	1 (1)	1	progesterone	glucagon	 	 	 	 	 	 	 	
TXNDC5	enzyme	 	1	 	biased	1.000	6.42E-03	4.45E-02	TXNDC5	CTSB	1 (1)	1	 	 	 	 	 	 	 	 	 	
ZNF202	transcription regulator	 	1	 	biased	-1.000	6.42E-03	2.07E-02	ZNF202	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ZNRF3	enzyme	 	1	 	biased	-1.000	6.42E-03	1.78E-02	ZNRF3	GLUL	1 (1)	1	 	 	 	 	 	 	 	 	 	
Zingiber officiale ginger extract	chemical drug	 	1	 	biased	-1.000	6.42E-03	3.93E-02	Zingiber officiale ginger extract	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
aclarubicin	chemical drug	 	1	 	 	-1.000	6.42E-03	4.83E-02	aclarubicin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
caseamembrin C	chemical reagent	 	1	 	 	-1.000	6.42E-03	4.83E-02	caseamembrin C	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
dacetuzumab	biologic drug	 	1	 	biased	1.000	6.42E-03	4.73E-02	dacetuzumab	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
dibucaine	chemical drug	 	1	 	biased	-1.000	6.42E-03	4.55E-02	dibucaine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
dimethyl succinate	chemical - endogenous mammalian	 	1	 	biased	-1.000	6.42E-03	1.77E-02	dimethyl succinate	BSG	1 (1)	1	 	 	 	 	 	 	 	 	 	
fedratinib	chemical drug	 	1	 	biased	-1.000	6.42E-03	4.83E-02	fedratinib	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ginkgetin	chemical - endogenous non-mammalian	 	1	 	 	-1.000	6.42E-03	5.00E-02	ginkgetin	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
gliclazide	chemical drug	 	1	 	 	1.000	6.42E-03	1.81E-02	gliclazide	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
glucose oxidase	group	 	1	 	 	1.000	6.42E-03	1.67E-02	glucose oxidase	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
lynestrenol	chemical drug	 	1	 	biased	1.000	6.42E-03	1.98E-02	lynestrenol	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
mefenamic acid	chemical drug	 	1	 	 	1.000	6.42E-03	4.74E-02	mefenamic acid	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
metacept-1	chemical reagent	 	1	 	 	-1.000	6.42E-03	4.73E-02	metacept-1	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
phytic acid	chemical - endogenous non-mammalian	 	1	 	biased	-1.000	6.42E-03	4.77E-02	phytic acid	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
pinitol	chemical drug	 	1	 	 	-1.000	6.42E-03	4.94E-02	pinitol	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
rutaecarpine	chemical - endogenous non-mammalian	 	1	 	biased	1.000	6.42E-03	2.01E-02	rutaecarpine	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
sepantronium	chemical drug	 	1	 	biased	-1.000	6.42E-03	4.94E-02	sepantronium	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
EGR3	transcription regulator	 	1	 	 	0.000	8.08E-03	4.30E-02	EGR3	BCL2L1,BCL6	2 (1)	1	 	filgrastim	 	 	 	 	 	 	 	
ABCB6	transporter	 	1	 	 	-1.414	8.46E-03	2.30E-02	ABCB6	GLRX5,SLC25A37	2 (1)	1	 	 	 	 	 	 	 	 	 	
CTSD	peptidase	 	1	 	biased	1.000	9.62E-03	2.90E-02	CTSD	ABCA1	1 (1)	1	PI3K (family),PRL,TCR,tretinoin	hydroxypropyl-beta-cyclodextrin	 	 	 	 	 	 	 	
DUB	group	 	1	 	biased	1.000	9.62E-03	2.90E-02	DUB	ABCA1	1 (1)	1	 	betulinic acid	 	 	 	 	 	 	 	
ENO1	enzyme	 	1	 	biased	-1.000	9.62E-03	4.69E-02	ENO1	BCL2L1	1 (1)	1	filgrastim,PRL	CD 437,GAPDH	 	 	 	 	 	 	 	
ENPP1	enzyme	 	1	 	biased	1.000	9.62E-03	2.73E-02	ENPP1	ALPL	1 (1)	1	progesterone	GAPDH,TRPS1	 	 	 	 	 	 	 	
HSPH1	other	 	1	 	biased	1.000	9.62E-03	1.92E-02	HSPH1	BCL6	1 (1)	1	 	 	 	 	 	 	 	 	 	
Integrin alpha 4 beta 1	complex	 	1	 	biased	-1.000	9.62E-03	4.72E-02	Integrin alpha 4 beta 1	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
LSS	enzyme	 	1	 	biased	-1.000	9.62E-03	3.07E-02	LSS	ABCA1	1 (1)	1	 	WT1	 	 	 	 	 	 	 	
PLK3	kinase	 	1	 	biased	-1.000	9.62E-03	3.09E-02	PLK3	SIAH2	1 (1)	1	 	tretinoin	 	 	 	 	 	 	 	
PPP1R3C	phosphatase	 	1	 	biased	-1.000	9.62E-03	3.25E-02	PPP1R3C	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
PRMT7	enzyme	 	1	 	biased	-1.000	9.62E-03	2.67E-02	PRMT7	BCL6	1 (1)	1	 	 	 	IRF4,PRDM1	 	 	 	 	 	
RBM8A	other	 	1	 	biased	-1.000	9.62E-03	4.76E-02	RBM8A	BCL2L1	1 (1)	1	SRPK1,tretinoin	 	 	 	 	 	 	 	 	
SLC48A1	transporter	 	1	 	biased	1.000	9.62E-03	2.62E-02	SLC48A1	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
ethyl-3-trifluoromethylbenzyl-alpha-ketoglutarate	chemical reagent	 	1	 	biased	-1.000	9.62E-03	2.70E-02	ethyl-3-trifluoromethylbenzyl-alpha-ketoglutarate	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
hyodeoxycholic acid	chemical - endogenous mammalian	 	1	 	biased	1.000	9.62E-03	2.87E-02	hyodeoxycholic acid	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
interferon beta-1b	biologic drug	 	1	 	biased	-1.000	9.62E-03	2.85E-02	interferon beta-1b	BSG	1 (1)	1	 	 	 	 	 	 	 	 	 	
mir-191	microRNA	 	1	 	biased	-1.000	9.62E-03	1.53E-02	mir-191	MXI1	1 (1)	1	 	 	 	 	 	 	 	 	 	
paxilline	chemical - endogenous non-mammalian	 	1	 	biased	1.000	9.62E-03	1.17E-02	paxilline	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
stigmasterol	chemical - endogenous mammalian	 	1	 	biased	1.000	9.62E-03	2.96E-02	stigmasterol	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
vinorelbine	chemical drug	 	1	 	biased	-1.000	9.62E-03	4.81E-02	vinorelbine	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
1-butanol	chemical - endogenous non-mammalian	 	1	 	biased	1.000	1.28E-02	2.98E-02	1-butanol	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
2-[[4-[(e)-styryl]phenoxy]methyl]oxirane	chemical reagent	 	1	 	biased	1.000	1.28E-02	4.01E-02	2-[[4-[(e)-styryl]phenoxy]methyl]oxirane	ABCA1	1 (1)	1	 	 	 	 	cholesterol	 	 	 	 	
AKR1C3	enzyme	 	1	 	biased	1.000	1.28E-02	2.75E-02	AKR1C3	SIAH2	1 (1)	1	progesterone	LGR5,NPC2,PRL	 	 	 	 	 	 	 	
ARID2	transcription regulator	 	1	 	biased	1.000	1.28E-02	3.42E-02	ARID2	ALPL	1 (1)	1	 	 	 	 	 	 	 	 	 	
BAG2	other	 	1	 	biased	1.000	1.28E-02	9.70E-03	BAG2	CTSB	1 (1)	1	 	valproic acid	 	 	 	 	 	 	 	
BRD3	kinase	 	1	 	biased	1.000	1.28E-02	2.64E-02	BRD3	SLC4A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
HCAR1	G-protein coupled receptor	 	1	 	biased	1.000	1.28E-02	3.62E-02	HCAR1	BSG	1 (1)	1	 	 	 	 	 	 	 	 	 	
HLA-B	transmembrane receptor	 	1	 	biased	-1.000	1.28E-02	3.60E-02	HLA-B	OAS2	1 (1)	1	TGM2,tretinoin	IL22RA2,NKX2-3	 	Immunoglobulin	 	 	 	 	 	
MAD1L1	other	 	1	 	biased	-1.000	1.28E-02	1.82E-02	MAD1L1	MXI1	1 (1)	1	valproic acid	 	 	 	 	 	 	 	 	
PAK4	kinase	 	1	 	biased	1.000	1.28E-02	2.77E-02	PAK4	CTSB	1 (1)	1	Pka catalytic subunit,SRPK1	 	 	 	 	 	 	 	 	
PAPPA	peptidase	 	1	 	biased	-1.000	1.28E-02	3.67E-02	PAPPA	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
SOAT2	enzyme	 	1	 	 	-1.000	1.28E-02	4.03E-02	SOAT2	ABCA1	1 (1)	1	HNF1A	 	 	cholesterol	HDL-cholesterol	 	 	 	 	
Stat dimer	complex	 	1	 	biased	1.000	1.28E-02	4.65E-02	Stat dimer	BCL2L1	1 (1)	1	 	 	 	 	 	 	 	 	 	
durapatite	chemical - endogenous mammalian	 	1	 	biased	1.000	1.28E-02	4.02E-02	durapatite	ALPL	1 (1)	1	 	 	 	 	 	 	 	 	 	
firtecan pegol	chemical drug	 	1	 	biased	-1.000	1.28E-02	3.72E-02	firtecan pegol	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
methylamine	chemical - endogenous mammalian	 	1	 	 	1.000	1.28E-02	2.00E-02	methylamine	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
miR-127-3p (miRNAs w/seed CGGAUCC)	mature microRNA	 	1	 	biased	-1.000	1.28E-02	3.38E-02	miR-127-3p (miRNAs w/seed CGGAUCC)	BCL6	1 (1)	1	hydroxypropyl-beta-cyclodextrin	 	 	 	PRDM1	 	 	 	 	
miR-339-5p (and other miRNAs w/seed CCCUGUC)	mature microRNA	 	1	 	biased	-1.000	1.28E-02	2.68E-02	miR-339-5p (and other miRNAs w/seed CCCUGUC)	BCL6	1 (1)	1	AGO2	 	 	 	 	 	 	 	 	
neopterin	chemical - endogenous mammalian	 	1	 	biased	-1.000	1.28E-02	1.95E-02	neopterin	ABCA1	1 (1)	1	 	 	 	 	 	 	 	 	 	
parbendazole	chemical reagent	 	1	 	biased	1.000	1.28E-02	3.45E-02	parbendazole	ALPL	1 (1)	1	 	 	 	 	 	 	 	 	 	
phenformin	chemical drug	 	1	 	 	1.000	1.28E-02	2.71E-02	phenformin	SLC2A1	1 (1)	1	 	 	 	NBR2	 	 	 	 	 	
glucagon	biologic drug	 	1	 	biased	1.414	1.36E-02	4.70E-02	glucagon	MME,SNX3	2 (1)	1	 	 	 	PPP1R1B	TJP2	 	 	 	 	
CREB3L4	transcription regulator	 	1	 	biased	1.000	1.60E-02	3.53E-02	CREB3L4	AQP9	1 (1)	1	 	 	 	 	 	 	 	 	 	
DAB1	other	 	1	 	biased	1.000	1.60E-02	3.92E-02	DAB1	ABCA1	1 (1)	1	L-dopa	LRP8	 	 	 	 	 	 	 	
EN2	transcription regulator	 	1	 	biased	1.000	1.60E-02	4.55E-02	EN2	SNCA	1 (1)	1	 	 	 	 	 	 	 	 	 	
FOXI1	transcription regulator	 	1	 	biased	1.000	1.60E-02	1.76E-02	FOXI1	SLC4A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
LRP8	transmembrane receptor	 	1	 	 	1.000	1.60E-02	3.67E-02	LRP8	ABCA1	1 (1)	1	 	 	 	 	DAB1	 	 	 	 	
glimepiride	chemical drug	 	1	 	biased	1.000	1.60E-02	4.31E-02	glimepiride	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
APBA3	transporter	 	1	 	biased	1.000	1.91E-02	4.89E-02	APBA3	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	
Presenilin	group	 	1	 	biased	-1.000	1.91E-02	4.28E-02	Presenilin	FKBP8	1 (1)	1	 	 	 	 	 	 	 	 	 	
RNF17	other	 	1	 	biased	1.000	1.91E-02	4.40E-02	RNF17	MXI1	1 (1)	1	 	 	 	 	 	 	 	 	 	
CCNT1	transcription regulator	 	1	 	biased	1.000	2.23E-02	3.98E-02	CCNT1	SLC2A1	1 (1)	1	MYCN	 	 	INS	 	 	 	 	 	
pictilisib	chemical drug	 	1	 	 	-1.000	2.23E-02	4.75E-02	pictilisib	SLC2A1	1 (1)	1	 	 	 	 	 	 	 	 	 	

Diseases and Bio Functions for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	renal cell cancer	Renal cell carcinoma	3.83E-10	 	 	 	 	GYPC,MPP1,AQP9,MME,PYGL,BNIP3L,ANK1,SIAH2,BAG1,BLVRB,SAMD9L,GLRX5,BSG,MXI1,SLC6A8,MAP2K3,KCNJ15,BCL2L1,DDX60L,OPTN,SPTB,SLC4A1	22	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	neoplasia	Renal tumor	9.12E-10	 	 	 	 	GYPC,MPP1,AQP9,MME,PYGL,RNF10,ANK1,BNIP3L,SIAH2,BAG1,BLVRB,SAMD9L,GLRX5,BSG,MXI1,SLC6A8,MAP2K3,KCNJ15,BCL2L1,DDX60L,OPTN,SPTB,SLC4A1	23	
Immunological Disease	systemic autoimmune syndrome	Systemic autoimmune syndrome	1.99E-08	 	 	 	 	AQP9,GLUL,C9orf78,MME,UBE2H,ABCA1,ADIPOR1,OAS2,PARP9,APOBEC3A,SAMD9L,GLRX5,MGAM,ALPL,BCL6,SNCA,RBM38,ACSL1,CTSB,UBB,KCNJ15,BCL2L1,ST6GALNAC4	23	
Inflammatory Disease	chronic inflammatory disorder	Chronic inflammatory disorder	2.48E-08	 	 	 	 	AQP9,GLUL,C9orf78,MME,UBE2H,ABCA1,ADIPOR1,SAMD9L,GLRX5,BSG,MGAM,ALPL,BCL6,SNCA,RBM38,ACSL1,CTSB,UBB,KCNJ15,BCL2L1,ST6GALNAC4	21	
Cardiovascular Disease, Cell Death and Survival, Connective Tissue Disorders, Developmental Disorder, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	dominant spherocytosis	Dominant spherocytosis	3.04E-08	 	 	 	 	ANK1,SPTB,SLC4A1	3	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	rheumatoid arthritis	Rheumatoid arthritis	4.26E-08	 	 	 	 	GLUL,AQP9,C9orf78,MME,UBE2H,ADIPOR1,SAMD9L,GLRX5,ALPL,BCL6,SNCA,RBM38,ACSL1,CTSB,UBB,KCNJ15,ST6GALNAC4	17	
Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	spherocytosis	Spherocytosis	4.48E-08	 	 	 	 	BNIP3L,ANK1,SPTB,SLC4A1	4	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	urinary tract tumor	Urinary tract tumor	5.10E-08	 	 	 	 	GYPC,UBA52,BNIP3L,BLVRB,GLRX5,BSG,NUCB1,SLC6A8,MAP2K3,KCNJ15,DDX60L,OPTN,SLC4A1,MPP1,AQP9,MME,PYGL,RNF10,ANK1,SIAH2,BAG1,OAS2,SAMD9L,SLC2A1,MXI1,NTNG2,BCL2L1,SPTB	28	
Connective Tissue Disorders, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	rheumatic disease	Rheumatic Disease	9.59E-08	 	 	 	 	AQP9,GLUL,C9orf78,MME,UBE2H,ADIPOR1,OAS2,PARP9,APOBEC3A,SAMD9L,GLRX5,ALPL,BCL6,SNCA,RBM38,ACSL1,CTSB,NFIX,UBB,KCNJ15,BCL2L1,ST6GALNAC4	22	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	urinary tract cancer	Urinary tract cancer	1.29E-07	 	 	 	 	GYPC,UBA52,BNIP3L,BLVRB,GLRX5,BSG,NUCB1,SLC6A8,MAP2K3,KCNJ15,DDX60L,OPTN,SLC4A1,MPP1,AQP9,MME,PYGL,ANK1,SIAH2,BAG1,OAS2,SAMD9L,SLC2A1,MXI1,NTNG2,BCL2L1,SPTB	27	
Small Molecule Biochemistry	metabolism	Metabolism of porphyrin	3.82E-07	 	 	 	 	SNX3,ANK1,BLVRB,BCL2L1,SPTB	5	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	inflammation	Inflammation of joint	9.65E-07	 	 	 	 	AQP9,GLUL,C9orf78,MME,UBE2H,ADIPOR1,SAMD9L,GLRX5,ALPL,BCL6,SNCA,RBM38,ACSL1,CTSB,NFIX,UBB,KCNJ15,ST6GALNAC4	18	
Small Molecule Biochemistry	synthesis	Synthesis of porphyrin	3.11E-06	 	 	 	 	SNX3,ANK1,BCL2L1,SPTB	4	
Cell Death and Survival	apoptosis	Apoptosis of hepatoma cell lines	4.03E-06	 	-0.431	 	-0.816	IGF2BP2,FKBP8,CTSB,MAP2K3,FOXO4,BCL2L1,BSG	7	
Protein Synthesis	metabolism	Metabolism of protein	5.97E-06	 	0.492	bias	-0.377	SNX3,UBXN6,UBA52,MME,SIAH2,DPM2,ABCA1,BAG1,SAMD9L,IGF2BP2,SNCA,RBM38,NUCB1,CTSB,UBB,MAP2K3,YBX1,BCL2L1	18	
Cancer, Organismal Injury and Abnormalities	genitourinary adenocarcinoma	Genitourinary adenocarcinoma	8.74E-06	 	 	 	 	GYPC,GLUL,C9orf78,BNIP3L,APOBEC3A,BLVRB,FOXO4,GLRX5,PITHD1,BSG,SNCA,ACSL1,NUCB1,SLC6A8,MAP2K3,KCNJ15,YBX1,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,MME,PYGL,RNF10,ANK1,SIAH2,GRINA,ABCA1,BAG1,OAS2,SAMD9L,SLC2A1,MGAM,BCL6,MXI1,CREB5,NTNG2,NFIX,UBB,SLC38A5,BCL2L1,GMPR,SPTB	45	
Cancer, Organismal Injury and Abnormalities	carcinoma	Carcinoma	1.43E-05	 	-1.982	 	-1.909	C9orf78,BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,PARP9,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,IGF2BP2,ALPL,BCL6,MXI1,CRISPLD2,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,UBA52,GLUL,PHOSPHO1,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,LYL1,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,FAM210B,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	68	
Cancer, Organismal Injury and Abnormalities	genitourinary carcinoma	Genitourinary carcinoma	1.70E-05	 	 	 	 	GYPC,UBA52,GLUL,C9orf78,BNIP3L,APOBEC3A,BLVRB,FOXO4,GLRX5,PITHD1,BSG,SNCA,ACSL1,NUCB1,SLC6A8,MAP2K3,KCNJ15,YBX1,DDX60L,OPTN,SLC4A1,ST6GALNAC4,STRADB,MPP1,AQP9,MME,PYGL,RNF10,ANK1,SIAH2,GRINA,ABCA1,BAG1,OAS2,SAMD9L,SLC2A1,MGAM,BCL6,MXI1,CREB5,NTNG2,CTSB,NFIX,UBB,SLC38A5,BCL2L1,GMPR,SPTB	48	
Infectious Diseases	infection	Viral Infection	2.92E-05	Increased	3.465	bias	 	STRADB,UBA52,GLUL,UBE2H,PYGL,RNF10,OAS2,PARP9,SLC2A1,BSG,MGAM,ACSL1,CTSB,UBB,MAP2K3,AP2A1,BCL2L1,YBX1,DDX60L,OPTN	20	
Cell Death and Survival	necrosis	Necrosis	3.02E-05	 	-1.176	 	-0.691	BNIP3L,ADIPOR1,FOXO4,BSG,ADGRG3,SNCA,ACSL1,FKBP8,SLC6A8,MAP2K3,YBX1,OPTN,LYL1,STRADB,HDGF,MME,PYGL,SIAH2,GRINA,BAG1,SLC2A1,IGF2BP2,BCL6,MXI1,CTSB,NFIX,UBB,BCL2L1	28	
Hematological System Development and Function, Lymphoid Tissue Structure and Development, Organ Morphology, Organismal Development, Tissue Morphology	morphology	Morphology of spleen	3.92E-05	 	 	 	 	ADGRG3,BCL6,ALPL,MXI1,RBM38,BNIP3L,ABCA1,BCL2L1,SLC4A1	9	
Hematological System Development and Function, Immunological Disease, Lymphoid Tissue Structure and Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	abnormal morphology	Abnormal morphology of spleen	5.84E-05	 	 	 	 	ADGRG3,BCL6,ALPL,MXI1,RBM38,BNIP3L,ABCA1,SLC4A1	8	
Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	poikilocytosis	Poikilocytosis	6.66E-05	 	 	 	 	BNIP3L,SPTB,SLC4A1	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	growth	Growth of mammary tumor	7.46E-05	 	0.669	 	0.180	SIAH2,CTSB,BAG1,MAP2K3,BCL2L1	5	
Cancer, Organismal Injury and Abnormalities	abdominal adenocarcinoma	Abdominal adenocarcinoma	7.96E-05	 	 	 	 	C9orf78,BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PHOSPHO1,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	61	
Cell Death and Survival	apoptosis	Apoptosis of tumor cell lines	8.20E-05	 	-1.178	 	-0.838	MME,BNIP3L,SIAH2,ADIPOR1,BAG1,FOXO4,SLC2A1,BSG,IGF2BP2,BCL6,MXI1,SNCA,FKBP8,CTSB,MAP2K3,BCL2L1,YBX1	17	
Lipid Metabolism, Molecular Transport, Nucleic Acid Metabolism, Small Molecule Biochemistry	concentration	Concentration of acyl-coenzyme A	8.43E-05	 	 	 	 	IGF2BP2,ACSL1,BCL2L1	3	
Hematological System Development and Function, Tissue Morphology	quantity	Quantity of blood cells	8.82E-05	 	0.668	bias	-0.171	MPP1,BNIP3L,ABCA1,SLC2A1,ADGRG3,ALPL,BCL6,SNCA,RBM38,CTSB,BCL2L1,YBX1,LYL1,SPTB,SLC4A1	15	
Cancer, Organismal Injury and Abnormalities	frequency	Frequency of tumor	9.07E-05	 	-0.318	 	0.134	BNIP3L,ADIPOR1,APOBEC3A,BLVRB,FOXO4,GLRX5,NUCB1,KCNJ15,HDGF,MME,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,MAP2K3,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	51	
Endocrine System Disorders, Gastrointestinal Disease, Metabolic Disease, Organismal Injury and Abnormalities	non-insulin-dependent diabetes mellitus	Non-insulin-dependent diabetes mellitus	9.52E-05	 	 	 	 	IGF2BP2,MGAM,ALPL,SNCA,MME,CREB5,ABCA1,ADIPOR1,BCL2L1	9	
Connective Tissue Disorders, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	hereditary elliptocytosis	Hereditary elliptocytosis	9.83E-05	 	 	 	 	SPTB,SLC4A1	2	
Cardiovascular Disease, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	hereditary stomatocytosis	Hereditary stomatocytosis	9.83E-05	 	 	 	 	SLC2A1,SLC4A1	2	
Cancer, Organismal Injury and Abnormalities	incidence	Incidence of tumor	9.94E-05	 	-0.185	 	0.200	BNIP3L,ADIPOR1,APOBEC3A,BLVRB,FOXO4,GLRX5,NUCB1,KCNJ15,ST6GALNAC4,HDGF,MME,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,MAP2K3,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	52	
Cardiovascular Disease, Hematological Disease, Organismal Injury and Abnormalities	anemia	Anemia	1.06E-04	Decreased	-2.228	bias	 	RBM38,SLC25A37,BNIP3L,ANK1,GLRX5,BCL2L1,SLC2A1,SPTB,SLC4A1	9	
Cellular Assembly and Organization	transport	Transport of endosomes	1.10E-04	 	 	 	 	SNX3,UBA52,UBB,ABCA1	4	
Cell Death and Survival	cell death	Cell death of neuroblastoma cell lines	1.21E-04	 	1.387	 	1.598	MXI1,SNCA,FKBP8,BAG1,MAP2K3,BCL2L1	6	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastrointestinal carcinoma	Gastrointestinal carcinoma	1.25E-04	 	 	 	 	BNIP3L,DPM2,ADIPOR1,BLVRB,APOBEC3A,FOXO4,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PHOSPHO1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	57	
Neurological Disease, Organismal Injury and Abnormalities	abnormality	Abnormality of cerebrum	1.26E-04	 	0.911	bias	1.610	SNCA,MME,FKBP8,CTSB,NFIX,ABCA1,BCL2L1	7	
Cellular Assembly and Organization, Cellular Function and Maintenance	permeability	Permeability of cellular membrane	1.28E-04	 	 	 	 	SNCA,BNIP3L,BCL2L1	3	
Cancer, Organismal Injury and Abnormalities	development	Development of malignant tumor	1.38E-04	 	0.199	 	0.726	BNIP3L,ADIPOR1,APOBEC3A,BLVRB,FOXO4,GLRX5,NUCB1,KCNJ15,HDGF,MME,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,MAP2K3,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,ANK1,ABCA1,BAG1,OAS2,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	50	
Cancer, Organismal Injury and Abnormalities	tumorigenesis	Tumorigenesis of epithelial neoplasm	1.45E-04	 	 	 	 	BNIP3L,ADIPOR1,APOBEC3A,BLVRB,FOXO4,GLRX5,NUCB1,KCNJ15,HDGF,MME,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,MAP2K3,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	50	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	leukemia	Initiation of leukemia	1.47E-04	 	 	 	 	BCL6,BCL2L1	2	
Cancer, Organismal Injury and Abnormalities	extracranial solid tumor	Extracranial solid tumor	1.55E-04	 	-0.608	 	-0.553	C9orf78,BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,PARP9,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,IGF2BP2,ALPL,BCL6,MXI1,CRISPLD2,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,UBA52,GLUL,PHOSPHO1,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,LYL1,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,FAM210B,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	68	
Cell Death and Survival	cell death	Cell death of tumor cell lines	1.59E-04	 	-0.911	 	-0.549	MME,BNIP3L,SIAH2,GRINA,ADIPOR1,BAG1,FOXO4,SLC2A1,BSG,IGF2BP2,BCL6,MXI1,SNCA,FKBP8,CTSB,NFIX,MAP2K3,BCL2L1,YBX1	19	
Hematological Disease	hemorrhagic disease	Hemorrhagic disease	1.69E-04	 	-1.082	bias	 	BCL6,CTSB,ABCA1,OAS2,BCL2L1,LYL1,SLC4A1	7	
Cancer, Organismal Injury and Abnormalities	development	Development of adenocarcinoma	1.77E-04	 	 	 	 	GYPC,GLUL,BNIP3L,APOBEC3A,BLVRB,FOXO4,GLRX5,PITHD1,BSG,ACSL1,NUCB1,SLC6A8,MAP2K3,KCNJ15,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,MME,PYGL,ANK1,SIAH2,ABCA1,BAG1,SAMD9L,MGAM,BCL6,MXI1,CREB5,NFIX,SLC38A5,BCL2L1,GMPR,SPTB	36	
Cell Death and Survival, Renal and Urological System Development and Function	cell viability	Cell viability of kidney cell lines	1.92E-04	 	 	 	 	BCL6,APOBEC3A,BCL2L1,SLC2A1	4	
Organismal Injury and Abnormalities	cytosis	Cytosis of blood cells	1.94E-04	 	 	 	 	BNIP3L,ANK1,SPTB,BSG,SLC4A1	5	
Cell Death and Survival	cell death	Cell death of cervical cancer cell lines	2.00E-04	 	-1.258	 	-1.050	SNCA,FKBP8,CTSB,BNIP3L,GRINA,BAG1,FOXO4,BCL2L1	8	
Cell Death and Survival, Embryonic Development	cell death	Cell death of embryonic cell lines	2.00E-04	 	0.028	bias	-0.641	BCL6,SNCA,FKBP8,CTSB,BNIP3L,ADIPOR1,BAG1,BCL2L1	8	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastrointestinal tract cancer	Gastrointestinal tract cancer	2.05E-04	 	 	 	 	BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PHOSPHO1,BSG,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	58	
Connective Tissue Disorders, Endocrine System Disorders, Organ Morphology, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease, Tissue Morphology	loss	Loss of epididymal fat	2.06E-04	 	 	 	 	ABCA1,SLC2A1	2	
Cell Death and Survival	apoptosis	Apoptosis	2.13E-04	 	-1.200	 	-0.499	UBA52,BNIP3L,ADIPOR1,FOXO4,BSG,ADGRG3,SNCA,ACSL1,FKBP8,MAP2K3,YBX1,OPTN,LYL1,STRADB,HDGF,MME,SIAH2,ABCA1,BAG1,SLC2A1,IGF2BP2,BCL6,MXI1,CTSB,UBB,BCL2L1	26	
Cell Death and Survival	apoptosis	Apoptosis of erythroid precursor cells	2.19E-04	 	 	 	 	BNIP3L,BCL2L1,LYL1	3	
Organismal Development	abnormal morphology	Abnormal morphology of body cavity	2.20E-04	 	 	 	 	BNIP3L,ABCA1,GLRX5,BSG,ADGRG3,ALPL,BCL6,MXI1,RBM38,ACSL1,SLC6A8,CTSB,NFIX,MAP2K3,BCL2L1,YBX1,SLC4A1	17	
Carbohydrate Metabolism	catabolism	Catabolism of polysaccharide	2.27E-04	 	 	 	 	MGAM,PYGL,CTSB,AP2A1	4	
Cancer, Organismal Injury and Abnormalities	development	Development of carcinoma	2.42E-04	 	 	 	 	BNIP3L,ADIPOR1,APOBEC3A,BLVRB,FOXO4,GLRX5,NUCB1,KCNJ15,HDGF,MME,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,MAP2K3,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,ANK1,ABCA1,BAG1,OAS2,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	49	
Cancer, Organismal Injury and Abnormalities	malignant genitourinary solid tumor	Malignant genitourinary solid tumor	2.62E-04	 	 	 	 	C9orf78,BNIP3L,APOBEC3A,BLVRB,FOXO4,GLRX5,SNCA,NUCB1,KCNJ15,ST6GALNAC4,MME,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,GYPC,UBA52,GLUL,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,CTSB,SLC38A5,GMPR	50	
Cell Death and Survival	apoptosis	Apoptosis of cervical cancer cell lines	2.72E-04	 	-1.400	 	-1.239	SNCA,FKBP8,CTSB,BNIP3L,BAG1,FOXO4,BCL2L1	7	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	resistance to malaria	Resistance to malaria	2.74E-04	 	 	 	 	GYPC,SLC4A1	2	
Neurological Disease, Skeletal and Muscular Disorders	sensorimotor impairment	Sensorimotor impairment	2.74E-04	 	 	 	 	SNCA,ABCA1	2	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy of mitochondria	2.77E-04	 	 	 	 	SNCA,UBB,BCL2L1	3	
Carbohydrate Metabolism	metabolism	Metabolism of carbohydrate	2.84E-04	 	1.976	bias	 	MGAM,AQP9,SNCA,PYGL,CTSB,DPM2,PHOSPHO1,AP2A1,SLC2A1,OPTN,BSG	11	
Cellular Assembly and Organization, Cellular Compromise	formation	Formation of cellular inclusion bodies	2.88E-04	 	 	 	 	SNCA,SIAH2,CTSB,BCL2L1	4	
Cardiovascular Disease, Cell Death and Survival, Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	hemolytic anemia	Hemolytic anemia	2.88E-04	 	 	 	 	ANK1,BCL2L1,SPTB,SLC4A1	4	
Cell Morphology, Hematological System Development and Function, Hematopoiesis, Tissue Morphology	morphology	Morphology of red blood cells	3.11E-04	 	 	 	 	RBM38,BNIP3L,SPTB,SLC4A1	4	
Organismal Development	morphology	Morphology of body cavity	3.28E-04	 	 	 	 	BNIP3L,ABCA1,ADIPOR1,GLRX5,BSG,ADGRG3,ALPL,BCL6,MXI1,RBM38,ACSL1,SLC6A8,CTSB,NFIX,MAP2K3,BCL2L1,YBX1,SLC4A1	18	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	large intestine adenocarcinoma	Large intestine adenocarcinoma	3.29E-04	 	 	 	 	BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,GLRX5,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PHOSPHO1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	54	
Cell Death and Survival	cell viability	Cell viability of breast cancer cell lines	3.32E-04	Increased	2.379	bias	 	BCL6,ADIPOR1,BAG1,MAP2K3,BCL2L1,YBX1	6	
Cell Death and Survival	apoptosis	Apoptosis of breast cancer cell lines	3.39E-04	 	-1.074	 	-0.996	BCL6,BNIP3L,BAG1,FOXO4,MAP2K3,BCL2L1,SLC2A1	7	
Molecular Transport	export	Export of molecule	3.49E-04	 	0.706	bias	 	STRADB,SNCA,ACSL1,ABCA1,MAP2K3,SLC4A1,BSG	7	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	fluidity	Fluidity of plasma membrane	3.51E-04	 	 	 	 	SNCA,ABCA1	2	
Lipid Metabolism, Molecular Transport, Nucleic Acid Metabolism, Small Molecule Biochemistry	quantity	Quantity of long-chain acyl-coenzyme A	3.51E-04	 	 	 	 	IGF2BP2,ACSL1	2	
Cellular Assembly and Organization, Tissue Development	formation	Formation of fibrils	3.67E-04	 	 	 	 	SNCA,MME,CTSB	3	
Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	thrombocytopenia	Thrombocytopenia	3.77E-04	 	-1.960	bias	 	BCL6,ABCA1,OAS2,BCL2L1,LYL1,SLC4A1	6	
Cancer, Organismal Injury and Abnormalities	abdominal neoplasm	Abdominal neoplasm	3.98E-04	 	0.277	 	0.439	C9orf78,BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,UBA52,GLUL,PHOSPHO1,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,FAM210B,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	64	
Hematological System Development and Function, Organismal Development, Tissue Morphology	quantity	Quantity of blood	4.11E-04	Decreased	-2.067	 	-2.265	BNIP3L,ABCA1,BCL2L1,LYL1,SPTB,SLC4A1	6	
Metabolic Disease, Organismal Injury and Abnormalities	amyloidosis	Amyloidosis	4.22E-04	 	 	 	 	BCL6,SNCA,MME,CTSB,UBB,ABCA1,BAG1,BCL2L1,SLC2A1,DDX60L	10	
Cell Death and Survival	cell death	Cell death of neuronal hybrid cells	4.38E-04	 	 	 	 	BCL2L1,OPTN	2	
Protein Degradation, Protein Synthesis	catabolism	Catabolism of protein	4.53E-04	 	-0.156	bias	-1.045	SNX3,UBXN6,SNCA,MME,CTSB,SIAH2,DPM2,BAG1,SAMD9L,BCL2L1	10	
Cancer, Organismal Injury and Abnormalities	abdominal carcinoma	Abdominal carcinoma	4.72E-04	 	 	 	 	C9orf78,BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,UBA52,GLUL,PHOSPHO1,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,MPP1,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	62	
Molecular Transport	transport	Transport of molecule	4.87E-04	Increased	2.222	bias	 	SNX3,STRADB,AQP9,GLUL,SLC25A37,ANK1,ABCA1,SLC2A1,BSG,SNCA,ACSL1,SLC6A8,SLC38A5,MAP2K3,AP2A1,KCNJ15,OPTN,SLC4A1	18	
Cancer, Dermatological Diseases and Conditions, Developmental Disorder, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous marginal zone B-cell lymphoma	Primary cutaneous marginal zone B-cell lymphoma	5.34E-04	 	 	 	 	BCL6,MME	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	unclassifiable B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma	Unclassifiable B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma	5.34E-04	 	 	 	 	BCL6,MME	2	
Organismal Injury and Abnormalities	visceromegaly	Visceromegaly	5.40E-04	 	 	 	 	MXI1,RBM38,ACSL1,SLC6A8,CTSB,BNIP3L,ABCA1,MAP2K3,GLRX5,BCL2L1,SLC4A1	11	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	concentration	Concentration of D-glucose	5.72E-04	 	-0.555	 	-0.645	IGF2BP2,AQP9,ACSL1,ADIPOR1,GBP5,BAG1,SLC2A1	7	
Neurological Disease	movement disorder	Movement Disorders	6.07E-04	 	-0.937	bias	 	GYPC,MME,RNF10,ABCA1,SAMD9L,SLC2A1,BCL6,SNCA,CTSB,NFIX,UBB,BCL2L1,DDX60L,OPTN	14	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of glycine	6.40E-04	 	 	 	 	SLC38A5,SLC4A1	2	
Cellular Movement	migration	Migration of cells	6.61E-04	Increased	2.346	bias	0.698	GYPC,MPP1,AQP9,HDGF,MME,SIAH2,GRINA,ABCA1,ADIPOR1,BAG1,PARP9,FOXO4,SLC2A1,BSG,ADGRG3,BCL6,CTSB,NFIX,MAP2K3,BCL2L1,YBX1	21	
Carbohydrate Metabolism	quantity	Quantity of carbohydrate	6.70E-04	 	0.000	 	-0.359	IGF2BP2,AQP9,SNCA,ACSL1,GBP5,ABCA1,ADIPOR1,BAG1,SLC2A1	9	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	quantity	Quantity of sphingolipid	6.71E-04	 	 	 	 	ACSL1,ADIPOR1,ABCA1,GRINA	4	
Protein Synthesis	metabolism	Metabolism of cellular protein	6.83E-04	 	 	 	 	SNCA,UBA52,NUCB1,SIAH2,UBB	5	
Hair and Skin Development and Function	pallor	Pallor	7.33E-04	 	 	 	 	SNCA,SLC25A37,YBX1,SLC4A1	4	
Molecular Transport	transport	Transport of carboxylic acid	7.33E-04	 	 	 	 	AQP9,ACSL1,SLC2A1,BSG	4	
Cell Death and Survival	cytolysis	Cytolysis	7.39E-04	 	 	 	 	AQP9,MME,ANK1,BCL2L1,SPTB,SLC4A1	6	
Protein Trafficking	targeting	Targeting of protein	7.40E-04	 	 	 	 	STRADB,UBA52,UBB,GBP5,OPTN	5	
Cell Death and Survival	apoptosis	Apoptosis of nervous tissue cell lines	7.48E-04	 	 	 	 	SNCA,BCL2L1,OPTN	3	
Post-Translational Modification	lipidation	Lipidation of protein	7.48E-04	 	 	 	 	GLUL,DPM2,ABCA1	3	
Neurological Disease, Organismal Injury and Abnormalities	abnormality	Abnormality of cerebral cortex	7.50E-04	 	0.911	bias	1.674	SNCA,MME,CTSB,NFIX,ABCA1,BCL2L1	6	
Cell Death and Survival, Embryonic Development	apoptosis	Apoptosis of embryonic stem cell lines	7.54E-04	 	 	 	 	SNCA,BCL2L1	2	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy of prostate cancer cell lines	7.54E-04	 	 	 	 	BNIP3L,BCL2L1	2	
Cancer, Developmental Disorder, Gastrointestinal Disease, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	gastric mucosa-associated lymphoid tissue lymphoma	Gastric mucosa-associated lymphoid tissue lymphoma	7.54E-04	 	 	 	 	BCL6,MME	2	
Organismal Survival	survival	Survival of organism	7.58E-04	 	0.369	bias	-0.586	BCL6,AQP9,SNCA,GLUL,ACSL1,MME,CTSB,SIAH2,BCL2L1,SLC2A1,SLC4A1	11	
Infectious Diseases	infection	Infection of kidney cell lines	7.62E-04	Increased	2.224	bias	 	UBE2H,RNF10,CTSB,PARP9,YBX1,BSG	6	
Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of organ	7.80E-04	 	-0.007	bias	0.664	MME,ABCA1,APOBEC3A,GLRX5,BSG,MGAM,BCL6,MXI1,SNCA,FKBP8,CTSB,MAP2K3,BCL2L1,YBX1,DDX60L,OPTN	16	
Post-Translational Modification	deubiquitination	Deubiquitination of protein	7.85E-04	 	 	 	 	SNX3,UBA52,SIAH2,UBB,FOXO4	5	
Cell Death and Survival	cell death	Cell death of pheochromocytoma cell lines	8.22E-04	 	1.732	 	1.467	SNCA,BNIP3L,MAP2K3,BCL2L1	4	
Molecular Transport, Small Molecule Biochemistry	transport	Transport of amine	8.29E-04	 	 	 	 	SNCA,AQP9,MAP2K3	3	
Cardiovascular Disease, Cell Death and Survival, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	apoptosis	Apoptosis of cardiomyocytes	8.66E-04	 	-0.580	 	-0.146	ACSL1,BNIP3L,BAG1,MAP2K3,BCL2L1	5	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Tissue Morphology	neurodegeneration	Neurodegeneration of striatal neurons	8.78E-04	 	 	 	 	SNCA,BCL2L1	2	
Cellular Function and Maintenance, Hematological System Development and Function	presence	Presence of red blood cells	8.78E-04	 	 	 	 	BNIP3L,SLC4A1	2	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy	8.94E-04	 	1.671	 	1.245	UBXN6,SNCA,ACSL1,CTSB,BNIP3L,UBB,BCL2L1,OPTN	8	
Neurological Disease, Organismal Injury and Abnormalities	neurodegeneration	Neurodegeneration of brain	8.94E-04	 	-0.747	bias	 	SNCA,MME,CTSB,BCL2L1	4	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	digestive organ tumor	Digestive organ tumor	9.08E-04	 	 	 	 	C9orf78,BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PHOSPHO1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,FAM210B,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	61	
Cell Death and Survival	apoptosis	Apoptosis of fibrosarcoma cell lines	9.15E-04	 	 	 	 	CTSB,BCL2L1,YBX1	3	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	proliferation	Proliferation of myeloid progenitor cells	9.15E-04	 	 	 	 	FOXO4,SAMD9L,BCL2L1	3	
Cell Death and Survival	apoptosis	Apoptosis of neuroblastoma cell lines	9.97E-04	 	1.526	 	1.687	MXI1,FKBP8,MAP2K3,BCL2L1	4	
Cardiovascular System Development and Function, Organ Development	cardioprotection	Cardioprotection	1.01E-03	 	 	 	 	SIAH2,ABCA1	2	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	growth	Growth of neuroendocrine tumor	1.01E-03	 	 	 	 	MME,CTSB	2	
Cell Death and Survival	apoptosis	Apoptosis of B-lymphocyte derived cell lines	1.05E-03	 	-1.948	 	-1.948	FKBP8,BAG1,BCL2L1,SLC2A1	4	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	digestive system cancer	Digestive system cancer	1.06E-03	 	 	 	 	C9orf78,BNIP3L,DPM2,ADIPOR1,APOBEC3A,FOXO4,BLVRB,GLRX5,SNCA,NUCB1,PPDPF,KCNJ15,ST6GALNAC4,UBXN6,HDGF,MME,SLC25A37,SIAH2,GRINA,SAMD9L,MGAM,ALPL,BCL6,MXI1,RBM38,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PHOSPHO1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,MAP2K3,YBX1,DDX60L,OPTN,SLC4A1,STRADB,AQP9,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,DCAF12,CTSB,SLC38A5,AP2A1,GMPR	60	
Cell Death and Survival	apoptosis	Apoptosis of sarcoma cell lines	1.06E-03	 	-0.837	 	-0.987	BCL6,CTSB,BAG1,BCL2L1,YBX1	5	
Cell Death and Survival	cell death	Cell death of blood cells	1.14E-03	 	-0.962	 	-1.240	ADGRG3,BCL6,FKBP8,CTSB,BNIP3L,BAG1,MAP2K3,BCL2L1,SLC2A1,LYL1	10	
Cell-To-Cell Signaling and Interaction, Small Molecule Biochemistry	metabolism	Metabolism of neurotransmitter	1.16E-03	 	 	 	 	GLUL,SNCA,SLC6A8	3	
Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Alzheimer disease	Alzheimer disease	1.19E-03	 	 	 	 	SNCA,MME,CTSB,UBB,ABCA1,BAG1,BCL2L1,SLC2A1,DDX60L	9	
Cellular Movement	cell movement	Cell movement	1.21E-03	Increased	2.532	bias	0.803	GYPC,MPP1,AQP9,HDGF,MME,SIAH2,GRINA,ABCA1,ADIPOR1,BAG1,PARP9,FOXO4,SLC2A1,BSG,ADGRG3,BCL6,SNCA,CTSB,NFIX,MAP2K3,BCL2L1,YBX1	22	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	juvenile rheumatoid arthritis	Juvenile rheumatoid arthritis	1.25E-03	 	 	 	 	BCL6,C9orf78,MME,UBB,GLRX5	5	
Antimicrobial Response, Inflammatory Response	antiviral response	Antiviral response	1.27E-03	 	 	 	 	BNIP3L,OAS2,PARP9,APOBEC3A,BCL2L1	5	
Hematological Disease, Metabolic Disease, Organismal Injury and Abnormalities	acidemia	Acidemia	1.30E-03	 	 	 	 	GLRX5,SLC4A1	2	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of squamous cell carcinoma cell lines	1.30E-03	 	 	 	 	CTSB,BSG	2	
Psychological Disorders	sporadic psychological disorder	Sporadic psychological disorder	1.37E-03	 	 	 	 	SNCA,UBB,BCL2L1	3	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of amino acids	1.42E-03	 	1.944	bias	 	GLUL,SLC6A8,SLC38A5,SLC4A1	4	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	concentration	Concentration of lipid	1.44E-03	 	-1.228	 	-1.460	IGF2BP2,AQP9,SNCA,ACSL1,SIAH2,GBP5,ABCA1,GRINA,ADIPOR1,FOXO4,BCL2L1	11	
Cellular Function and Maintenance	homeostasis	Cellular homeostasis	1.45E-03	Increased	2.085	bias	1.005	UBXN6,PYGL,ANK1,BNIP3L,ABCA1,ADIPOR1,SLC2A1,BSG,BCL6,SNCA,ACSL1,CTSB,UBB,BCL2L1,OPTN,LYL1,SLC4A1	17	
Cell Cycle	cell cycle progression	Arrest in cell cycle progression of lymphocytes	1.46E-03	 	 	 	 	BCL6,BCL2L1	2	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy of neurons	1.46E-03	 	 	 	 	SNCA,OPTN	2	
Cell Death and Survival	cell death	Cell death of monocyte-derived macrophages	1.46E-03	 	 	 	 	CTSB,BCL2L1	2	
Cell Death and Survival, Organismal Injury and Abnormalities	cell death	Cell death of epithelial cell lines	1.47E-03	 	-0.168	 	-0.711	BCL6,SNCA,FKBP8,BNIP3L,BAG1,BCL2L1	6	
Cell Death and Survival, Hematological System Development and Function	cell viability	Cell viability of B-lymphocyte derived cell lines	1.49E-03	 	 	 	 	SNCA,BAG1,BCL2L1	3	
Cell Death and Survival, Organismal Injury and Abnormalities	necrosis	Necrosis of epithelial tissue	1.51E-03	 	0.705	 	0.698	BCL6,SNCA,FKBP8,CTSB,BNIP3L,BAG1,MAP2K3,FOXO4,BCL2L1	9	
Connective Tissue Development and Function, Tissue Morphology	quantity	Quantity of connective tissue	1.53E-03	 	-0.457	 	-1.090	ALPL,RBM38,CREB5,BNIP3L,ABCA1,BCL2L1,LYL1,SPTB,SLC4A1	9	
Hematological System Development and Function, Tissue Morphology	quantity	Quantity of myeloid cells	1.54E-03	 	-0.480	 	-0.564	MPP1,BCL6,SNCA,RBM38,CTSB,ABCA1,BCL2L1,YBX1	8	
Cell Death and Survival	apoptosis	Apoptosis of erythroblasts	1.63E-03	 	 	 	 	BNIP3L,LYL1	2	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	damage	Damage of hippocampus	1.63E-03	 	 	 	 	CTSB,BCL2L1	2	
Cell Morphology, Cellular Growth and Proliferation, Connective Tissue Development and Function, Tissue Development	size	Size of fibroblast cell lines	1.63E-03	 	 	 	 	FOXO4,BCL2L1	2	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of red blood cells	1.66E-03	 	-1.812	 	-1.835	BNIP3L,BCL2L1,LYL1,SPTB,SLC4A1	5	
Cell Morphology, Cellular Function and Maintenance	transmembrane potential	Transmembrane potential of mitochondria	1.66E-03	 	 	 	 	SNCA,BNIP3L,UBB,BCL2L1,OPTN	5	
Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of abdomen	1.70E-03	 	 	 	 	ADGRG3,ALPL,BCL6,MXI1,RBM38,NFIX,BNIP3L,ABCA1,YBX1,SLC4A1,BSG	11	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of erythroid precursor cells	1.71E-03	 	-1.969	 	-1.684	BNIP3L,BCL2L1,LYL1,SLC4A1	4	
Energy Production, Lipid Metabolism, Small Molecule Biochemistry	oxidation	Oxidation of lipid	1.77E-03	 	0.254	bias	-0.546	SNCA,ACSL1,ADIPOR1,ABCA1,SLC2A1	5	
Cellular Assembly and Organization	accumulation	Accumulation of lysosome	1.81E-03	 	 	 	 	SNCA,CTSB	2	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	permeability	Permeability of mitochondrial membrane	1.81E-03	 	 	 	 	BNIP3L,BCL2L1	2	
Gene Expression	expression	Expression of RNA	1.88E-03	 	0.094	 	-0.705	UBA52,ASCC2,HDGF,MME,RNF10,BAG1,PARP9,FOXO4,IGF2BP2,BCL6,MXI1,SNCA,CREB5,FKBP8,NFIX,UBB,MAP2K3,BCL2L1,YBX1,OPTN,LYL1	21	
Cell Death and Survival	cell viability	Cell viability of neuroblastoma cell lines	1.95E-03	 	 	 	 	SNCA,BCL2L1,SLC2A1	3	
Cancer, Organismal Injury and Abnormalities	extraadrenal retroperitoneal tumor	Extraadrenal retroperitoneal tumor	1.95E-03	 	 	 	 	GYPC,BNIP3L,APOBEC3A,BLVRB,GLRX5,BSG,SLC6A8,MAP2K3,KCNJ15,DDX60L,OPTN,SLC4A1,MPP1,AQP9,MME,PYGL,RNF10,ANK1,SIAH2,BAG1,SAMD9L,MGAM,ALPL,MXI1,CTSB,BCL2L1,SPTB	27	
Gene Expression	transcription	Transcription of RNA	1.98E-03	 	0.138	 	-0.664	UBA52,ASCC2,HDGF,MME,RNF10,BAG1,PARP9,FOXO4,BCL6,MXI1,SNCA,CREB5,NFIX,UBB,MAP2K3,YBX1,BCL2L1,LYL1	18	
Energy Production, Lipid Metabolism, Small Molecule Biochemistry	oxidation	Oxidation of oleic acid	2.00E-03	 	 	 	 	ACSL1,ABCA1	2	
Cellular Assembly and Organization	binding	Binding of cellular membrane	2.03E-03	 	 	 	 	ABCA1,BCL2L1,SLC4A1	3	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	accumulation	Accumulation of lipid	2.09E-03	 	-0.394	 	-0.538	ACSL1,ABCA1,GRINA,ADIPOR1,FOXO4,BCL2L1	6	
Carbohydrate Metabolism	synthesis	Synthesis of carbohydrate	2.10E-03	 	1.154	bias	 	AQP9,SNCA,PYGL,DPM2,PHOSPHO1,SLC2A1,OPTN,BSG	8	
Gene Expression	transcription	Transcription	2.14E-03	 	0.277	 	-0.582	UBA52,ASCC2,HDGF,MME,RNF10,BAG1,PARP9,FOXO4,BCL6,MXI1,SNCA,CREB5,FKBP8,NFIX,UBB,MAP2K3,BCL2L1,YBX1,OPTN,LYL1	20	
Tissue Morphology	quantity	Quantity of cells	2.14E-03	 	1.882	bias	0.824	MPP1,HDGF,MME,BNIP3L,ABCA1,SLC2A1,BSG,ADGRG3,ALPL,BCL6,RBM38,SNCA,CTSB,BCL2L1,YBX1,LYL1,SPTB,SLC4A1	18	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	germinal center B-cell-like diffuse large B-cell lymphoma	Germinal center B-cell-like diffuse large B-cell lymphoma	2.19E-03	 	 	 	 	BCL6,MME	2	
Immunological Disease	allergy	Allergy	2.22E-03	 	 	 	 	MXI1,MME,FKBP8,ABCA1,MAP2K3,BCL2L1,OPTN	7	
Hematological System Development and Function, Immunological Disease, Inflammatory Disease, Lymphoid Tissue Structure and Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	enlargement	Enlargement of spleen	2.30E-03	 	 	 	 	MXI1,RBM38,BNIP3L,ABCA1,SLC4A1	5	
Organismal Survival	organismal death	Organismal death	2.31E-03	Decreased	-4.179	bias	 	MME,SLC25A37,BNIP3L,SIAH2,ABCA1,BAG1,SLC2A1,BSG,ALPL,BCL6,MXI1,RBM38,SNCA,CREB5,FKBP8,CTSB,NFIX,UBB,MAP2K3,BCL2L1,YBX1,SLC4A1	22	
Cell Morphology, Hematological System Development and Function, Hematopoiesis, Tissue Morphology	abnormal morphology	Abnormal morphology of red blood cells	2.33E-03	 	 	 	 	RBM38,BNIP3L,SLC4A1	3	
Cardiovascular Disease, Cardiovascular System Development and Function, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	enlargement	Enlargement of heart	2.34E-03	 	 	 	 	ACSL1,SLC6A8,CTSB,ABCA1,MAP2K3,GLRX5,BCL2L1,SLC4A1	8	
Cell Death and Survival	cell death	Cell death of pro-B lymphocytes	2.40E-03	 	 	 	 	CTSB,BCL2L1	2	
Cell Death and Survival, Skeletal and Muscular System Development and Function	cell viability	Cell viability of muscle cell lines	2.40E-03	 	 	 	 	BCL6,CTSB	2	
Neurological Disease	sporadic motor neuron disease	Sporadic motor neuron disease	2.40E-03	 	 	 	 	SNCA,BCL2L1	2	
Infectious Diseases	infection	Infection by RNA virus	2.48E-03	Increased	2.965	bias	 	MGAM,UBE2H,RNF10,CTSB,AP2A1,PARP9,BCL2L1,YBX1,SLC2A1,DDX60L,BSG	11	
Cell Death and Survival, Organismal Injury and Abnormalities	apoptosis	Apoptosis of epithelial cell lines	2.52E-03	 	0.281	 	-0.162	BCL6,SNCA,FKBP8,BNIP3L,BCL2L1	5	
Dermatological Diseases and Conditions, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	dermatitis	Dermatitis	2.52E-03	 	 	 	 	MXI1,MME,FKBP8,ABCA1,MAP2K3,BCL2L1,OPTN	7	
Immunological Disease	immediate hypersensitivity	Immediate hypersensitivity	2.52E-03	 	 	 	 	MXI1,MME,FKBP8,ABCA1,BCL2L1,OPTN	6	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy of colorectal cancer cell lines	2.61E-03	 	 	 	 	BNIP3L,BCL2L1	2	
Cellular Development, Cellular Growth and Proliferation	cell proliferation	Cell proliferation of mesothelioma cell lines	2.61E-03	 	 	 	 	SAMD9L,BCL2L1	2	
Cell Death and Survival	cell death	Cell death of fibroblast cell lines	2.61E-03	 	0.455	 	0.019	STRADB,BCL6,FKBP8,CTSB,BNIP3L,ADIPOR1,BCL2L1	7	
Neurological Disease, Organismal Injury and Abnormalities	brain atrophy	Brain atrophy	2.67E-03	 	 	 	 	SNCA,CTSB,UBB	3	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	concentration	Concentration of triacylglycerol	2.79E-03	 	-1.620	 	-1.571	AQP9,ACSL1,ADIPOR1,GBP5,ABCA1,FOXO4	6	
Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	hepatic injury	Hepatic injury	2.82E-03	 	0.762	 	0.836	MGAM,CTSB,MAP2K3,BCL2L1,BSG	5	
Cell Cycle, Humoral Immune Response	cell cycle progression	Cell cycle progression of B lymphocytes	2.83E-03	 	 	 	 	BCL6,BCL2L1	2	
Cell Morphology	conversion	Conversion of connective tissue cells	2.83E-03	 	 	 	 	BCL6,BCL2L1	2	
Lipid Metabolism, Small Molecule Biochemistry	internalization	Internalization of lipid	2.83E-03	 	 	 	 	ACSL1,ABCA1	2	
Endocrine System Development and Function	insulin sensitivity	Insulin sensitivity	2.95E-03	 	1.067	bias	 	CREB5,ADIPOR1,ABCA1,FOXO4	4	
Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoproliferative disorder of the skin	Lymphoproliferative disorder of the skin	2.95E-03	 	 	 	 	BCL6,MXI1,MME,OAS2	4	
Cancer, Organismal Injury and Abnormalities	growth	Growth of tumor	2.96E-03	 	1.361	 	0.685	MME,HDGF,CTSB,SIAH2,BAG1,MAP2K3,BCL2L1,YBX1,SLC2A1,LYL1,BSG	11	
Cell Death and Survival, Skeletal and Muscular Disorders	cell death	Cell death of muscle cells	3.11E-03	 	-1.035	 	-0.539	BCL6,ACSL1,BNIP3L,BAG1,MAP2K3,BCL2L1	6	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of steroid	3.12E-03	 	 	 	 	AQP9,ACSL1,ABCA1,MAP2K3	4	
Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	acanthocytosis	Acanthocytosis	3.17E-03	 	 	 	 	SLC4A1	1	
Cellular Growth and Proliferation	accumulation	Accumulation of mesothelioma cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	adult hypophosphatasia	Adult hypophosphatasia	3.17E-03	 	 	 	 	ALPL	1	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	amyotrophic lateral sclerosis type 12	Amyotrophic lateral sclerosis type 12	3.17E-03	 	 	 	 	OPTN	1	
Cell Death and Survival	apoptosis	Apoptosis of bone marrow derived eosinophils	3.17E-03	 	 	 	 	BCL2L1	1	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	argyrophilic grain disease	Argyrophilic grain disease	3.17E-03	 	 	 	 	UBB	1	
Cell Cycle, Humoral Immune Response	cell cycle progression	Arrest in cell cycle progression of germinal center B lymphocytes	3.17E-03	 	 	 	 	BCL6	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	differentiation	Arrest in differentiation of erythroid cells	3.17E-03	 	 	 	 	LYL1	1	
Hematological Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	ataxia-pancytopenia syndrome	Ataxia-pancytopenia syndrome	3.17E-03	 	 	 	 	SAMD9L	1	
Neurological Disease, Organismal Injury and Abnormalities	atrophy	Atrophy of pontine nucleus	3.17E-03	 	 	 	 	SNCA	1	
Cardiovascular Disease, Cellular Compromise, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	atrophy	Atrophy of ventricular myocytes	3.17E-03	 	 	 	 	MAP2K3	1	
Lipid Metabolism, Small Molecule Biochemistry	attachment	Attachment of cholesterol	3.17E-03	 	 	 	 	ABCA1	1	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy by retinal ganglion cells	3.17E-03	 	 	 	 	OPTN	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	autosomal dominant Parkinson disease 4	Autosomal dominant Parkinson disease 4	3.17E-03	 	 	 	 	SNCA	1	
Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	autosomal dominant distal renal tubular acidosis	Autosomal dominant distal renal tubular acidosis	3.17E-03	 	 	 	 	SLC4A1	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive GLUT1 deficiency syndrome type 1	Autosomal recessive GLUT1 deficiency syndrome type 1	3.17E-03	 	 	 	 	SLC2A1	1	
Cardiovascular Disease, Cell Death and Survival, Connective Tissue Disorders, Developmental Disorder, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	autosomal recessive spherocytosis type 1	Autosomal recessive spherocytosis type 1	3.17E-03	 	 	 	 	ANK1	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Nervous System Development and Function	binding	Binding of synaptic vesicles	3.17E-03	 	 	 	 	SNCA	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	budding	Budding of clathrin-coated pits	3.17E-03	 	 	 	 	ANK1	1	
Cell Morphology, Infectious Diseases, Organismal Development	budding	Budding of respiratory syncytial virus	3.17E-03	 	 	 	 	OPTN	1	
Carbohydrate Metabolism	catabolism	Catabolism of starch	3.17E-03	 	 	 	 	MGAM	1	
Cell Death and Survival, Embryonic Development	cell death	Cell death of trophoblast giant cells	3.17E-03	 	 	 	 	BCL2L1	1	
Cell Death and Survival	cell death	Cell death of type 1 macrophages	3.17E-03	 	 	 	 	CTSB	1	
Cancer, Cellular Response to Therapeutics, Organismal Injury and Abnormalities	chemosensitivity	Chemosensitivity of pancreatic cancer cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	childhood hypophosphatasia	Childhood hypophosphatasia	3.17E-03	 	 	 	 	ALPL	1	
Developmental Disorder, Hematological Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	childhood-onset spasticity with hyperglycinemia	Childhood-onset spasticity with hyperglycinemia	3.17E-03	 	 	 	 	GLRX5	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	colony formation	Colony formation of Ewing's sarcoma cells	3.17E-03	 	 	 	 	HDGF	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	congenital disorder of glycosylation type 1u	Congenital disorder of glycosylation type 1u	3.17E-03	 	 	 	 	DPM2	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	creatine deficiency syndrome 1	Creatine deficiency syndrome 1	3.17E-03	 	 	 	 	SLC6A8	1	
Cardiovascular Disease, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	cryohydrocytosis	Cryohydrocytosis	3.17E-03	 	 	 	 	SLC4A1	1	
Cell Morphology, Cellular Compromise	deformability	Deformability of plasma membrane	3.17E-03	 	 	 	 	SLC4A1	1	
Lipid Metabolism, Small Molecule Biochemistry	esterification	Delay in initiation of esterification of cholesterol	3.17E-03	 	 	 	 	ABCA1	1	
Cellular Compromise	depletion	Depletion of lipid droplets	3.17E-03	 	 	 	 	ABCA1	1	
Cellular Assembly and Organization, Cellular Compromise	disruption	Disruption of fibrils	3.17E-03	 	 	 	 	SNCA	1	
Cellular Assembly and Organization, Cellular Compromise	disruption	Disruption of vesicle aggregates	3.17E-03	 	 	 	 	SNCA	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	distribution	Distribution of T-cell non-Hodgkin lymphoma	3.17E-03	 	 	 	 	BCL6	1	
Psychological Disorders	dopamine dysregulation syndrome	Dopamine dysregulation syndrome	3.17E-03	 	 	 	 	SNCA	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of lactic acid	3.17E-03	 	 	 	 	BSG	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of long chain fatty acid	3.17E-03	 	 	 	 	ACSL1	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry, Vitamin and Mineral Metabolism	efflux	Efflux of retinol	3.17E-03	 	 	 	 	ABCA1	1	
Cellular Function and Maintenance, Molecular Transport	efflux	Efflux of sulfate	3.17E-03	 	 	 	 	SLC4A1	1	
Connective Tissue Disorders, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	elliptocytosis type 3	Elliptocytosis type 3	3.17E-03	 	 	 	 	SPTB	1	
Carbohydrate Metabolism, Cellular Function and Maintenance, Lipid Metabolism, Small Molecule Biochemistry	endocytosis	Endocytosis of phosphatidylserine	3.17E-03	 	 	 	 	ABCA1	1	
Cellular Function and Maintenance, Lipid Metabolism, Small Molecule Biochemistry	endocytosis	Endocytosis of sphingomyelin	3.17E-03	 	 	 	 	ABCA1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	episodic choreoathetosis/spasticity	Episodic choreoathetosis/spasticity	3.17E-03	 	 	 	 	SLC2A1	1	
Hematological Disease	erythroblastosis	Erythroblastosis of bone marrow	3.17E-03	 	 	 	 	BNIP3L	1	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	erythroblastosis	Erythroblastosis of spleen	3.17E-03	 	 	 	 	BNIP3L	1	
Cell Cycle	G1 checkpoint	Exit from G1 checkpoint of breast cell lines	3.17E-03	 	 	 	 	YBX1	1	
Cell Cycle	G1 checkpoint	Exit from G1 checkpoint of epithelial cell lines	3.17E-03	 	 	 	 	YBX1	1	
Cellular Function and Maintenance, Molecular Transport	exocytosis	Exocytosis of lipid	3.17E-03	 	 	 	 	ABCA1	1	
Cellular Assembly and Organization, Nervous System Development and Function	fasciculation	Fasciculation of parallel fiber	3.17E-03	 	 	 	 	NFIX	1	
Cardiovascular Disease, Cell Death and Survival, Connective Tissue Disorders, Developmental Disorder, Hematological Disease, Organismal Injury and Abnormalities	fatal and near-fatal neonatal hemolytic anemia	Fatal and near-fatal neonatal hemolytic anemia	3.17E-03	 	 	 	 	SPTB	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	fluidity	Fluidity of mitochondrial membrane	3.17E-03	 	 	 	 	SNCA	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Nervous System Development and Function, Organismal Development, Tissue Development	formation	Formation of Lewy neurites	3.17E-03	 	 	 	 	SNCA	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	generation	Generation of erythroblasts	3.17E-03	 	 	 	 	RBM38	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	glut1 deficiency syndrome type 2	Glut1 deficiency syndrome type 2	3.17E-03	 	 	 	 	SLC2A1	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	glutamine synthase deficiency	Glutamine synthase deficiency	3.17E-03	 	 	 	 	GLUL	1	
Developmental Disorder, Gastrointestinal Disease, Hepatic System Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	glycogen storage disease type VI	Glycogen storage disease type VI	3.17E-03	 	 	 	 	PYGL	1	
Infectious Diseases, Organismal Development	growth	Growth of Reoviridae	3.17E-03	 	 	 	 	CTSB	1	
Cardiovascular Disease, Cell Death and Survival, Connective Tissue Disorders, Developmental Disorder, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	hereditary spherocytosis type 2	Hereditary spherocytosis type 2	3.17E-03	 	 	 	 	SPTB	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	hyperplasia	Hyperplasia of macrophages	3.17E-03	 	 	 	 	BCL6	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	infantile hypophosphatasia	Infantile hypophosphatasia	3.17E-03	 	 	 	 	ALPL	1	
Cellular Compromise	infectibility	Infectibility of monocytes	3.17E-03	 	 	 	 	APOBEC3A	1	
Cellular Growth and Proliferation	inhibition	Inhibition of lung cancer cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Cell Cycle	S phase	Initiation of S phase of thymocytes	3.17E-03	 	 	 	 	BCL2L1	1	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	lethal perinatal hypophosphatasia	Lethal perinatal hypophosphatasia	3.17E-03	 	 	 	 	ALPL	1	
Cell Death and Survival, Cell Morphology, Embryonic Development, Nervous System Development and Function, Neurological Disease, Ophthalmic Disease, Organ Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Development, Tissue Morphology, Visual System Development and Function	loss	Loss of RPE cells	3.17E-03	 	 	 	 	OPTN	1	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	lysis	Lysis of glioma cells	3.17E-03	 	 	 	 	MME	1	
Developmental Disorder, Skeletal and Muscular Disorders	Marshall-Smith syndrome	Marshall-Smith syndrome	3.17E-03	 	 	 	 	NFIX	1	
Cellular Development, Embryonic Development, Organismal Development	maturation	Maturation of embryonic stem cells	3.17E-03	 	 	 	 	BCL2L1	1	
Cancer, Hereditary Disorder, Organismal Injury and Abnormalities, Renal and Urological Disease	familial clear cell renal carcinoma	Metastatic familial clear cell renal carcinoma	3.17E-03	 	 	 	 	BCL2L1	1	
Cell Death and Survival	mitochondrial cell death	Mitochondrial cell death of B-lymphocyte derived cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Carbohydrate Metabolism, Lipid Metabolism, Small Molecule Biochemistry	movement	Movement of phosphatidylethanolamine	3.17E-03	 	 	 	 	ABCA1	1	
Cell Death and Survival, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	necrosis	Necrosis of pancreatic acinus	3.17E-03	 	 	 	 	CTSB	1	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	neurodegeneration	Neurodegeneration of nigrostriatal dopamine system neuron	3.17E-03	 	 	 	 	SNCA	1	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Respiratory Disease	neutrophilia	Neutrophilia of lung tissue	3.17E-03	 	 	 	 	BSG	1	
Developmental Disorder, Hematological Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	non-classical Tangier disease	Non-classical Tangier disease	3.17E-03	 	 	 	 	ABCA1	1	
Cellular Function and Maintenance	non-clathrin endocytosis	Non-clathrin endocytosis by embryonic cell lines	3.17E-03	 	 	 	 	ABCA1	1	
Cellular Function and Maintenance	non-clathrin endocytosis	Non-clathrin endocytosis by fibroblast cell lines	3.17E-03	 	 	 	 	ABCA1	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	odontohypophosphatasia	Odontohypophosphatasia	3.17E-03	 	 	 	 	ALPL	1	
Hereditary Disorder, Ophthalmic Disease, Organismal Injury and Abnormalities	open angle glaucoma type 1E	Open angle glaucoma type 1E	3.17E-03	 	 	 	 	OPTN	1	
Connective Tissue Development and Function, Embryonic Development, Organ Development, Organismal Development, Skeletal and Muscular System Development and Function, Tissue Development	ossification	Ossification of vertebral body	3.17E-03	 	 	 	 	NFIX	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	Parkinson disease 1	Parkinson disease 1	3.17E-03	 	 	 	 	SNCA	1	
Cellular Assembly and Organization	production	Production of cytoplasmic aggregates	3.17E-03	 	 	 	 	SNCA	1	
Cardiovascular Disease, Developmental Disorder, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	pyridoxine-refractory sideroblastic anemia type 3	Pyridoxine-refractory sideroblastic anemia type 3	3.17E-03	 	 	 	 	GLRX5	1	
Organismal Development, Tissue Morphology	quantity	Quantity of Plasmodium falciparum	3.17E-03	 	 	 	 	SLC4A1	1	
Organ Morphology, Tissue Morphology, Visual System Development and Function	quantity	Quantity of RPE cells	3.17E-03	 	 	 	 	MME	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	quantity	Quantity of actin-rich protrusion	3.17E-03	 	 	 	 	BSG	1	
Cellular Assembly and Organization	quantity	Quantity of dense core granules	3.17E-03	 	 	 	 	SNCA	1	
Cellular Assembly and Organization	quantity	Quantity of mitochondrial contact sites	3.17E-03	 	 	 	 	BCL2L1	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tissue Morphology, Tumor Morphology	quantity	Quantity of non-small-cell lung cancer cells	3.17E-03	 	 	 	 	CTSB	1	
Cellular Assembly and Organization	quantity	Quantity of stress granule	3.17E-03	 	 	 	 	YBX1	1	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	radiosensitivity process	Radiosensitivity process of prostate cancer cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Molecular Transport, Nucleic Acid Metabolism, Small Molecule Biochemistry	release	Release of ADP	3.17E-03	 	 	 	 	BAG1	1	
Molecular Transport, Protein Synthesis	release	Release of protein fragment	3.17E-03	 	 	 	 	BAG1	1	
Infectious Diseases	replication	Replication of Newcastle disease virus La Sota strain	3.17E-03	 	 	 	 	BCL2L1	1	
Cell Death and Survival, Hematological System Development and Function, Hematopoiesis	repopulation	Repopulation of erythroid cells	3.17E-03	 	 	 	 	LYL1	1	
Infectious Diseases	resistance to Encephalomyocarditis virus	Resistance to Encephalomyocarditis virus	3.17E-03	 	 	 	 	OAS2	1	
Cancer, Cellular Function and Maintenance, Organismal Injury and Abnormalities	respiration	Respiration of cultured osteosarcoma cells	3.17E-03	 	 	 	 	BCL2L1	1	
Cell-To-Cell Signaling and Interaction	sensitization	Sensitization of B-lymphocyte derived cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Tissue Morphology	separation	Separation of thyroid cells	3.17E-03	 	 	 	 	ACSL1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	shuttling	Shuttling of creatine	3.17E-03	 	 	 	 	SLC6A8	1	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	solitary mastocytoma	Solitary mastocytoma	3.17E-03	 	 	 	 	BCL2L1	1	
Connective Tissue Disorders, Developmental Disorder, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease, Skeletal and Muscular Disorders	Sotos syndrome 2	Sotos syndrome 2	3.17E-03	 	 	 	 	NFIX	1	
Connective Tissue Disorders, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	Southeast Asian ovalocytosis	Southeast Asian ovalocytosis	3.17E-03	 	 	 	 	SLC4A1	1	
Cardiovascular Disease, Cell Death and Survival, Connective Tissue Disorders, Developmental Disorder, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	spherocytosis type 4	Spherocytosis type 4	3.17E-03	 	 	 	 	SLC4A1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	spinocerebellar ataxia type 43	Spinocerebellar ataxia type 43	3.17E-03	 	 	 	 	MME	1	
Cellular Assembly and Organization, Skeletal and Muscular System Development and Function	stabilization	Stabilization of sarcoplasmic reticulum	3.17E-03	 	 	 	 	ANK1	1	
Cardiovascular Disease, Developmental Disorder, Hematological Disease, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	stomatin-deficient cryohydrocytosis	Stomatin-deficient cryohydrocytosis	3.17E-03	 	 	 	 	SLC2A1	1	
Cell Cycle	sub-G1 phase	Sub-G1 phase of ovarian cancer cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	susceptibility to idiopathic generalized epilepsy type 12	Susceptibility to idiopathic generalized epilepsy type 12	3.17E-03	 	 	 	 	SLC2A1	1	
Cell Morphology	thickness	Thickness of keratinocyte cancer cell lines	3.17E-03	 	 	 	 	BAG1	1	
Cell Morphology, Cellular Function and Maintenance	transmembrane potential	Transmembrane potential of lymphoma cell lines	3.17E-03	 	 	 	 	BCL2L1	1	
Cellular Movement	transmigration	Transmigration of stomach cancer cell lines	3.17E-03	 	 	 	 	BAG1	1	
Cell-To-Cell Signaling and Interaction, Small Molecule Biochemistry	upregulation	Upregulation of dopamine	3.17E-03	 	 	 	 	SNCA	1	
Molecular Transport	uptake	Uptake of arsenite	3.17E-03	 	 	 	 	AQP9	1	
Cellular Function and Maintenance	uptake	Uptake of fibroblasts	3.17E-03	 	 	 	 	ABCA1	1	
Amino Acid Metabolism, Small Molecule Biochemistry	utilization	Utilization of L-glutamic acid	3.17E-03	 	 	 	 	GLUL	1	
Cell Morphology	morphology	Morphology of blood cells	3.17E-03	 	 	 	 	ADGRG3,MXI1,RBM38,BNIP3L,BCL2L1,SPTB,SLC4A1	7	
DNA Replication, Recombination, and Repair	global genomic repair	Global genomic repair	3.30E-03	 	 	 	 	UBA52,UBB	2	
Cancer, Organismal Injury and Abnormalities	growth	Growth of malignant tumor	3.41E-03	 	1.611	bias	0.924	MME,HDGF,CTSB,BAG1,MAP2K3,BCL2L1,BSG	7	
Dermatological Diseases and Conditions, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	atopic dermatitis	Atopic dermatitis	3.51E-03	 	 	 	 	MXI1,FKBP8,ABCA1,BCL2L1,OPTN	5	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	leg type primary cutaneous diffuse large B-cell lymphoma	Leg type primary cutaneous diffuse large B-cell lymphoma	3.55E-03	 	 	 	 	BCL6,MME	2	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	primary cutaneous follicle center lymphoma	Primary cutaneous follicle center lymphoma	3.55E-03	 	 	 	 	BCL6,MME	2	
Cell Morphology, Cellular Assembly and Organization	size	Size of mitochondria	3.55E-03	 	 	 	 	SNCA,BCL2L1	2	
Small Molecule Biochemistry	synthesis	Synthesis of heme	3.55E-03	 	 	 	 	SNX3,BCL2L1	2	
Infectious Diseases	transport	Transport of virus	3.55E-03	 	 	 	 	UBA52,UBB	2	
Cell Death and Survival, DNA Replication, Recombination, and Repair	fragmentation	Fragmentation of DNA	3.55E-03	 	 	 	 	SNCA,FOXO4,BCL2L1,BSG	4	
DNA Replication, Recombination, and Repair	repair	Repair of DNA	3.61E-03	 	 	 	 	ASCC2,UBA52,UBB,PARP9,BCL2L1,YBX1	6	
Gene Expression, RNA Damage and Repair, RNA Post-Transcriptional Modification	stabilization	Stabilization of mRNA	3.63E-03	 	 	 	 	IGF2BP2,UBA52,UBB	3	
Cardiovascular Disease, Neurological Disease, Organismal Injury and Abnormalities	stroke	Stroke	3.65E-03	 	 	 	 	MGAM,BCL6,SNCA,PYGL,ABCA1	5	
Neurological Disease, Organismal Injury and Abnormalities	astrocytosis	Astrocytosis	3.73E-03	 	 	 	 	SNCA,MME,CTSB	3	
Cellular Development, Nervous System Development and Function	differentiation	Differentiation of Schwann cells	3.80E-03	 	 	 	 	GLUL,BAG1	2	
Cell Morphology, Cellular Compromise	swelling	Swelling of mitochondria	3.80E-03	 	 	 	 	SNCA,BCL2L1	2	
Molecular Transport, Small Molecule Biochemistry	transport	Transport of monoamines	3.80E-03	 	 	 	 	SNCA,MAP2K3	2	
Hematological System Development and Function, Tissue Morphology	quantity	Quantity of leukocytes	3.84E-03	 	1.792	bias	1.019	ADGRG3,ALPL,MPP1,BCL6,SNCA,CTSB,ABCA1,BCL2L1,YBX1,SLC2A1,LYL1	11	
Cell Cycle	interphase	Arrest in interphase	3.89E-03	 	 	 	 	MXI1,RBM38,SIAH2,MAP2K3,APOBEC3A,FOXO4,BCL2L1	7	
Cell Death and Survival	cell death	Neuronal cell death	3.92E-03	 	0.597	 	0.636	SNCA,HDGF,SLC6A8,CTSB,BAG1,MAP2K3,BCL2L1,SLC2A1,OPTN	9	
Cell Death and Survival	cell death	Cell death of antigen presenting cells	3.95E-03	 	 	 	 	BCL6,CTSB,MAP2K3,BCL2L1	4	
Infectious Diseases	infection	Infection of epithelial cell lines	4.00E-03	Increased	2.000	bias	 	UBE2H,RNF10,PARP9,YBX1,BSG	5	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Tissue Development	cell proliferation	Cell proliferation of fibroblasts	4.01E-03	 	0.152	bias	-0.588	HDGF,CTSB,ADIPOR1,FOXO4,MAP2K3,YBX1	6	
Cellular Assembly and Organization	organization	Organization of cellular membrane	4.05E-03	 	 	 	 	SNCA,UBA52,UBB,AP2A1,SPTB	5	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	binding	Binding of plasma membrane	4.06E-03	 	 	 	 	ABCA1,SLC4A1	2	
Immunological Disease, Inflammatory Response	function	Abnormal function of immune system	4.29E-03	 	 	 	 	ADGRG3,BCL6,CRISPLD2	3	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	development	Development of hematological system tumor	4.31E-03	 	0.106	bias	 	BCL6,MXI1,RBM38,BCL2L1	4	
Cardiovascular Disease, Organismal Injury and Abnormalities	peripheral vascular disease	Peripheral vascular disease	4.38E-03	 	 	 	 	MGAM,BCL6,SNCA,UBE2H,PYGL,CTSB,ABCA1	7	
Cell Signaling	protein kinase cascade	Protein kinase cascade	4.45E-03	 	 	 	 	STRADB,UBA52,ADIPOR1,UBB,MAP2K3,OPTN,SPTB	7	
Lymphoid Tissue Structure and Development, Tissue Morphology	quantity	Quantity of bone marrow cells	4.53E-03	 	 	 	 	BCL6,RBM38,BNIP3L,BCL2L1	4	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	hereditary neuropathy	Hereditary neuropathy	4.59E-03	 	 	 	 	SNCA,MME,SAMD9L,BCL2L1,OPTN	5	
Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection of embryonic cell lines	4.59E-03	Increased	2.000	bias	 	UBE2H,RNF10,PARP9,YBX1,BSG	5	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	cell death	Cell death of neuroblastoma cells	4.61E-03	 	 	 	 	UBB,BCL2L1	2	
Cardiovascular Disease, Cardiovascular System Development and Function, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of heart	4.73E-03	 	 	 	 	BCL6,ACSL1,SLC6A8,CTSB,ABCA1,MAP2K3,GLRX5,BCL2L1,SLC4A1	9	
Cancer, Organismal Injury and Abnormalities	malignant neoplasm of retroperitoneum	Malignant neoplasm of retroperitoneum	4.85E-03	 	 	 	 	GYPC,MPP1,AQP9,MME,PYGL,ANK1,BNIP3L,SIAH2,BAG1,BLVRB,SAMD9L,GLRX5,BSG,MGAM,ALPL,MXI1,SLC6A8,MAP2K3,KCNJ15,BCL2L1,DDX60L,OPTN,SPTB,SLC4A1	24	
Cellular Compromise, Inflammatory Response	degranulation	Degranulation of neutrophils	4.89E-03	 	 	 	 	ADGRG3,MGAM,CRISPLD2,PYGL,MME,CTSB	6	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	familial Parkinson disease	Familial Parkinson disease	4.90E-03	 	 	 	 	SNCA,BCL2L1	2	
Cell Death and Survival, Nervous System Development and Function	survival	Survival of dopaminergic neurons	4.90E-03	 	 	 	 	SNCA,BCL2L1	2	
Energy Production, Lipid Metabolism, Small Molecule Biochemistry	oxidation	Oxidation of fatty acid	5.00E-03	 	0.254	bias	-0.452	ACSL1,ADIPOR1,ABCA1,SLC2A1	4	
Carbohydrate Metabolism	metabolism	Metabolism of polysaccharide	5.06E-03	 	 	 	 	MGAM,PYGL,CTSB,AP2A1,BSG	5	
Endocrine System Disorders, Gastrointestinal Disease, Metabolic Disease, Organismal Injury and Abnormalities	diabetes mellitus	Diabetes mellitus	5.14E-03	 	 	 	 	IGF2BP2,MGAM,ALPL,SNCA,ACSL1,MME,CREB5,CTSB,ABCA1,ADIPOR1,SAMD9L,BCL2L1	12	
Cellular Assembly and Organization	quantity	Quantity of vesicles	5.16E-03	 	 	 	 	SNCA,ABCA1,OPTN	3	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	atrophy	Atrophy of muscle	5.17E-03	 	 	 	 	MME,BNIP3L,MAP2K3,BCL2L1	4	
Cellular Growth and Proliferation	colony formation	Colony formation of leukemia cell lines	5.20E-03	 	 	 	 	BCL6,CTSB	2	
Cell-To-Cell Signaling and Interaction, Molecular Transport, Small Molecule Biochemistry	transport	Transport of biogenic amine	5.20E-03	 	 	 	 	SNCA,MAP2K3	2	
Cardiovascular Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	ischemic stroke	Ischemic stroke	5.29E-03	 	 	 	 	BCL6,PYGL,ABCA1	3	
Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	encephalitis	Encephalitis	5.38E-03	 	1.561	 	1.410	BCL6,SNCA,MME,CTSB,BCL2L1,BSG	6	
Cell Death and Survival	cell death	Cell death of connective tissue cells	5.41E-03	 	0.706	 	0.543	STRADB,BCL6,FKBP8,CTSB,BNIP3L,ADIPOR1,MAP2K3,BCL2L1	8	
Inflammatory Disease	inflammatory disorder	Severe inflammatory disorder	5.42E-03	 	 	 	 	GLUL,ACSL1,PYGL,BCL2L1	4	
Lymphoid Tissue Structure and Development, Organ Morphology, Tissue Morphology	quantity	Quantity of spleen	5.42E-03	 	 	 	 	MXI1,RBM38,BNIP3L	3	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	apoptosis	Apoptosis of mammary tumor cells	5.50E-03	 	 	 	 	BAG1,BCL2L1	2	
Developmental Disorder, Neurological Disease, Psychological Disorders	behavioral deficit	Behavioral deficit	5.50E-03	 	 	 	 	SNCA,SLC6A8	2	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	liver adenoma	Hepatocellular adenoma	5.50E-03	 	 	 	 	GLUL,SLC2A1	2	
Reproductive System Development and Function	lordosis	Lordosis	5.50E-03	 	 	 	 	RBM38,NFIX	2	
Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Tissue Development, Tissue Morphology	size	Size of epiphyseal growth plate	5.50E-03	 	 	 	 	ALPL,NFIX	2	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	cell death	Cell death of brain cells	5.62E-03	 	0.304	 	0.277	SNCA,BAG1,MAP2K3,BCL2L1,SLC2A1	5	
Organismal Development	size	Size of body	5.62E-03	Increased	3.129	bias	 	ALPL,BCL6,SNCA,FKBP8,SLC6A8,NFIX,BNIP3L,ABCA1,SLC4A1,BSG	10	
Cell Cycle	G2/M phase	G2/M phase	5.75E-03	 	 	 	 	MXI1,SIAH2,FOXO4,BCL2L1,OPTN	5	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	familial motor neuron disease	Familial motor neuron disease	5.83E-03	 	 	 	 	SNCA,BCL2L1,OPTN	3	
Endocrine System Development and Function	glucose tolerance	Glucose tolerance	5.89E-03	 	-0.277	 	-0.794	CRISPLD2,CREB5,ADIPOR1,ABCA1,FOXO4	5	
Cellular Growth and Proliferation	colony formation	Colony formation	5.99E-03	 	0.690	 	0.279	BCL6,HDGF,CTSB,BNIP3L,BAG1,FOXO4,BCL2L1,LYL1	8	
Cell Death and Survival	apoptosis	Apoptosis of prostate cancer cell lines	6.04E-03	 	-1.232	 	-1.259	MME,SIAH2,MAP2K3,BCL2L1	4	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	accumulation	Accumulation of triacylglycerol	6.12E-03	 	 	 	 	ACSL1,ADIPOR1,FOXO4	3	
Cell Morphology, Connective Tissue Development and Function	morphology	Morphology of fibroblast cell lines	6.12E-03	 	 	 	 	STRADB,FOXO4,BCL2L1	3	
Cell Death and Survival	cell viability	Cell viability of pheochromocytoma cell lines	6.13E-03	 	 	 	 	SNCA,BCL2L1	2	
Cellular Growth and Proliferation, Embryonic Development	colony formation	Colony formation of embryonic cell lines	6.13E-03	 	 	 	 	FOXO4,BCL2L1	2	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of memory T lymphocytes	6.13E-03	 	 	 	 	BCL6,SLC2A1	2	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	familial amyotrophic lateral sclerosis	Familial amyotrophic lateral sclerosis	6.13E-03	 	 	 	 	BCL2L1,OPTN	2	
Dental Disease, Digestive System Development and Function, Gastrointestinal Disease, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	abnormal morphology	Abnormal morphology of cementum	6.33E-03	 	 	 	 	ALPL	1	
Hematological System Development and Function, Immunological Disease, Lymphoid Tissue Structure and Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	abnormal morphology	Abnormal morphology of pale spleen	6.33E-03	 	 	 	 	ALPL	1	
Amino Acid Metabolism, Small Molecule Biochemistry	accumulation	Accumulation of glutamine	6.33E-03	 	 	 	 	GLUL	1	
Post-Translational Modification	activation	Activation of glycoprotein	6.33E-03	 	 	 	 	CTSB	1	
Neurological Disease	alpha-synucleinopathy	Alpha-synucleinopathy	6.33E-03	 	 	 	 	SNCA	1	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	angiogenesis	Angiogenesis of pancreatic endocrine tumor	6.33E-03	 	 	 	 	CTSB	1	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	apoptosis	Apoptosis of cultured osteosarcoma cells	6.33E-03	 	 	 	 	BCL2L1	1	
Cell Death and Survival	apoptosis	Apoptosis of skin-derived mast cells	6.33E-03	 	 	 	 	BCL2L1	1	
Neurological Disease, Organismal Injury and Abnormalities	atrophy	Atrophy of olivary nucleus	6.33E-03	 	 	 	 	SNCA	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	axonal Charcot-Marie-Tooth disease type 2T	Axonal Charcot-Marie-Tooth disease type 2T	6.33E-03	 	 	 	 	MME	1	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	beta-catenin activating mutation positive hepatocellular adenoma	Beta-catenin activating mutation positive hepatocellular adenoma	6.33E-03	 	 	 	 	GLUL	1	
Cell Death and Survival	cell viability	Cell viability of bladder cell lines	6.33E-03	 	 	 	 	BCL2L1	1	
Cellular Response to Therapeutics	chemotherapy resistance	Chemotherapy resistance of chronic lymphocytic leukemia cells	6.33E-03	 	 	 	 	BCL2L1	1	
Carbohydrate Metabolism, Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	clearance	Clearance of choline-phospholipid	6.33E-03	 	 	 	 	ABCA1	1	
Drug Metabolism	cleavage	Cleavage of coumarin	6.33E-03	 	 	 	 	CTSB	1	
Embryonic Development, Organismal Development, Tissue Development, Tissue Morphology	closure	Closure of otic vesicle	6.33E-03	 	 	 	 	BCL2L1	1	
Cell-To-Cell Signaling and Interaction, Inflammatory Response	cytotoxic reaction	Cytotoxic reaction of nervous tissue cell lines	6.33E-03	 	 	 	 	SNCA	1	
Cell Death and Survival, Cellular Compromise, Nervous System Development and Function	cytotoxicity	Cytotoxicity of dopaminergic neurons	6.33E-03	 	 	 	 	SNCA	1	
Cell Death and Survival, Drug Metabolism, Lipid Metabolism, Small Molecule Biochemistry	cytotoxicity	Cytotoxicity of paclitaxel	6.33E-03	 	 	 	 	BCL2L1	1	
Cellular Development	dedifferentiation	Dedifferentiation of hepatoma cell lines	6.33E-03	 	 	 	 	BSG	1	
Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	deformation	Deformation of vertebral column	6.33E-03	 	 	 	 	NFIX	1	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Tissue Morphology	degeneration	Degeneration of myelin figure	6.33E-03	 	 	 	 	SNCA	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	clearance	Delay in clearance of triacylglycerol	6.33E-03	 	 	 	 	ABCA1	1	
Cellular Development	differentiation	Delay in initiation of differentiation of lung cell lines	6.33E-03	 	 	 	 	CTSB	1	
Gene Expression	derepression	Derepression of RNA	6.33E-03	 	 	 	 	UBB	1	
Cellular Compromise	destabilization	Destabilization of lipid bilayer	6.33E-03	 	 	 	 	BCL2L1	1	
Cardiovascular System Development and Function	development	Development of microvasculature	6.33E-03	 	 	 	 	CTSB	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	dissociation	Dissociation of ADP	6.33E-03	 	 	 	 	BAG1	1	
Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities, Renal and Urological Disease	distal renal tubular acidosis with hemolytic anemia	Distal renal tubular acidosis with hemolytic anemia	6.33E-03	 	 	 	 	SLC4A1	1	
Cellular Compromise	dysfunction	Dysfunction of regulatory T lymphocytes	6.33E-03	 	 	 	 	SNCA	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry, Vitamin and Mineral Metabolism	efflux	Efflux of vitamin E	6.33E-03	 	 	 	 	ABCA1	1	
Cell Death and Survival, Cellular Assembly and Organization	engulfment	Engulfment of apoptotic bodies	6.33E-03	 	 	 	 	ABCA1	1	
Cellular Function and Maintenance, Molecular Transport	exocytosis	Exocytosis of L-glutamic acid	6.33E-03	 	 	 	 	SNCA	1	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Humoral Immune Response, Lymphoid Tissue Structure and Development	expansion	Expansion of pro-B lymphocytes	6.33E-03	 	 	 	 	BCL2L1	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance, Nervous System Development and Function	extension	Extension of parallel fiber	6.33E-03	 	 	 	 	NFIX	1	
Cellular Development	fate determination	Fate determination of myeloma cell lines	6.33E-03	 	 	 	 	BCL6	1	
Cellular Assembly and Organization, Tissue Development	formation	Formation of protofibrils	6.33E-03	 	 	 	 	SNCA	1	
Cell-To-Cell Signaling and Interaction	function	Function of dopamine	6.33E-03	 	 	 	 	SNCA	1	
Hematological System Development and Function	half-life	Half-life of blood platelets	6.33E-03	 	 	 	 	BCL2L1	1	
Cardiovascular Disease, Connective Tissue Disorders, Developmental Disorder, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	hereditary pyropoikilocytosis	Hereditary pyropoikilocytosis	6.33E-03	 	 	 	 	SPTB	1	
Developmental Disorder, Hematological Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	high density lipoprotein deficiency type 2	High density lipoprotein deficiency type 2	6.33E-03	 	 	 	 	ABCA1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	In situ follicular neoplasia	In situ follicular neoplasia	6.33E-03	 	 	 	 	MME	1	
Amino Acid Metabolism, Small Molecule Biochemistry	inactivation	Inactivation of L-glutamic acid	6.33E-03	 	 	 	 	GLUL	1	
Lipid Metabolism, Small Molecule Biochemistry	incorporation	Incorporation of linoleic acid	6.33E-03	 	 	 	 	ACSL1	1	
Infectious Diseases	infectivity	Infectivity of Sclerotinia sclerotiorum	6.33E-03	 	 	 	 	BCL2L1	1	
Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	inflammation	Inflammation of substantia nigra	6.33E-03	 	 	 	 	SNCA	1	
Cellular Growth and Proliferation	inhibition	Inhibition of carcinoma cell lines	6.33E-03	 	 	 	 	BCL2L1	1	
Immunological Disease, Organismal Injury and Abnormalities	injury	Injury of spleen	6.33E-03	 	 	 	 	MAP2K3	1	
Lipid Metabolism, Small Molecule Biochemistry	internalization	Internalization of arachidonic acid	6.33E-03	 	 	 	 	ACSL1	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	internalization	Internalization of docosahexaenoic acid	6.33E-03	 	 	 	 	ACSL1	1	
Lipid Metabolism, Small Molecule Biochemistry	internalization	Internalization of oleic acid	6.33E-03	 	 	 	 	ACSL1	1	
Cell Death and Survival	internucleosomal DNA fragmentation	Internucleosomal DNA fragmentation of lymphoma cell lines	6.33E-03	 	 	 	 	BCL2L1	1	
Carbohydrate Metabolism, Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	localization	Localization of phosphatidylinositol-3,4,5-triphosphate	6.33E-03	 	 	 	 	MPP1	1	
Connective Tissue Disorders, Organismal Injury and Abnormalities	loss	Loss of retroperitoneal fat pad	6.33E-03	 	 	 	 	ABCA1	1	
Lipid Metabolism, Small Molecule Biochemistry	loss	Loss of sterol	6.33E-03	 	 	 	 	ABCA1	1	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	bile duct carcinoma	Malignant bile duct carcinoma	6.33E-03	 	 	 	 	ALPL	1	
Cellular Movement	migration	Migration of glioblastoma cells	6.33E-03	 	 	 	 	CTSB	1	
Embryonic Development, Organ Development, Organ Morphology, Organismal Development, Reproductive System Development and Function, Tissue Development	morphogenesis	Morphogenesis of placenta	6.33E-03	 	 	 	 	ABCA1	1	
Cell Signaling, Vitamin and Mineral Metabolism	movement	Movement of Ca2+	6.33E-03	 	 	 	 	BCL2L1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	pediatric-type follicular lymphoma	Pediatric-type follicular lymphoma	6.33E-03	 	 	 	 	BCL6	1	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	primary biliary tract carcinoma	Primary biliary tract carcinoma	6.33E-03	 	 	 	 	ALPL	1	
Cellular Assembly and Organization	production	Production of cellular inclusion bodies	6.33E-03	 	 	 	 	SNCA	1	
Cardiovascular System Development and Function, Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Digestive System Development and Function, Hepatic System Development and Function, Organ Development, Organismal Development, Skeletal and Muscular System Development and Function, Tissue Development	proliferation	Proliferation of hepatic stellate cells/myofibroblasts	6.33E-03	 	 	 	 	CTSB	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities, Tumor Morphology	proliferation	Proliferation of pancreatic endocrine tumor	6.33E-03	 	 	 	 	CTSB	1	
Cancer, Cardiovascular Disease, Organismal Injury and Abnormalities	pyogenic granuloma	Pyogenic granuloma	6.33E-03	 	 	 	 	BCL2L1	1	
Cellular Assembly and Organization	quantity	Quantity of autolysosomes	6.33E-03	 	 	 	 	OPTN	1	
Carbohydrate Metabolism	quantity	Quantity of ribose	6.33E-03	 	 	 	 	SLC2A1	1	
Cell Cycle	quiescence	Quiescence of neural stem cells	6.33E-03	 	 	 	 	NFIX	1	
Cell Cycle	quiescence	Quiescence of stem cell lines	6.33E-03	 	 	 	 	NFIX	1	
Drug Metabolism, Small Molecule Biochemistry	release	Release of quinacrine	6.33E-03	 	 	 	 	ABCA1	1	
Developmental Disorder, Hematological Disease, Hereditary Disorder, Infectious Diseases, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	resistance to cerebral malaria	Resistance to cerebral malaria	6.33E-03	 	 	 	 	SLC4A1	1	
Cell-To-Cell Signaling and Interaction, Drug Metabolism, Molecular Transport, Small Molecule Biochemistry	reuptake	Reuptake of dopamine	6.33E-03	 	 	 	 	SNCA	1	
Behavior	reward learning	Reward learning	6.33E-03	 	 	 	 	SNCA	1	
Lipid Metabolism, Post-Translational Modification, Small Molecule Biochemistry	sialylation	Sialylation of ganglioside M1b	6.33E-03	 	 	 	 	ST6GALNAC4	1	
Cell Morphology, Cellular Development, Embryonic Development, Tissue Development	stratification	Stratification of keratinocyte cancer cell lines	6.33E-03	 	 	 	 	BAG1	1	
Cell Death and Survival, Visual System Development and Function	survival	Survival of RPE cells	6.33E-03	 	 	 	 	BCL2L1	1	
Immunological Disease, Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	experimental autoimmune encephalomyelitis	Symptomatic experimental autoimmune encephalomyelitis	6.33E-03	 	 	 	 	BSG	1	
Inflammatory Response	T cell-dependent B cell activation	T cell-dependent B cell activation by T lymphocytes	6.33E-03	 	 	 	 	BCL6	1	
Cellular Development	transition	Transition of adventitial fibroblasts	6.33E-03	 	 	 	 	ADIPOR1	1	
Cell Morphology, Cellular Function and Maintenance	transmembrane potential	Transmembrane potential of liposome	6.33E-03	 	 	 	 	BCL2L1	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of mannose	6.33E-03	 	 	 	 	SLC2A1	1	
Cellular Function and Maintenance, Hematopoiesis, Humoral Immune Response	turnover	Turnover of transitional B lymphocytes	6.33E-03	 	 	 	 	BCL2L1	1	
Gastrointestinal Disease, Immunological Disease, Organismal Injury and Abnormalities	type II refractory celiac disease	Type II refractory celiac disease	6.33E-03	 	 	 	 	BCL2L1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of creatine	6.33E-03	 	 	 	 	SLC6A8	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of glycerol	6.33E-03	 	 	 	 	AQP9	1	
Cell Morphology, Cellular Compromise	vacuolation	Vacuolation of cisternae	6.33E-03	 	 	 	 	BCL2L1	1	
Cardiovascular System Development and Function	vasoconstriction	Vasoconstriction of umbilical artery	6.33E-03	 	 	 	 	MME	1	
Cancer, Organismal Injury and Abnormalities	liquid tumor	Liquid tumor	6.34E-03	 	 	 	 	STRADB,MME,PYGL,DPM2,ABCA1,BAG1,SAMD9L,SLC2A1,BCL6,DCAF12,FKBP8,SLC6A8,NFIX,UBB,KCNJ15,BCL2L1,DDX60L,OPTN,ST6GALNAC4	19	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	apoptosis	Apoptosis of tumor cells	6.44E-03	 	-1.195	 	-1.029	CTSB,BAG1,FOXO4,BCL2L1,BSG	5	
Cell-To-Cell Signaling and Interaction, Molecular Transport, Small Molecule Biochemistry	transport	Transport of neurotransmitter	6.46E-03	 	 	 	 	SNCA,MAP2K3	2	
Cancer, Organismal Injury and Abnormalities	cancer	Cancer of secretory structure	6.75E-03	 	 	 	 	C9orf78,BNIP3L,ADIPOR1,BLVRB,PARP9,GLRX5,SNCA,PPDPF,ST6GALNAC4,UBXN6,HDGF,MME,SIAH2,GRINA,MGAM,IGF2BP2,ALPL,BCL6,MXI1,CRISPLD2,CREB5,NTNG2,NFIX,UBB,BCL2L1,SPTB,SNX3,GYPC,GLUL,PHOSPHO1,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,YBX1,DDX60L,OPTN,LYL1,SLC4A1,STRADB,MPP1,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,FAM210B,DCAF12,CTSB,SLC38A5,AP2A1	56	
Post-Translational Modification	ubiquitination	Ubiquitination of protein	6.76E-03	 	 	 	 	UBA52,SNCA,UBE2H,RNF10,SIAH2,UBB	6	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	encephalopathy	Autosomal dominant encephalopathy	7.01E-03	 	 	 	 	SNCA,MME,SAMD9L,SLC2A1	4	
Cell Death and Survival, Organismal Injury and Abnormalities	cell death	Cell death of epithelial cells	7.08E-03	 	0.200	 	0.076	BCL6,SNCA,FKBP8,CTSB,BNIP3L,BAG1,BCL2L1	7	
Cellular Assembly and Organization, Neurological Disease, Organismal Development, Tissue Development	formation	Formation of amyloid fibrils	7.14E-03	 	 	 	 	SNCA,MME	2	
Cell Morphology, Cellular Function and Maintenance	mitochondrial membrane potential	Mitochondrial membrane potential	7.14E-03	 	 	 	 	UBB,BCL2L1	2	
Small Molecule Biochemistry	synthesis	Synthesis of amine	7.18E-03	 	 	 	 	SNCA,SLC6A8,PHOSPHO1	3	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	hematologic cancer	Hematologic cancer	7.20E-03	 	0.195	 	0.571	STRADB,MME,PYGL,DPM2,ABCA1,BAG1,OAS2,SAMD9L,SLC2A1,ALPL,BCL6,MXI1,RBM38,DCAF12,FKBP8,SLC6A8,NFIX,UBB,MAP2K3,KCNJ15,BCL2L1,DDX60L,OPTN,ST6GALNAC4	24	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	colony formation	Colony formation of cancer cells	7.49E-03	 	 	 	 	HDGF,CTSB	2	
Cell Death and Survival	killing	Killing of lymphoma cell lines	7.49E-03	 	 	 	 	BCL6,BCL2L1	2	
Cellular Assembly and Organization	quantity	Quantity of granules	7.49E-03	 	 	 	 	SNCA,YBX1	2	
Cellular Function and Maintenance	respiration	Respiration of mitochondria	7.49E-03	 	 	 	 	ACSL1,BCL2L1	2	
Cellular Development, Cellular Growth and Proliferation	cell proliferation	Cell proliferation of tumor cell lines	7.50E-03	 	1.665	 	0.840	HDGF,SIAH2,ADIPOR1,BAG1,FOXO4,SAMD9L,SLC2A1,BSG,BCL6,MXI1,RBM38,SNCA,CTSB,MAP2K3,BCL2L1,YBX1	16	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of cholesterol	7.50E-03	 	 	 	 	ACSL1,ABCA1,MAP2K3	3	
Infectious Diseases, Inflammatory Disease, Organismal Injury and Abnormalities, Respiratory Disease	severe acute respiratory syndrome	Severe acute respiratory syndrome	7.50E-03	 	 	 	 	GLUL,ACSL1,PYGL	3	
Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of thoracic cavity	7.52E-03	 	 	 	 	ALPL,BCL6,ACSL1,SLC6A8,CTSB,ABCA1,MAP2K3,GLRX5,BCL2L1,SLC4A1	10	
Inflammatory Response	inflammation	Inflammation of body cavity	7.56E-03	 	-1.772	bias	-0.936	MGAM,BCL6,MME,CTSB,ABCA1,MAP2K3,GLRX5,BCL2L1,DDX60L,BSG	10	
Infectious Diseases	infection	Infection of cells	7.62E-03	Increased	2.972	bias	 	UBE2H,RNF10,CTSB,PARP9,AP2A1,YBX1,SLC2A1,DDX60L,BSG	9	
Carbohydrate Metabolism, Molecular Transport	transport	Transport of carbohydrate	7.63E-03	 	 	 	 	AQP9,ABCA1,MAP2K3,SLC2A1	4	
Cell Morphology, Cellular Function and Maintenance	macroautophagy	Macroautophagy of cells	7.84E-03	 	 	 	 	UBXN6,SNCA,BNIP3L	3	
Connective Tissue Development and Function, Tissue Morphology	quantity	Quantity of fibroblast cell lines	7.85E-03	 	 	 	 	BCL6,BCL2L1	2	
Cell Cycle	senescence	Senescence of cells	8.16E-03	 	 	 	 	BCL6,RBM38,MAP2K3,BCL2L1,YBX1	5	
Cell Death and Survival, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	necrosis	Necrosis of pancreas	8.17E-03	 	 	 	 	MME,CTSB,BCL2L1	3	
Cellular Function and Maintenance	function	Function of blood cells	8.19E-03	 	 	 	 	BCL6,AQP9,ABCA1,MAP2K3,BCL2L1,SLC2A1,LYL1	7	
Cell Death and Survival	apoptosis	Apoptosis of oligodendrocytes	8.21E-03	 	 	 	 	SNCA,BCL2L1	2	
Neurological Disease, Organismal Injury and Abnormalities	neurodegeneration	Neurodegeneration of hippocampus	8.21E-03	 	 	 	 	SNCA,MME	2	
Gastrointestinal Disease, Hepatic System Disease, Inflammatory Disease, Organismal Injury and Abnormalities	primary sclerosing cholangitis	Primary sclerosing cholangitis	8.21E-03	 	 	 	 	BCL2L1,BSG	2	
Neurological Disease	neurological disorder	Progressive neurological disorder	8.24E-03	 	 	 	 	SNCA,RNF10,CTSB,UBB,BCL2L1,SLC2A1,OPTN,BSG	8	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	disorder of basal ganglia	Disorder of basal ganglia	8.25E-03	 	 	 	 	GYPC,BCL6,SNCA,RNF10,UBB,BCL2L1,SLC2A1,DDX60L,OPTN	9	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	endocrine gland tumor	Endocrine gland tumor	8.36E-03	 	 	 	 	ADIPOR1,APOBEC3A,FOXO4,BLVRB,PARP9,GLRX5,SNCA,PPDPF,ST6GALNAC4,UBXN6,HDGF,MME,SIAH2,GRINA,MGAM,IGF2BP2,BCL6,MXI1,CRISPLD2,NTNG2,NFIX,BCL2L1,SPTB,SNX3,GLUL,PHOSPHO1,PITHD1,BSG,ACSL1,FKBP8,SLC6A8,GBP5,YBX1,DDX60L,OPTN,LYL1,SLC4A1,STRADB,MPP1,ASCC2,PYGL,RNF10,ANK1,ABCA1,BAG1,OAS2,SLC2A1,FAM210B,DCAF12,CTSB,SLC38A5,AP2A1	52	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy of cervical cancer cell lines	8.59E-03	 	 	 	 	SNCA,BCL2L1	2	
Cancer, Cell-To-Cell Signaling and Interaction, Inflammatory Response	cytotoxic reaction	Cytotoxic reaction of tumor cell lines	8.59E-03	 	 	 	 	SNCA,BCL2L1	2	
Lymphoid Tissue Structure and Development, Organ Morphology, Tissue Morphology	quantity	Quantity of white pulp	8.59E-03	 	 	 	 	MXI1,RBM38	2	
Cell Death and Survival, Cellular Development, Cellular Function and Maintenance	self-renewal	Self-renewal of blood cells	8.59E-03	 	 	 	 	BCL6,FOXO4	2	
Hematological System Development and Function	hematocrit	Hematocrit	8.70E-03	 	 	 	 	RBM38,BNIP3L,SLC4A1	3	

Tox Functions for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Renal Necrosis/Cell Death	cell viability	Cell viability of kidney cell lines	1.92E-04	 	 	 	 	BCL6,APOBEC3A,BCL2L1,SLC2A1	4	
Cardiac Necrosis/Cell Death	apoptosis	Apoptosis of cardiomyocytes	8.66E-04	 	-0.580	 	-0.146	ACSL1,BNIP3L,BAG1,MAP2K3,BCL2L1	5	
Cardiac Enlargement	enlargement	Enlargement of heart	2.34E-03	 	 	 	 	ACSL1,SLC6A8,CTSB,ABCA1,MAP2K3,GLRX5,BCL2L1,SLC4A1	8	
Liver Damage	hepatic injury	Hepatic injury	2.82E-03	 	0.762	 	0.836	MGAM,CTSB,MAP2K3,BCL2L1,BSG	5	
Increased Levels of Hematocrit	hematocrit	Increased Levels of Hematocrit	3.63E-03	 	 	 	 	RBM38,BNIP3L,SLC4A1	3	
Liver Hyperplasia/Hyperproliferation	liver adenoma	Hepatocellular adenoma	5.50E-03	 	 	 	 	GLUL,SLC2A1	2	
Liver Hyperplasia/Hyperproliferation	beta-catenin activating mutation positive hepatocellular adenoma	Beta-catenin activating mutation positive hepatocellular adenoma	6.33E-03	 	 	 	 	GLUL	1	
Liver Fibrosis, Liver Proliferation	proliferation	Proliferation of hepatic stellate cells/myofibroblasts	6.33E-03	 	 	 	 	CTSB	1	
Cardiac Dysfunction	dysfunction	Dysfunction of heart	8.76E-03	 	 	 	 	MME,ABCA1,SLC2A1,SLC4A1	4	
Cardiac Dysfunction, Heart Failure	chronic systolic heart failure	Chronic systolic heart failure	9.47E-03	 	 	 	 	MME	1	
Cardiac Proliferation	proliferation	Proliferation of adventitial fibroblasts	9.47E-03	 	 	 	 	ADIPOR1	1	
Renal Necrosis/Cell Death	cell death	Cell death of kidney cell lines	9.59E-03	 	-0.404	bias	-0.858	BCL6,SNCA,BNIP3L,BAG1,BCL2L1	5	
Liver Hypoplasia	hypoplasia	Liver Hypoplasia	9.75E-03	 	 	 	 	BAG1,YBX1	2	
Renal Atrophy	atrophy of kidney	Atrophy of kidney	1.02E-02	 	 	 	 	MXI1,SLC4A1	2	
Renal Damage, Renal Tubule Injury	damage	Damage of tubular cells	1.26E-02	 	 	 	 	YBX1	1	
Heart Failure	heart failure with preserved ejection fraction	Heart failure with preserved ejection fraction	1.57E-02	 	 	 	 	MME	1	
Renal Necrosis/Cell Death	apoptosis	Apoptosis of kidney cell lines	1.60E-02	 	 	 	 	BCL6,SNCA,BNIP3L,BCL2L1	4	
Renal Inflammation, Renal Nephritis	membranoproliferative glomerulonephritis	Membranoproliferative glomerulonephritis	1.89E-02	 	 	 	 	ABCA1	1	
Renal Inflammation, Renal Nephritis	autoimmune glomerulonephritis	Autoimmune glomerulonephritis	2.14E-02	 	 	 	 	MME,ABCA1	2	
Cardiac Dilation, Cardiac Enlargement	dilated cardiomyopathy	Dilated cardiomyopathy	2.15E-02	 	 	 	 	ACSL1,SLC6A8,BCL2L1,GLRX5	4	
Liver Hyperplasia/Hyperproliferation	liver tumor	Liver tumor	2.17E-02	 	 	 	 	GLUL,C9orf78,ADIPOR1,BSG,ACSL1,FKBP8,MAP2K3,KCNJ15,YBX1,DDX60L,SLC4A1,ST6GALNAC4,STRADB,UBXN6,ASCC2,MME,PYGL,RNF10,ANK1,ABCA1,SAMD9L,SLC2A1,FAM210B,MGAM,ALPL,BCL6,RBM38,CREB5,CTSB,NFIX,UBB,BCL2L1,SPTB	33	
Cardiac Arteriopathy	premature coronary artery disease	Early-onset premature coronary artery disease	2.20E-02	 	 	 	 	ABCA1	1	
Heart Failure	cardiac death	Cardiac death	2.42E-02	 	 	 	 	MGAM,MME	2	
Liver Hyperplasia/Hyperproliferation	cancer	Liver cancer	2.49E-02	 	 	 	 	GLUL,C9orf78,ADIPOR1,BSG,ACSL1,FKBP8,MAP2K3,KCNJ15,DDX60L,SLC4A1,ST6GALNAC4,STRADB,UBXN6,ASCC2,MME,PYGL,RNF10,ANK1,ABCA1,SAMD9L,SLC2A1,MGAM,ALPL,BCL6,CREB5,CTSB,NFIX,BCL2L1,SPTB	29	
Cardiac Dysfunction	left ventricular dysfunction	Left ventricular dysfunction	2.60E-02	 	 	 	 	MME,ABCA1,SLC4A1	3	
Liver Damage, Liver Inflammation/Hepatitis	chronic hepatitis C	Chronic hepatitis C	2.61E-02	 	 	 	 	MGAM,BCL2L1	2	
Renal Atrophy	atrophy	Atrophy of renal medulla	2.82E-02	 	 	 	 	SLC4A1	1	
Liver Inflammation/Hepatitis	fulminant hepatitis	Fulminant hepatitis	2.82E-02	 	 	 	 	BCL2L1	1	
Glomerular Injury, Renal Atrophy	atrophy	Atrophy of renal glomerulus	3.12E-02	 	 	 	 	MXI1	1	
Renal Inflammation, Renal Nephritis	idiopathic membranous nephropathy	Idiopathic membranous nephropathy	3.12E-02	 	 	 	 	MME	1	
Renal Atrophy	atrophy	Atrophy of renal cortex	3.43E-02	 	 	 	 	MXI1	1	
Cardiac Fibrosis	fibrosis	Fibrosis of heart	3.94E-02	 	 	 	 	BCL6,ACSL1,SLC4A1	3	
Renal Damage	damage	Damage of kidney	4.03E-02	 	 	 	 	MME,MAP2K3,YBX1	3	
Liver Cirrhosis	primary biliary cirrhosis	Primary biliary cirrhosis	4.09E-02	 	 	 	 	ALPL,BSG	2	
Liver Steatosis	hepatic steatosis	Hepatic steatosis	4.17E-02	 	 	 	 	RBM38,ACSL1,ABCA1,DDX60L	4	
Liver Cirrhosis	cirrhosis	Cirrhosis of liver	4.20E-02	 	 	 	 	ALPL,DDX60L,BSG	3	
Increased Levels of Red Blood Cells	quantity	Increased Levels of Red Blood Cells	4.31E-02	 	 	 	 	BNIP3L,SLC4A1	2	
Increased Levels of Creatinine	clearance	Increased clearance of creatinine	4.35E-02	 	 	 	 	SLC4A1	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatocellular carcinoma	Hepatocellular carcinoma	4.47E-02	 	 	 	 	MGAM,GLUL,MME,SAMD9L,BCL2L1,DDX60L,SLC4A1,BSG	8	
Liver Inflammation/Hepatitis	inflammation	Inflammation of liver	5.78E-02	 	 	 	 	MGAM,BCL6,BCL2L1,DDX60L	4	
Cardiac Enlargement	hypertrophy	Hypertrophy of heart	6.51E-02	 	 	 	 	CTSB,ABCA1,MAP2K3,SLC4A1	4	
Renal Degeneration	degeneration	Degeneration of kidney	7.04E-02	 	 	 	 	MXI1	1	
Renal Dysfunction	dysfunction	Dysfunction of kidney	7.34E-02	 	 	 	 	BSG	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatocellular carcinoma	Unresectable hepatocellular carcinoma	7.34E-02	 	 	 	 	BSG	1	
Liver Steatosis	microvesicular hepatic steatosis	Microvesicular hepatic steatosis	7.63E-02	 	 	 	 	ACSL1	1	
Liver Necrosis/Cell Death	necrosis	Necrosis of liver	7.77E-02	 	 	 	 	MME,CTSB,BCL2L1	3	
Liver Hyperplasia/Hyperproliferation	development	Development of liver tumor	7.83E-02	 	 	 	 	RBM38,BSG	2	
Cardiac Dilation	dilation	Dilation of left ventricle	8.21E-02	 	 	 	 	SLC2A1	1	
Cardiac Enlargement	right ventricular hypertrophy	Right ventricular hypertrophy	8.51E-02	 	 	 	 	ABCA1	1	
Cardiac Fibrosis	interstitial fibrosis	Interstitial fibrosis of heart	9.09E-02	 	 	 	 	ACSL1	1	
Pulmonary Hypertension	primary pulmonary hypertension	Primary pulmonary hypertension	9.09E-02	 	 	 	 	BCL2L1	1	
Liver Necrosis/Cell Death	apoptosis	Apoptosis of hepatocytes	9.44E-02	 	 	 	 	CTSB,BCL2L1	2	
Cardiac Necrosis/Cell Death	cell viability	Cell viability of cardiomyocytes	9.95E-02	 	 	 	 	ADIPOR1	1	
Liver Fibrosis	fibrosis	Fibrosis of liver	1.02E-01	 	 	 	 	HDGF,CTSB	2	
Renal Inflammation, Renal Nephritis	IgA nephropathy	IgA nephropathy	1.08E-01	 	 	 	 	ABCA1	1	
Renal Damage	injury	Injury of kidney	1.13E-01	 	 	 	 	MME,MAP2K3	2	
Heart Failure	failure	Failure of heart	1.16E-01	 	 	 	 	MGAM,MME,BCL2L1	3	
Cardiac Enlargement	hypertrophy	Hypertrophy of heart cells	1.20E-01	 	 	 	 	CTSB,MAP2K3	2	
Cardiac Damage	injury	Injury of heart	1.22E-01	 	 	 	 	MAP2K3	1	
Liver Hyperplasia/Hyperproliferation	liver carcinoma	Liver carcinoma	1.23E-01	 	 	 	 	GLUL,C9orf78,ADIPOR1,BSG,ACSL1,FKBP8,MAP2K3,KCNJ15,DDX60L,SLC4A1,ST6GALNAC4,STRADB,UBXN6,ASCC2,MME,PYGL,RNF10,ANK1,ABCA1,SAMD9L,MGAM,CREB5,NFIX,BCL2L1,SPTB	25	
Liver Necrosis/Cell Death	cell death	Cell death of liver cell lines	1.25E-01	 	 	 	 	BCL2L1	1	
Liver Inflammation/Hepatitis, Liver Steatosis	nonalcoholic steatohepatitis	Nonalcoholic steatohepatitis	1.30E-01	 	 	 	 	DDX60L	1	
Heart Failure	acute heart failure	Acute heart failure	1.33E-01	 	 	 	 	MME	1	
Cardiac Inflammation	myocarditis	Myocarditis	1.39E-01	 	 	 	 	BCL6	1	
Cardiac Inflammation	inflammation	Inflammation of heart	1.44E-01	 	 	 	 	BCL6	1	
Bradycardia, Cardiac Arrythmia	bradycardia	Bradycardia	1.50E-01	 	 	 	 	AQP9	1	
Cardiac Dysfunction	left ventricular dilation	Left ventricular dilation	1.50E-01	 	 	 	 	SLC4A1	1	
Liver Cholestasis	progressive familial intrahepatic cholestasis type 1	Progressive familial intrahepatic cholestasis type 1	1.71E-01	 	 	 	 	ACSL1	1	
Renal Inflammation, Renal Nephritis	nephritis	Nephritis	1.96E-01	 	 	 	 	MME,ABCA1,YBX1	3	
Increased Levels of Alkaline Phosphatase	quantity	Increased Levels of Alkaline Phosphatase	2.25E-01	 	 	 	 	ALPL	1	
Renal Damage	acute kidney injury	Acute kidney injury	2.44E-01	 	 	 	 	MME	1	
Renal Damage, Renal Tubule Injury	proximal tubular toxicity	Proximal tubular toxicity	2.56E-01	 	 	 	 	YBX1	1	
Cardiac Infarction	infarction	Infarction of heart	2.59E-01	 	 	 	 	MGAM,BCL2L1	2	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	development	Development of hepatocellular carcinoma	2.93E-01	 	 	 	 	BSG	1	
Cardiac Dysfunction, Cardiac Enlargement	hypertrophy	Hypertrophy of left ventricle	2.95E-01	 	 	 	 	ABCA1	1	
Cardiac Arteriopathy	coronary artery disease	Coronary artery disease	3.19E-01	 	 	 	 	MGAM,ABCA1	2	
Cardiac Enlargement	hypertrophy	Hypertrophy of cardiomyocytes	3.99E-01	 	 	 	 	MAP2K3	1	
Glomerular Injury	glomerulosclerosis	Glomerulosclerosis	4.33E-01	 	 	 	 	ABCA1	1	
Cardiac Infarction	myocardial infarction	Myocardial infarction	6.21E-01	 	 	 	 	MGAM	1	

Regulator Effects for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Consistency Score	Node Total	Regulator Total	Regulators	Target Total	Target Molecules in Dataset	Disease & Function Total	Diseases & Functions	Known Regulator-Disease/Function Relationships
5.485	19	2	HNF4A,TCR	12	ADIPOR1,AP2A1,AQP9,BCL2L1,BCL6,BSG,CTSB,MPP1,PARP9,SIAH2,SLC2A1,YBX1	5	Cell viability of breast cancer cell lines,Infection by RNA virus,Infection of cells,Migration of cells,Organismal death	40% (4/10)	
2.000	6	1	STAT6	4	ACSL1,BCL2L1,BCL6,CTSB	1	Cellular homeostasis	100% (1/1)	
Networks for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
ID	Analysis	Molecules in Network	Score	Focus Molecules	Top Diseases and Functions	
1	Observation 1	ABCA1,ACSL1,ADIPOR1,AMPK,ANK1,AQP9,BAG1,BLVRB,BNIP3L,CRISPLD2,ERK1/2,FOXO4,FSH,GMPR,Growth hormone,Immunoglobulin,Insulin,JINK1/2,Lh,MAP1LC3,MAP2K3,N-cor,PI3K (family),PYGL,Proinsulin,RBM38,Rxr,SLC25A37,SLC2A1,SLC4A1,SLC6A8,SNX3,SPTB,TCF,hemoglobin	44	20	Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	
2	Observation 1	26s Proteasome,BCL2L1,BCL6,BCR (complex),CTSB,Calcineurin A,Ck2,Collagen type I,FKBP8,GBP5,GYPC,HDGF,Hsp70,Hsp90,IFN Beta,IGF2BP2,IL12 (complex),Ifn gamma,IgG,IgG2a,Igm,LYL1,MPP1,Mek,NFkB (complex),OPTN,RNF10,SNCA,Tgf beta,UBA52,UBB,UBE2H,Ubiquitin,YBX1,caspase	36	17	Cell Morphology, Cellular Function and Maintenance, Cancer	
3	Observation 1	AJAP1,AP2A1,APP,ARPP19,BOLA1,C3orf33,C9orf78,CTNNB1,DCAF12,DDX60L,DLG4,DTD2,ELAVL1,GLOD4,GLRX5,GRIN3A,GRINA,KCNJ15,MARCH10,MCFD2,MXI1,NMDA Receptor,NTNG2,OSBPL2,PATJ,PITHD1,RALGPS1,SETD3,SLC38A5,SLC48A1,SMARCA4,ST6GALNAC4,STRADB,UBXN6,VAMP2	28	14	Cell-To-Cell Signaling and Interaction, Nervous System Development and Function, Organ Morphology	
4	Observation 1	APOBEC3A,ASCC2,Akt,BSG,CD3,CREB5,Calmodulin,Creb,ERK,Focal adhesion kinase,GLUL,IL1,IL12 (family),Ifn,Interferon alpha,Jnk,MME,NFIX,OAS2,P38 MAPK,PARP9,PHOSPHO1,PI3K (complex),Pkc(s),Pro-inflammatory Cytokine,RAS,RNA polymerase II,SAMD9L,SIAH2,TCR,Tnf (family),Vegf,calpain,cytokine,trypsin	23	12	Connective Tissue Disorders, Inflammatory Disease, Organismal Injury and Abnormalities	
5	Observation 1	ADGRG1,ADGRG3,AGTR2,ALOX15,ALPL,ARHGEF12,Agtr1b,BAG1,BDKRB2,CCR6,DEFB103A/DEFB103B,DLX5,DPM1,DPM2,EDNRB,GRM2,GRP,HTR2B,HTT,LPAR2,Ldh (complex),Muscarinic cholinergic receptor,NUCB1,OPRK1,P2RY2,PIKFYVE,PLA2G6,PLCE1,PTGS2,Ppp1cc,RHOA,S1PR3,SIRPA,WISP1,mir-27	8	5	Cell-To-Cell Signaling and Interaction, Lipid Metabolism, Small Molecule Biochemistry	
6	Observation 1	MGAM,NCF1,ZMYND11,alpha-glucosidase,glucan 1,4-alpha-glucosidase	2	1	Carbohydrate Metabolism, Developmental Disorder, Hereditary Disorder	
7	Observation 1	ATP6V0D1,FAM210B,HTR2C,LPAR1,REEP5,RTN1,RTN4,TM4SF20,TSPAN17,TSPAN5	2	1	Cellular Assembly and Organization, DNA Replication, Recombination, and Repair, Cellular Function and Maintenance	

My Lists for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
My Lists	 -log(p-value)	Ratio	Molecules 

Tox Lists for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
Ingenuity Toxicity Lists	 -log(p-value)	Ratio	Molecules 
Cardiac Necrosis/Cell Death	3.44E00	2.01E-02	ACSL1,BNIP3L,ADIPOR1,BAG1,MAP2K3,BCL2L1
Renal Necrosis/Cell Death	2.7E00	1.24E-02	BCL6,SNCA,BNIP3L,BAG1,APOBEC3A,BCL2L1,SLC2A1
Increases Liver Damage	2.47E00	3.16E-02	CTSB,MAP2K3,BSG
Anti-Apoptosis	2.34E00	6.25E-02	BAG1,BCL2L1
Protection from Hypoxia-induced Renal Ischemic Injury (Rat)	1.9E00	2.5E-01	SLC2A1
Decreases Permeability Transition of Mitochondria and Mitochondrial Membrane	1.66E00	1.43E-01	BCL2L1
PPARα/RXRα Activation	1.64E00	1.56E-02	ADIPOR1,ABCA1,MAP2K3
Hormone Receptor Regulated Cholesterol Metabolism	1.6E00	1.25E-01	ABCA1
Cardiac Fibrosis	1.46E00	1.33E-02	BCL6,ACSL1,SLC4A1
Increases Renal Damage	1.44E00	2.11E-02	MAP2K3,YBX1
TGF-β Signaling	1.4E00	2.02E-02	UBB,MAP2K3
Swelling of Mitochondria	1.33E00	6.67E-02	BCL2L1
Decreases Transmembrane Potential of Mitochondria and Mitochondrial Membrane	1.21E00	1.56E-02	BNIP3L,BCL2L1
Increases Bradycardia	1.17E00	4.55E-02	AQP9
Liver Necrosis/Cell Death	1.1E00	9.43E-03	MME,CTSB,BCL2L1
Decreases Depolarization of Mitochondria and Mitochondrial Membrane	1.01E00	3.12E-02	BCL2L1
Cardiac Hypertrophy	9.56E-01	8.17E-03	CTSB,ABCA1,MAP2K3
Pro-Apoptosis	9.04E-01	2.38E-02	BNIP3L
Increases Transmembrane Potential of Mitochondria and Mitochondrial Membrane	8.33E-01	2E-02	BCL2L1
Increases Cardiac Dysfunction	7.67E-01	1.69E-02	SLC2A1
Increases Renal Nephritis	7.48E-01	1.61E-02	YBX1
LPS/IL-1 Mediated Inhibition of RXR Function	7.13E-01	7.84E-03	ACSL1,ABCA1
NRF2-mediated Oxidative Stress Response	7.11E-01	7.81E-03	UBB,MAP2K3
Hypoxia-Inducible Factor Signaling	7E-01	1.43E-02	UBE2H
TR/RXR Activation	5.65E-01	1E-02	SLC2A1
p53 Signaling	5.17E-01	8.77E-03	BCL2L1
Fatty Acid Metabolism	5.08E-01	8.55E-03	ACSL1
LXR/RXR Activation	4.9E-01	8.13E-03	ABCA1
Aryl Hydrocarbon Receptor Signaling	3.97E-01	6.21E-03	NFIX
Mitochondrial Dysfunction	3.75E-01	5.81E-03	SNCA
Liver Proliferation	2.63E-01	4.05E-03	CTSB
Xenobiotic Metabolism Signaling	0E00	2.72E-03	MAP2K3

My Pathways for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
My Pathways	 -log(p-value)	Ratio	Molecules 

Analysis Ready Molecules for My Projects->AIH_WGCNA->Unique to Elites - 2019-06-04 10:46 PM - 2019-06-04 10:50 PM->Observation 1
ID	Symbol	Expr Log Ratio	Expr p-value
ENSG00000165029	ABCA1	0.467479974221978	0.344581401769442
ENSG00000151726	ACSL1	0.398569873727836	0.514113789175057
ENSG00000182885	ADGRG3	0.365630368358488	0.488644014086714
ENSG00000159346	ADIPOR1	0.536255038149721	0.489292586406382
ENSG00000162551	ALPL	0.237160390850527	0.769502392913669
ENSG00000029534	ANK1	0.38138418830543	0.663084272313013
ENSG00000196961	AP2A1	0.29401575828936	0.63654870638194
ENSG00000128383	APOBEC3A	0.402113899260025	0.347476458628166
ENSG00000103569	AQP9	0.362682837541628	0.478954506951096
ENSG00000100325	ASCC2	0.384934015939277	0.588884910138858
ENSG00000107262	BAG1	0.394983066597917	0.557056235353402
ENSG00000171552	BCL2L1	0.459389874592405	0.586854342314452
ENSG00000113916	BCL6	0.424997353271395	0.402227590183282
ENSG00000090013	BLVRB	0.420182669679885	0.563767024288325
ENSG00000104765	BNIP3L	0.376224695431384	0.590432495933146
ENSG00000172270	BSG	0.575199107216044	0.425109186681359
ENSG00000136819	C9orf78	0.516377632764469	0.495575245148563
ENSG00000146592	CREB5	0.32426368881935	0.425440660524625
ENSG00000103196	CRISPLD2	0.584353317476802	0.286377841898858
ENSG00000164733	CTSB	0.281515974004937	0.530098106065239
ENSG00000198876	DCAF12	0.545617672373838	0.515967666929607
ENSG00000181381	DDX60L	0.419379033410147	0.329166317592562
ENSG00000136908	DPM2	0.423540483794023	0.567644337984751
ENSG00000124098	FAM210B	0.584686720017355	0.495895791991879
ENSG00000105701	FKBP8	0.594270620994597	0.503923784374098
ENSG00000184481	FOXO4	0.595086954503183	0.405030792737955
ENSG00000154451	GBP5	0.513642179731551	0.277446743193362
ENSG00000182512	GLRX5	0.556354859478104	0.492611851119882
ENSG00000135821	GLUL	0.441084418794783	0.321311844466016
ENSG00000137198	GMPR	0.59810865032055	0.489991958575088
ENSG00000178719	GRINA	0.354173919913931	0.592729680146891
ENSG00000136732	GYPC	0.573390732065675	0.440005452266609
ENSG00000143321	HDGF	0.524164791049796	0.433612428861693
ENSG00000073792	IGF2BP2	0.528916872172078	0.519761660000155
ENSG00000157551	KCNJ15	0.38247980542999	0.487138149218466
ENSG00000104903	LYL1	0.430621271083779	0.495575245148563
ENSG00000034152	MAP2K3	0.41547908713494	0.545083772964781
ENSG00000257335	MGAM	0.477060026984549	0.386467806760707
ENSG00000196549	MME	0.317221457919727	0.577940783674491
ENSG00000130830	MPP1	0.323967324817611	0.653123733368222
ENSG00000119950	MXI1	0.582743306709462	0.461187189903376
ENSG00000008441	NFIX	0.421416454882575	0.600735562685161
ENSG00000196358	NTNG2	0.313234006406556	0.540970706618287
ENSG00000104805	NUCB1	0.36435729723685	0.329166317592562
ENSG00000111335	OAS2	0.582577521014431	0.3734946880414
ENSG00000123240	OPTN	0.282803997096823	0.568221384979406
ENSG00000138496	PARP9	0.54907499135803	0.150528215231024
ENSG00000173868	PHOSPHO1	0.35019436769497	0.58736662964586
ENSG00000057757	PITHD1	0.516331167220546	0.53432471846568
ENSG00000125534	PPDPF	0.541369668230297	0.358811171328213
ENSG00000100504	PYGL	0.41231663210107	0.38304458344763
ENSG00000132819	RBM38	0.431959335626335	0.555202531307386
ENSG00000022840	RNF10	0.439510674281715	0.562761834279332
ENSG00000177409	SAMD9L	0.560984501743427	0.187631983436694
ENSG00000181788	SIAH2	0.535929081505292	0.447488127943194
ENSG00000147454	SLC25A37	0.442787610897752	0.543750728687838
ENSG00000117394	SLC2A1	0.284473282543485	0.560724027098635
ENSG00000017483	SLC38A5	0.354635773859012	0.702611103934313
ENSG00000004939	SLC4A1	0.47472187258691	0.599007496994791
ENSG00000130821	SLC6A8	0.510141469580899	0.569978953059114
ENSG00000145335	SNCA	0.460833155103929	0.573892114609618
ENSG00000112335	SNX3	0.520762018016348	0.393072426330497
ENSG00000070182	SPTB	0.559568865017976	0.51881432256459
ENSG00000136840	ST6GALNAC4	0.420407948889087	0.579338817257469
ENSG00000082146	STRADB	0.422732936816719	0.613823015091939
ENSG00000221983	UBA52	0.414856440413737	0.453973991305788
ENSG00000170315	UBB	0.422157813292332	0.585637186013708
ENSG00000186591	UBE2H	0.456609373274669	0.411665578744195
ENSG00000167671	UBXN6	0.413507485198889	0.578337188041462
ENSG00000065978	YBX1	0.48745331279195	0.433612428861693

